Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

Articles published in
Int J Infect Dis
    February 2024
  1. IKEBE T, Okuno R, Uchitani Y, Yamaguchi T, et al
    Epidemiological shifts in and impact of COVID-19 on streptococcal toxic shock syndrome in Japan: A genotypic analysis of Group A Streptococcus isolates.
    Int J Infect Dis. 2024 Feb 19:S1201-9712(24)00022.
    >> Share

  2. BERENTSCHOT JC, Martine Bek L, Heijenbrok-Kal MH, van den Berg-Emons RJG, et al
    Acute COVID-19 treatment is not associated with health problems 2 years after hospitalization.
    Int J Infect Dis. 2024 Feb 15:S1201-9712(24)00036.
    >> Share

  3. BIANCHI FP, Rizzi D, Daleno A, Stefanizzi P, et al
    Assessing the temporal and cause-effect relationship between myocarditis and mRNA COVID-19 vaccines. A retrospective observational study.
    Int J Infect Dis. 2024 Feb 14:S1201-9712(24)00028.
    >> Share

  4. TANG Q, Xie X, Peng L, Yang L, et al
    Pre-existing Renal Graft Dysfunction As A Major Risk Factor for SARS-CoV-2 Omicron Variant Pneumonia: a Post-Infection Cross-Sectional Study of 312 Immunosuppressed Renal Transplant Recipients.
    Int J Infect Dis. 2024 Feb 13:S1201-9712(24)00030.
    >> Share

  5. DOHERTY TM, Pasquale AD, Finnegan G, Lele J, et al
    Sustaining the momentum for adult vaccination post-COVID-19 to leverage the global uptake of life-course immunisation: a scoping review.
    Int J Infect Dis. 2024 Feb 12:S1201-9712(24)00031.
    >> Share

  6. FUENTE A, Postigo T, Ferri FS, Dominguez-Gil M, et al
    Synergistic impact of N-antigenemia profiled by a rapid antigen test and low anti-S1 antibodies on the risk of hospitalization in COVID-19.
    Int J Infect Dis. 2024 Feb 2:S1201-9712(24)00019.
    >> Share

  7. XIA Q, Yang Y, Wang F, Huang Z, et al
    Case fatality rates of COVID-19 during epidemic periods of variants of concern: a meta-analysis by continents.
    Int J Infect Dis. 2024 Feb 1:S1201-9712(24)00018.
    >> Share

    January 2024
  8. VOORDEN AJV, Groot CJM, Ris-Stalpers C, Afink GB, et al
    COVID-19 mRNA vaccination during pregnancy does not harm syncytiotrophoblast development.
    Int J Infect Dis. 2024 Jan 25:S1201-9712(24)00015.
    >> Share

    December 2023
  9. PUGNI L, Crippa BL, Raimondi F, Vento G, et al
    SARS-CoV-2 perinatal transmission and neonatal outcomes across four different waves of COVID-19 pandemic: a nationwide prospective cohort study from the Italian Society of Neonatology.
    Int J Infect Dis. 2023 Dec 27:S1201-9712(23)00814.
    >> Share

  10. BOWN A, Sweed A, Catton M, Cowne JN, et al
    Detection of SARS-CoV-2 BA.2.86 by lateral flow devices.
    Int J Infect Dis. 2023 Dec 25:S1201-9712(23)00813.
    >> Share

  11. SALMON D, Slama D, Linard F, Dumesges N, et al
    Long COVID patients continue to experience significant symptoms at 12 months and factors associated with improvement: a prospective cohort study in France (PERSICOR).
    Int J Infect Dis. 2023 Dec 21:S1201-9712(23)00798.
    >> Share

  12. SILI U MD, PHD, Tekin A MD, Bilgin H MD, MPH, Khan SA MD, et al
    Early empiric antibiotic use in COVID-19 patients: results from the international VIRUS registry.
    Int J Infect Dis. 2023 Dec 19:S1201-9712(23)00810.
    >> Share

  13. MICHAEL F, Mirambo MM, Misinzo G, Minzi O, et al
    Trends of measles in Tanzania: a five-year review of case-based surveillance data, 2018-2022.
    Int J Infect Dis. 2023 Dec 18:S1201-9712(23)00809.
    >> Share

  14. TICONA JPA, Xiao M, Li D, Nery N Jr, et al
    Extensive transmission of SARS-CoV-2 BQ.1* variant in a population with high levels of hybrid immunity: A prevalence survey.
    Int J Infect Dis. 2023 Dec 7:S1201-9712(23)00801.
    >> Share

  15. JUNYONG M, Wang Y, Liu J, Wu Y, et al
    Impact of perioperative SARS-CoV-2 Omicron infection on postoperative complications in liver cancer hepatectomy: A single-center matched study.
    Int J Infect Dis. 2023 Dec 6:S1201-9712(23)00803.
    >> Share

  16. SANTOS CAD, Paula AP, Filho GGF, Alves MM, et al
    Developmental impairment in children exposed during pregnancy to maternal SARS-COV2: A Brazilian cohort study.
    Int J Infect Dis. 2023 Dec 5:S1201-9712(23)00802.
    >> Share

  17. FINSTERER J, Scorza FA
    The frequency of SARS-CoV-2 infection/vaccination-related chorea depends on the inclusion/exclusion criteria.
    Int J Infect Dis. 2023;137:161.
    >> Share

  18. ROSCA EC, Bilavu R, Cornea A, Simu M, et al
    The frequency of SARS-CoV-2 infection/vaccination-related chorea depends on the inclusion/exclusion criteria - author's reply.
    Int J Infect Dis. 2023;137:159-160.
    >> Share

    November 2023
  19. FLORES-GONZALEZ J, Chavez-Galan L, Falfan-Valencia R, Roldan IB, et al
    Variant rs4986790 of TLR4 affects the signaling and induces cell dysfunction in severe COVID-19 patients.
    Int J Infect Dis. 2023 Nov 27:S1201-9712(23)00793.
    >> Share

  20. YOSHIMURA M, Sakamoto A, Ozuru R, Kurihara Y, et al
    The appearance of anti-spike RBD IgG4 responses after repetitive immunization with mRNA-based COVID-19 vaccines.
    Int J Infect Dis. 2023 Nov 27:S1201-9712(23)00789.
    >> Share

  21. MOSTAGHIM A, Minkove S, Aguilar-Company J, Ruiz-Camps I, et al
    Prior immune checkpoint inhibitor (ICI) therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry.
    Int J Infect Dis. 2023 Nov 27:S1201-9712(23)00782.
    >> Share

  22. TANDLER C, Heitmann JS, Michel TM, Marconato M, et al
    Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults.
    Int J Infect Dis. 2023 Nov 26:S1201-9712(23)00770.
    >> Share

  23. YANG X, Zhang J, Liu Z, Chen S, et al
    COVID-19 breakthrough infections among people with and without HIV: a statewide cohort analysis.
    Int J Infect Dis. 2023 Nov 25:S1201-9712(23)00790.
    >> Share

  24. HARRIES M, Jaeger VK, Rodiah I, Hassenstein MJ, et al
    Bridging the gap - estimation of 2022/2023 SARS-CoV-2 healthcare burden in Germany based on multidimensional data from a rapid epidemic panel.
    Int J Infect Dis. 2023 Nov 24:S1201-9712(23)00776.
    >> Share

  25. NAVARATNAM AM, O'Callaghan C, Beale S, Nguyen V, et al
    Eyeglasses and risk of COVID-19 transmission - analysis of the Virus Watch Community Cohort study.
    Int J Infect Dis. 2023 Nov 24:S1201-9712(23)00759.
    >> Share

  26. NGUYEN TTN, Choo EM, Nakamura Y, Suzuki R, et al
    Pre-existing cross-reactive neutralizing activity against SARS-CoV-2 and seasonal coronaviruses prior to the COVID-19 pandemic (2014-2019) with limited immunity against recent emerging SARS-CoV-2 variants, Vietnam.
    Int J Infect Dis. 2023 Nov 18:S1201-9712(23)00769.
    >> Share

  27. LI Y, Wu Z, Yan Y, Shi Y, et al
    Prevalence of respiratory viruses among hospitalized children with lower respiratory tract infections during the COVID-19 pandemic in Wuhan, China.
    Int J Infect Dis. 2023 Nov 18:S1201-9712(23)00780.
    >> Share

  28. BELLERBA F, Bardeck N, Boehm M, D'Ecclesiis O, et al
    SARS-CoV-2 trends in Italy, Germany and Portugal and school opening during the period of Omicron variant dominance: a quasi-experimental study.
    Int J Infect Dis. 2023 Nov 11:S1201-9712(23)00763.
    >> Share

  29. CHOGA WT, Kurusa Gasenna GK, San JE, Ookame T, et al
    Rapid dynamic changes of FL.2 variant: a case report of COVID-19 breakthrough infection.
    Int J Infect Dis. 2023 Nov 10:S1201-9712(23)00772.
    >> Share

  30. DALLMEYER LK, Schuz ML, Fragkou PC, Omony J, et al
    Epidemiology of respiratory viruses among children during the SARS-CoV-2 pandemic: A systematic review and meta-analysis.
    Int J Infect Dis. 2023 Nov 9:S1201-9712(23)00761.
    >> Share

  31. LOVELL JF, Miura K, Baik YO, Lee C, et al
    One-year Antibody Durability Induced by EuCorVac-19, a Liposome-Displayed COVID-19 RBD Subunit Vaccine, in Healthy Korean Subjects.
    Int J Infect Dis. 2023 Nov 7:S1201-9712(23)00765.
    >> Share

  32. LEE IT, Lin PJ, Yen HH
    Pediatric Neuroimaging Findings and Clinical Presentations of COVID-19: A Systematic Review.
    Int J Infect Dis. 2023 Nov 7:S1201-9712(23)00767.
    >> Share

    October 2023
  33. AGERGAARD J, Gunst JD, Schiottz-Christensen B, Ostergaard L, et al
    Long-term Prognosis at 1.5 years after Infection with Wild-type strain of SARS-CoV-2 and Alpha, Delta, as well as Omicron Variants.
    Int J Infect Dis. 2023 Oct 29:S1201-9712(23)00760.
    >> Share

  34. ROSSI G, Salmanton-Garcia J, Cattaneo C, Marchesi F, et al
    Age, Successive Waves, Immunization, and Mortality in Elderly COVID-19 Haematological Patients: EPICOVIDEHA Findings.
    Int J Infect Dis. 2023 Oct 18:S1201-9712(23)00749.
    >> Share

  35. RAVLO E, Ianevski A, Starheim E, Wang W, et al
    Boosted production of antibodies which neutralized different SARS-CoV-2 variants in a COVID-19 convalescent following mRNA vaccination - a case study.
    Int J Infect Dis. 2023 Oct 16:S1201-9712(23)00748.
    >> Share

  36. SHARMA A, Gupta B, Petersen E, Lee SS, et al
    Enhancing preparedness for reducing transmission and globalisation of Antimicrobial Resistance at the Ardh Kumbh Mela 2025, the world's largest recurring religious mass gathering.
    Int J Infect Dis. 2023 Oct 16:S1201-9712(23)00751.
    >> Share

  37. BERG J, Thies-Lagergren L, Svedenkrans J, Samkutty J, et al
    Umbilical cord clamping in the early phases of the COVID-19 era - A systematic review and meta-analysis of reported practice and recommendations in guidelines.
    Int J Infect Dis. 2023 Oct 13:S1201-9712(23)00747.
    >> Share

  38. XU Y, Chen H, Wang B, Zhu X, et al
    Immunogenicity and safety of concomitant administration of the sabin-strain-based inactivated poliovirus vaccine, the diphtheria-tetanus-acellular pertussis vaccine and measles-mumps-rubella vaccine to healthy infants aged 18 months in China.
    Int J Infect Dis. 2023 Oct 11:S1201-9712(23)00743.
    >> Share

  39. HEJAZI NS, Shen X, Carpp LN, Benkeser D, et al
    Stochastic Interventional Approach to Assessing Immune Correlates of Protection: Application to the COVE mRNA-1273 Vaccine Trial.
    Int J Infect Dis. 2023 Oct 9:S1201-9712(23)00727.
    >> Share

  40. SCHUZ ML, Dallmeyer L, Fragkou PC, Omony J, et al
    Global prevalence of respiratory virus infections in adults and adolescents during the COVID-19 pandemic: A systematic review and meta-analysis.
    Int J Infect Dis. 2023 Oct 6:S1201-9712(23)00738.
    >> Share

  41. INABA M, Miyake Y, Yasuda K
    Secondary household transmission of SARS-CoV-2: A case-control study on factors associated with reduced transmission risk.
    Int J Infect Dis. 2023 Oct 1:S1201-9712(23)00733.
    >> Share

  42. GONCALVES YMP, de Assuncao TSF, de Sousa MAD, Ferreira LM Junior, et al
    Progressive multifocal leukoencephalopathy triggered by COVID-19 in a previously asymptomatic person living with undiagnosed HIV infection.
    Int J Infect Dis. 2023 Oct 1:S1201-9712(23)00730.
    >> Share

    September 2023
  43. FOCOSI D, Maggi F, D'Abramo A, Nicastri E, et al
    Antiviral combination therapies for persistent COVID-19 in immunocompromised patients.
    Int J Infect Dis. 2023 Sep 29:S1201-9712(23)00734.
    >> Share

  44. LAI MY, Bukhari FDM, Zulkefli NZ, Ismail I, et al
    Corrigendum to "Colorimetric detection of SARS-CoV-2 by uracil-DNA glycosylase (UDG) reverse transcription loop-mediated isothermal amplification (RT-LAMP)" [International Journal of Infectious Diseases 120 (2023) Pages 132-134].
    Int J Infect Dis. 2023;136:91.
    >> Share

  45. WONG HM, Mun CH, Loke WK, Lim WQ, et al
    Moist heat as a promising method to decontaminate N95 masks - a large scale clinical study comparing four decontamination modalities: moist heat, steam, ultraviolet-C irradiation and hydrogen peroxide plasma.
    Int J Infect Dis. 2023 Sep 25:S1201-9712(23)00729.
    >> Share

  46. CASTRO-RODRIGUEZ B, Morales-Jadan D, Viteri-Davila C, Rodriguez AS, et al
    "The fake positive results of COVID-19 rapid antigen tests with the use of beverages vary between brands of test kits".
    Int J Infect Dis. 2023 Sep 22:S1201-9712(23)00718.
    >> Share

  47. GIACOMELLI A, Gagliardini R, Tavelli A, De Benedittis S, et al
    Risk of COVID-19 in-hospital mortality in people living with HIV compared to general population according to age and CD4 strata: data from the Icona network.
    Int J Infect Dis. 2023 Sep 21:S1201-9712(23)00728.
    >> Share

  48. PREGER A, Wei R, Berg B, Golomb BA, et al
    Covid-19-Associated Rhabdomyolysis: A Scoping Review.
    Int J Infect Dis. 2023 Sep 18:S1201-9712(23)00713.
    >> Share

  49. KAYA H, Tani H, Inasaki N, Yazawa S, et al
    Virus evolution and reduced viral viability during treatment of persistent COVID-19 Omicron BA.5 infection in an immunocompromised host.
    Int J Infect Dis. 2023 Sep 16:S1201-9712(23)00721.
    >> Share

  50. HUJAMBERDIEVA LM, Chimed-Ochir O, Yumiya Y, Tanaka J, et al
    Relationship between clinical symptom profiles and COVID-19 infection status during delta-dominant period versus omicron-dominant period - analysis of real-world data collected in Hiroshima Prefecture, Japan.
    Int J Infect Dis. 2023 Sep 15:S1201-9712(23)00717.
    >> Share

  51. NAYYERABADI M, Fourcade L, Joshi SA, Chandrasekaran P, et al
    Vaccination after developing long COVID: impact on clinical presentation, viral persistence and immune responses.
    Int J Infect Dis. 2023 Sep 15:S1201-9712(23)00720.
    >> Share

  52. CHEMAITELLY H, Faust JS, Krumholz HM, Ayoub HH, et al
    Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: A national cohort study.
    Int J Infect Dis. 2023 Sep 15:S1201-9712(23)00719.
    >> Share

  53. SSALI I, Mugaba S, Watelo AK, Bemanzi J, et al
    Spike Protein is a key target for stronger and more persistent T-Cell Responses - A study of mild and asymptomatic SARS-CoV-2 Infection.
    Int J Infect Dis. 2023 Sep 6:S1201-9712(23)00714.
    >> Share

  54. MIDDELKOOP K, Stewart J, Walker N, Delport C, et al
    Vitamin D supplementation to prevent tuberculosis infection in South African schoolchildren: multicenter phase 3 double-blind randomized placebo-controlled trial (ViDiKids).
    Int J Infect Dis. 2023;134:63-70.
    >> Share

  55. FAN Y, Gao R, Shang Y, Tian X, et al
    Presence of SARS-CoV-2 in middle ear fluid and characterization of otitis media with effusion in COVID-19 patients.
    Int J Infect Dis. 2023 Sep 1:S1201-9712(23)00709.
    >> Share

    August 2023
  56. HAUTEFORT C, Corre A, Poillon G, Jourdaine C, et al
    Local budesonide therapy in the management of persistent hyposmia in suspected non-severe COVID-19 patients: Results of a randomized controlled trial.
    Int J Infect Dis. 2023 Aug 29:S1201-9712(23)00707.
    >> Share

  57. YAN X, Li K, Lei Z, Luo J, et al
    Prevalence and associated outcomes of co-infection between SARS-CoV-2 and influenza: a systematic review and meta-analysis.
    Int J Infect Dis. 2023 Aug 28:S1201-9712(23)00705.
    >> Share

  58. DIEXER S, Klee B, Gottschick C, Xu C, et al
    Association between Virus Variants, Vaccination, Previous Infections, and Post COVID-19 Risk.
    Int J Infect Dis. 2023 Aug 25:S1201-9712(23)00702.
    >> Share

  59. MI Y, Huang L, Liu J, Chao H, et al
    High-altitude Resident Pulmonary Edema Induced by SARS-CoV-2 Infection in Children - A Case Series.
    Int J Infect Dis. 2023 Aug 21:S1201-9712(23)00700.
    >> Share

  60. JANHA RE, Bah A, Jah H, Touray F, et al
    SARS-CoV-2 seroprevalence in pregnant women during the first three COVID-19 waves in The Gambia.
    Int J Infect Dis. 2023 Aug 14:S1201-9712(23)00697.
    >> Share

  61. EDELSTEIN M, Beiruti KW, Ben-Amram H, Beer N, et al
    Vaccine-induced and hybrid immunity to SARS-CoV-2 after three or four doses of BNT162b2 - results from 22 months follow-up of a healthcare workers cohort, Israel, 2020-2022.
    Int J Infect Dis. 2023 Aug 10:S1201-9712(23)00694.
    >> Share

  62. CHAE C, Kim RK, Jang EJ, Shim JA, et al
    Comparing the Effectiveness of Bivalent and Monovalent COVID-19 Vaccines against COVID-19 Infection during the Winter Season of 2022-2023: A Real-World Retrospective Observational Matched Cohort Study in the Republic of Korea.
    Int J Infect Dis. 2023 Aug 10:S1201-9712(23)00695.
    >> Share

  63. LOW EV, Pathmanathan MD, Chidambaram SK, Kim WR, et al
    Real world nirmatrelvir-ritonavir outpatient treatment in reducing hospitalization for high-risk COVID-19 patients during Omicron BA.4, BA.5 and XBB subvariants dominance in Malaysia: A retrospective cohort study.
    Int J Infect Dis. 2023 Aug 9:S1201-9712(23)00688.
    >> Share

  64. WAILI BA, Yazidi LA, Hashami HA, Gheilani MA, et al
    A comparative study of SARS-CoV-2 and common human coronavirus infections among children presenting to tertiary care in Oman.
    Int J Infect Dis. 2023 Aug 9:S1201-9712(23)00690.
    >> Share

  65. DOMNICH A, Orsi A, Ricucci V, De Pace V, et al
    Real-world performance of SARS-CoV-2 rapid antigen testing through the Alpha-, Delta- and Omicron-dominant waves of the COVID-19 pandemic.
    Int J Infect Dis. 2023 Aug 2:S1201-9712(23)00679.
    >> Share

  66. TANAKA H, Namkoong H, Chubachi S, Irie S, et al
    Clinical characteristics of patients with COVID-19 harboring detectable intracellular SARS-CoV-2 RNA in peripheral blood cells.
    Int J Infect Dis. 2023 Aug 2:S1201-9712(23)00680.
    >> Share

    July 2023
  67. AGUARELES J, Villares-Fernandez P, Carralon-Gonzalez MM, Forne C, et al
    Outcomes and clinical characteristics of the compassionate use of plitidepsin for immunocompromised adult patients with COVID-19.
    Int J Infect Dis. 2023 Jul 21:S1201-9712(23)00661.
    >> Share

  68. FANG X, Lu K, Sun S, Zhang H, et al
    Infection caused by Cupriavidus gilardii in a convalescent COVID-19 patient.
    Int J Infect Dis. 2023 Jul 20:S1201-9712(23)00663.
    >> Share

  69. LIANG W, Lv H, Chen C, Sun Y, et al
    Lack of neutralizing antibodies against influenza A viruses in adults during the 2022/2023 winter season - a serological study using retrospective samples collected in Hong Kong.
    Int J Infect Dis. 2023 Jul 20:S1201-9712(23)00659.
    >> Share

  70. TIAN T, Fu L, Lu Z, Wu X, et al
    Changes in HPV prevalence, incidence, and clearance among MSM in Xinjiang, China after implementation of nonpharmaceutical interventions to control COVID-19: An interrupted time series analysis.
    Int J Infect Dis. 2023 Jul 13:S1201-9712(23)00654.
    >> Share

  71. HOWARD LM, Huang X, Chen W, Liu Y, et al
    Association between nasopharyngeal colonization with multiple pneumococcal serotypes and total pneumococcal colonization density in young Peruvian children.
    Int J Infect Dis. 2023 Jul 12:S1201-9712(23)00653.
    >> Share

  72. ROSCA EC, Bilavu R, Cornea A, Simu M, et al
    Chorea following SARS-CoV-2 infection and vaccination: a systematic review of reported cases.
    Int J Infect Dis. 2023 Jul 7:S1201-9712(23)00652.
    >> Share

  73. PUYAT JH, Fowokan A, Wilton J, Janjua NZ, et al
    Risk of COVID-19 Hospitalization in People Living with HIV and HIV-Negative Individuals and the Role of COVID-19 Vaccination: A Retrospective Cohort Study.
    Int J Infect Dis. 2023 Jul 5:S1201-9712(23)00650.
    >> Share

  74. COWAN J, Amson A, Christofides A, Chagla Z, et al
    Monoclonal antibodies as COVID-19 prophylaxis therapy in immunocompromised patient populations.
    Int J Infect Dis. 2023 Jul 1:S1201-9712(23)00645.
    >> Share

    June 2023
  75. SIRIPONGBOONSITTI T, Ungtrakul T, Tawinprai K, Nimmol T, et al
    Efficacy of Combination Therapy of Fluvoxamine and Favipiravir versus Favipiravir Monotherapy to Prevent Severe COVID-19 among Mild to Moderate COVID-19 Patients: Open-label Randomized Controlled Trial (EFFaCo Study).
    Int J Infect Dis. 2023 Jun 29:S1201-9712(23)00641.
    >> Share

  76. BONNA AS, Pavel SR, Mehjabin T, Ali M, et al
    Dengue in Bangladesh.
    Int J Infect Dis. 2023 Jun 29:S1201-9712(23)00644.
    >> Share

  77. MAEDA M, Murata F, Fukuda H
    Effect of COVID-19 Vaccination on Household Transmission of SARS-CoV-2 in the Omicron Era: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.
    Int J Infect Dis. 2023 Jun 23:S1201-9712(23)00642.
    >> Share

  78. KANG JM, Kang M, Kim YE, Choi Y, et al
    Severe coronavirus disease 2019 in pediatric solid organ transplant recipients: Big data convergence study in Korea (K-COV-N cohort).
    Int J Infect Dis. 2023 Jun 21:S1201-9712(23)00640.
    >> Share

  79. JIAO Y, Zhao J, Wang Z, Chen X, et al
    How do Orphan Disease Patients Live Under the Pandemic of Omicron Variant? - A Nationwide Survey of Spinal Muscular Atrophy Patients in China.
    Int J Infect Dis. 2023 Jun 21:S1201-9712(23)00639.
    >> Share

  80. VERGORI A, Matusali G, Lepri AC, Cimini E, et al
    Neutralizing activity and T Cell response after bivalent fifth dose of mRNA vaccine in person living with HIV.
    Int J Infect Dis. 2023 Jun 19:S1201-9712(23)00632.
    >> Share

  81. IOANNIDIS JPA, Contopoulos-Ioannidis DG
    Pre-pandemic cross-reactive humoral immunity to SARS-CoV-2 in Africa: systematic review and meta-analysis.
    Int J Infect Dis. 2023 Jun 14:S1201-9712(23)00631.
    >> Share

  82. MORENO-TORRES V, Martinez-Urbistondo M, Calderon-Parra J, Patricia Mills, et al
    COVID-19 in hospitalized solid organ transplant recipients in a nationwide registry study.
    Int J Infect Dis. 2023 Jun 13:S1201-9712(23)00629.
    >> Share

  83. COHEN PJF, Rybak DA, Werner DA, Kochert DF, et al
    Surveillance of non-invasive group A Streptococcus infections in French ambulatory pediatrics before and during the COVID-19 pandemic: a prospective multicenter study from 2018 to 2022.
    Int J Infect Dis. 2023 Jun 6:S1201-9712(23)00622.
    >> Share

  84. PITA-MARTINEZ C, Perez-Garcia F, Berdices AV, Martin-Vicente M, et al
    A deficient immune response to SARS-CoV-2 in the nasopharynx is associated with severe COVID-19 pneumonia.
    Int J Infect Dis. 2023 Jun 6:S1201-9712(23)00623.
    >> Share

    May 2023
  85. ZHANG R, Wen J, Wu K, Lin S, et al
    Influenza-associated neurologic complications in children from an H3N2 outbreak in Shenzhen, China during COVID-19 lockdown.
    Int J Infect Dis. 2023 May 30:S1201-9712(23)00616.
    >> Share

  86. BLANQUART F, Abad C, Ambroise J, Bernard M, et al
    Temporal, age and geographical variation in vaccine efficacy against infection by the Delta and Omicron variants in the community in France, December 2021 to March 2022.
    Int J Infect Dis. 2023 May 12:S1201-9712(23)00539.
    >> Share

  87. SERVIER C, Porcher R, Pane I, Ravaud P, et al
    Trajectories of the evolution of post COVID-19 condition, up to two years after symptoms onset.
    Int J Infect Dis. 2023 May 12:S1201-9712(23)00558.
    >> Share

  88. HUI DS, Yung L, Chan KK, Ng SS, et al
    Risk of air and surface contamination during application of different non-invasive respiratory support for patients with COVID-19.
    Int J Infect Dis. 2023 May 12:S1201-9712(23)00560.
    >> Share

  89. MARANGONI D, Antonello RM, Coppi M, Palazzo M, et al
    Combination regimen of nirmatrelvir/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: a case report and a scoping review of the literature.
    Int J Infect Dis. 2023 May 5:S1201-9712(23)00546.
    >> Share

  90. KUODI P, Gorelik Y, Gausi B, Bernstine T, et al
    Characterisation of post-COVID syndromes by symptom cluster and time period up to 12 months post-infection: A systematic review and meta-analysis.
    Int J Infect Dis. 2023 May 5:S1201-9712(23)00549.
    >> Share

  91. ZENS KD, Llanas-Cornejo D, Menges D, Fehr JS, et al
    Longitudinal Humoral and Cell-Mediated Immune Responses in a Population-Based Cohort in Zurich, Switzerland from March to June 2022 - Evidence for Protection against Omicron SARS-CoV-2 Infection by Neutralizing Antibodies and Spike-specific T cells.
    Int J Infect Dis. 2023 May 4:S1201-9712(23)00538.
    >> Share

  92. ORLANDO SA, Calderon JL, Leon-Sosa A, Patino L, et al
    Corrigendum to ";SARS-CoV-2 transmission from infected owner to household dogs and cats is associated with food sharing" [International Journal of Infectious Diseases, 122 (2022) Pages 295-299].
    Int J Infect Dis. 2023;130:214-215.
    >> Share

  93. ALBERTO-ORLANDO S, Garcia-Bereguiain MA
    Concerns regarding risk factors for SARS-CoV-2 transmission to pets: author's reply.
    Int J Infect Dis. 2023;130:212-213.
    >> Share

  94. WEESE S
    Concerns regarding risk factors for SARS-CoV-2 transmission to pets.
    Int J Infect Dis. 2023;130:211.
    >> Share

  95. GOLETTI D, Al-Abri S, Migliori GB, Coler R, et al
    World Tuberculosis Day 2023 theme "Yes! We Can End TB!".
    Int J Infect Dis. 2023;130 Suppl 1:S1-S3.
    >> Share

  96. GOLETTI D, Al-Abri S, Migliori GB, Coler R, et al
    World Tuberculosis Day 2023 theme "Yes! We Can End TB!".
    Int J Infect Dis. 2023;130 Suppl 1:S1-S3.
    >> Share

  97. GOLETTI D, Al-Abri S, Migliori GB, Coler R, et al
    World Tuberculosis Day 2023 theme "Yes! We Can End TB!".
    Int J Infect Dis. 2023;130 Suppl 1:S1-S3.
    >> Share

  98. GOLETTI D, Al-Abri S, Migliori GB, Coler R, et al
    World Tuberculosis Day 2023 theme "Yes! We Can End TB!".
    Int J Infect Dis. 2023;130 Suppl 1:S1-S3.
    >> Share

    April 2023
  99. TANAKA H, Chubachi S, Asakura T, Namkoong H, et al
    Characteristics and Clinical Effectiveness of COVID-19 Vaccination in Hospitalized Patients in Omicron-dominated Epidemic Wave - A Nationwide Study in Japan.
    Int J Infect Dis. 2023 Apr 20:S1201-9712(23)00529.
    >> Share

  100. HUIBERTS AJ, de Gier B, Hoeve CE, de Melker HE, et al
    Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from 12 July 2021 to 6 June 2022: a prospective cohort study.
    Int J Infect Dis. 2023 Apr 20:S1201-9712(23)00534.
    >> Share

  101. MOLINA KC, Kennerley V, Beaty LE, Bennett TD, et al
    Real-World Evaluation of Bebtelovimab Effectiveness During the Period of COVID-19 Omicron Variants including BA.4/BA.5.
    Int J Infect Dis. 2023 Apr 16:S1201-9712(23)00525.
    >> Share

  102. COHEN D, Izak M, Stoyanov E, Mandelboim M, et al
    Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic.
    Int J Infect Dis. 2023 Apr 16:S1201-9712(23)00526.
    >> Share

  103. LEE VH, Chan SK, Tam YH, Chau TC, et al
    Predictive factors of delayed viral clearance of asymptomatic omicron-related COVID-19 screened positive in cancer patients receiving active anti-cancer treatment.
    Int J Infect Dis. 2023 Apr 16:S1201-9712(23)00527.
    >> Share

  104. YIN S, Ren J, Xue J, Li P, et al
    Disparities in COVID-19 clinical studies from high-income and low-and middle-income countries.
    Int J Infect Dis. 2023 Apr 15:S1201-9712(23)00522.
    >> Share

  105. BUTT AA, Guerrero MD, Canlas EB, Al-Dwairi H, et al
    Immediate and Contributory Causes of Death in Patients Hospitalized with COVID-19.
    Int J Infect Dis. 2023 Apr 13:S1201-9712(23)00514.
    >> Share

  106. BRYNILDSRUD OB, Watle SV, Alfsnes K, Caugant DA, et al
    Invasive meningococcal disease in Norway in the two decades prior to the COVID-19 pandemic.
    Int J Infect Dis. 2023 Apr 6:S1201-9712(23)00136.
    >> Share

    March 2023
  107. VON BARTHELD CS, Wang L
    The prevalence of olfactory dysfunction with Omicron has decreased in Asia, similar to Western countries.
    Int J Infect Dis. 2023 Mar 30:S1201-9712(23)00121.
    >> Share

  108. LAWAL BJ, Gallagher KE, Kitonsa J, Tindanbil D, et al
    Prevalence of IgG and IgM to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone and Uganda: A Longitudinal Study.
    Int J Infect Dis. 2023 Mar 29:S1201-9712(23)00128.
    >> Share

  109. AZHAR EI, Velavan TP, Rungsung I, Traore T, et al
    Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - a ten-year (2012-2022) global analysis of human and camel infections, genomic sequences, lineages, and geographical origins.
    Int J Infect Dis. 2023 Mar 28:S1201-9712(23)00125.
    >> Share

  110. BODNER K, Irvine MA, Kwong JC, Mishra S, et al
    Observed negative vaccine effectiveness could be the canary in the coal mine for biases in observational Covid-19 studies.
    Int J Infect Dis. 2023 Mar 27:S1201-9712(23)00102.
    >> Share

  111. GUO Y, Wu S, Ye W, Zhao Z, et al
    Impact of public health and social measures on contact dynamics during a SARS-CoV-2 Omicron variant outbreak in Quanzhou, China, March to April 2022.
    Int J Infect Dis. 2023 Mar 24:S1201-9712(23)00104.
    >> Share

  112. NAVEED Z, Li J, Naus M, Garcia HAV, et al
    A Population-Based Assessment of Myocarditis Following mRNA COVID-19 booster Vaccination Among Adult Recipients.
    Int J Infect Dis. 2023 Mar 24:S1201-9712(23)00106.
    >> Share

  113. LARSEN SE, Baldwin SL, Coler RN
    TB Vaccines Update: is an RNA-based vaccine feasible for TB?
    Int J Infect Dis. 2023 Mar 22:S1201-9712(23)00114.
    >> Share

  114. ZINSZER K, Charland K, Pierce L, Saucier A, et al
    Pre-Omicron seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and teenagers in Montreal, Canada.
    Int J Infect Dis. 2023 Mar 22:S1201-9712(23)00115.
    >> Share

  115. TAN KS, Ong SWX, Koh MH, Tay DJW, et al
    SARS-CoV-2 Omicron variant shedding during respiratory activities.
    Int J Infect Dis. 2023 Mar 20:S1201-9712(23)00109.
    >> Share

  116. WU J, Shi X, Tao B, Zhan Y, et al
    Inactivated COVID-19 vaccines booster dose shortened the viral shedding time of patients infected with the Omicron variant BA.2.
    Int J Infect Dis. 2023 Mar 20:S1201-9712(23)00107.
    >> Share

  117. DAVIDO B, Jaffal K, Gault E, Bourlet S, et al
    Back to the Future of Viruses: A Case of Triple Coinfection caused by RSV, HCov-OC43 and Rhinovirus.
    Int J Infect Dis. 2023 Mar 20:S1201-9712(23)00101.
    >> Share

  118. NAJAFI-FARD S, Aiello A, Navarra A, Cuzzi G, et al
    Characterization of the immune impairment of tuberculosis and COVID-19 coinfected patients.
    Int J Infect Dis. 2023 Mar 19:S1201-9712(23)00099.
    >> Share

  119. NEVOLA R, Feola G, Ruocco R, Russo A, et al
    Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study.
    Int J Infect Dis. 2023 Mar 19:S1201-9712(23)00110.
    >> Share

  120. CHILLON TS, Demircan K, Weiss G, Minich WB, et al
    Detection of antibodies to SARS-CoV-2 after vaccination in seminal plasma and their association to sperm parameters.
    Int J Infect Dis. 2023 Mar 16:S1201-9712(23)00095.
    >> Share

  121. HAMA HO, Chenal T, Pible O, Miotello G, et al
    An ancient coronavirus from individuals in France, circa 16(th) century.
    Int J Infect Dis. 2023 Mar 14:S1201-9712(23)00093.
    >> Share

  122. ZANNOLI S, Brandolini M, Marino MM, Denicolo A, et al
    SARS-CoV-2 Co-Infection in Immunocompromised Host Leads to Generation of Recombinant Strain.
    Int J Infect Dis. 2023 Mar 14:S1201-9712(23)00088.
    >> Share

  123. MA Y, Gu Y, Shan Z, Huang Y, et al
    Safety and efficacy of inactivated COVID-19 vaccines in women vaccinated during the first trimester of pregnancy.
    Int J Infect Dis. 2023 Mar 14:S1201-9712(23)00094.
    >> Share

  124. WANG X, Tang Q, Li H, Jiang H, et al
    Autoantibodies against type I interferons in COVID-19 infection: a systematic review and meta-analysis.
    Int J Infect Dis. 2023 Mar 10:S1201-9712(23)00087.
    >> Share

  125. HOUBEN F, den Heijer CD, Dukers-Muijrers NH, Daamen AM, et al
    Facility- and ward-level factors associated with SARS-CoV-2 outbreaks among residents in long-term care facilities: a retrospective cohort study.
    Int J Infect Dis. 2023 Mar 9:S1201-9712(23)00082.
    >> Share

  126. THONG PM, Chong HT, Chang AJW, Ong CWM, et al
    COVID-19, the escalation of diabetes and the repercussions on Tuberculosis.
    Int J Infect Dis. 2023 Mar 8:S1201-9712(23)00055.
    >> Share

  127. NALUNJOGI J, Mucching-Toscano S, Sibomana JP, Centis R, et al
    Impact of COVID-19 on diagnosis of TB, MDR-TB and on mortality in 11 countries in Europe, Northern America and Australia. A Global Tuberculosis Network study.
    Int J Infect Dis. 2023 Mar 7:S1201-9712(23)00076.
    >> Share

  128. VENETI L, Berild JD, Watle SV, Starrfelt J, et al
    Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022.
    Int J Infect Dis. 2023 Mar 7:S1201-9712(23)00080.
    >> Share

  129. EVANS TS, Tan CW, Aung O, Phyu S, et al
    Exposure to diverse sarbecoviruses indicates frequent zoonotic spillover in human communities interacting with wildlife.
    Int J Infect Dis. 2023 Mar 2:S1201-9712(23)00064.
    >> Share

  130. VELAVAN TP, Ntoumi F, Kremsner PG, Lee SS, et al
    Emergence and geographic dominance of Omicron subvariants XBB/XBB.1.5 and BF.7 - the public health challenges.
    Int J Infect Dis. 2023;128:307-309.
    >> Share

  131. ZILVER SJM, de Groot CJM, Grobben M, Remmelzwaal S, et al
    Vaccination from the early second trimester onwards gives a robust SARS-CoV-2 antibody response throughout pregnancy and provides antibodies for the neonate.
    Int J Infect Dis. 2023 Mar 1:S1201-9712(23)00071.
    >> Share

    February 2023
  132. KANG W, Yang P, Dang B, Zhang W, et al
    Dynamics of disease characteristics and viral RNA decay in patients with asymptomatic and mild infections during the Omicron wave in Shanghai, China: A retrospective cohort study.
    Int J Infect Dis. 2023 Feb 25:S1201-9712(23)00067.
    >> Share

  133. HOWARD-JONES AR, Arnott A, Draper J, Gall M, et al
    Emergent Omicron BR.2.1 Sublineage of SARS-CoV-2 in New South Wales, Australia: A Subvariant with High Fitness but Without Increased Disease Severity.
    Int J Infect Dis. 2023 Feb 24:S1201-9712(23)00068.
    >> Share

  134. SANTOS AP, Werneck GL, Dalvi APR, Dos Santos CC, et al
    The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2 - The results of ProBCG: A Multicenter Randomized Clinical Trial in Brazil.
    Int J Infect Dis. 2023 Feb 23:S1201-9712(23)00065.
    >> Share

  135. CHANTASRISAWAD N, Techasaensiri C, Kosalaraksa P, Phongsamart W, et al
    The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial.
    Int J Infect Dis. 2023 Feb 23:S1201-9712(23)00066.
    >> Share

  136. PEREIRA PD, Pires MC, Gomes VMR, Nogueira MCA, et al
    Clinical characteristics and outcomes of hospital-manifested COVID-19 among Brazilians.
    Int J Infect Dis. 2023 Feb 20:S1201-9712(23)00059.
    >> Share

  137. WU Y, Guo Z, Yuan J, Cao G, et al
    Duration of viable virus shedding and PCR positivity of the SARS-CoV-2 Omicron variant in upper respiratory tract: a systematic review and meta-analysis.
    Int J Infect Dis. 2023 Feb 17:S1201-9712(23)00057.
    >> Share

  138. VAIRA LA, De Riu G, Mayo-Yanez M, Gengler IM, et al
    Prevalence of chemosensitive disorders with Omicron infections and the possible impacts of vaccination.
    Int J Infect Dis. 2023 Feb 15:S1201-9712(23)00054.
    >> Share

  139. BELLO-CHAVOLLA OY, Antonio-Villa NE, Valdes-Ferrer SI, Fermin-Martinez CA, et al
    Effectiveness of a nation-wide COVID-19 vaccination program in Mexico against symptomatic COVID-19, hospitalizations, and death: a retrospective analysis of national surveillance data.
    Int J Infect Dis. 2023 Feb 10:S1201-9712(23)00042.
    >> Share

  140. BANGAR S, Sonar P, Mane A, Sane S, et al
    Prevention of recurrence of bacterial vaginosis using lactobacilli-containing vaginal tablets among women with HIV: a randomized, placebo-controlled, double-blinded phase IV trial.
    Int J Infect Dis. 2023;129:197-204.
    >> Share

  141. DE CASTRO MV, Silva MVR, Oliveira LM, Gozzi-Silva SC, et al
    "Immunological evaluation of unvaccinated young patients with Turner Syndrome after COVID-19".
    Int J Infect Dis. 2023 Feb 7:S1201-9712(23)00044.
    >> Share

  142. SAITOH H, Sakai-Tagawa Y, Nagasawa S, Torimitsu S, et al
    High titers of infectious SARS-CoV-2 in COVID-19 corpses.
    Int J Infect Dis. 2023 Feb 6:S1201-9712(23)00047.
    >> Share

  143. SWETS MC, Moss RJ, Kor F, Hilarius D, et al
    A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19: a natural experiment due to drug shortages.
    Int J Infect Dis. 2023 Feb 2:S1201-9712(23)00041.
    >> Share

  144. LIU C, Lu J, Li P, Feng S, et al
    A Comparative study on epidemiological characteristics, transmissibility, and pathogenicity of three COVID-19 outbreaks caused by different variants.
    Int J Infect Dis. 2023 Feb 1:S1201-9712(23)00039.
    >> Share

  145. PATEL S, Truong GT, Rajan A, Creech Z, et al
    Discharge Disposition and Clinical Outcomes of Patients Hospitalized with COVID-19.
    Int J Infect Dis. 2023 Feb 1:S1201-9712(23)00040.
    >> Share

    January 2023
  146. BANKO A, Miljanovic D, Cirkovic A
    Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old players on the new field.
    Int J Infect Dis. 2023 Jan 31:S1201-9712(23)00037.
    >> Share

  147. SEERY V, Raiden S, Penedo JMG, Borda M, et al
    Persistent symptoms after COVID-19 in children and adolescents from Argentina.
    Int J Infect Dis. 2023 Jan 31:S1201-9712(23)00033.
    >> Share

  148. LIU Y, Xu L, Piao X, Li H, et al
    Epidemiological, Clinical and Household Transmission Characteristics of Children and Adolescents Infected with SARS-CoV-2 Omicron Variant in Shanghai, China: a Retrospective Multicenter Observational Study.
    Int J Infect Dis. 2023 Jan 29:S1201-9712(23)00031.
    >> Share

  149. PETRONE D, Mateo-Urdiales A, Sacco C, Riccardo F, et al
    Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 - February 2022).
    Int J Infect Dis. 2023 Jan 25:S1201-9712(23)00027.
    >> Share

  150. WU S, Wang L, Dong J, Bao Y, et al
    The Dose- and Time-Dependent Effectiveness and Safety Associated with COVID-19 Vaccination During Pregnancy: A Systematic Review and Meta-analysis.
    Int J Infect Dis. 2023;128:335-46.
    >> Share

  151. ATEF S, Hosani FA, AbdelWareth L, Al-Rifai RH, et al
    Susceptibility to Reinfection with SARS-CoV-2 Virus Relative to Existing Antibody Concentrations and T cell Response.
    Int J Infect Dis. 2023 Jan 23:S1201-9712(23)00005.
    >> Share

  152. YAMAMOTO S, Matsuda K, Maeda K, Horii K, et al
    Neutralizing antibodies following three doses of BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron predominant wave.
    Int J Infect Dis. 2023 Jan 21:S1201-9712(23)00023.
    >> Share

  153. METCHURTCHLISHVILI R, Chkhartishvili N, Abutidze A, Endeladze M, et al
    Effect of remdesivir on mortality and the need for mechanical ventilation among hospitalized COVID-19 patients: real-world data from resource-limited country.
    Int J Infect Dis. 2023 Jan 20:S1201-9712(23)00022.
    >> Share

  154. HELLER M, Henrici C, Buttner J, Leube S, et al
    SARS-CoV-2 Neutralizing Antibody Therapies: Early retrospective cohort study of 26 hospitalized patients treated with Bamlanivimab or Casirivimab/Imdevimab.
    Int J Infect Dis. 2023 Jan 20:S1201-9712(23)00012.
    >> Share

  155. NAGGIE S, Milstone A, Castro M, Collins SP, et al
    Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: A randomized, multicenter, placebo-controlled trial (HERO-HCQ).
    Int J Infect Dis. 2023 Jan 19:S1201-9712(23)00019.
    >> Share

  156. NIYOMNAITHAM S, Jongkaewwattana A, Meesing A, Pinpathomrat N, et al
    Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 mRNA vaccine after two doses of CoronaVac vaccines against Delta and Omicron variants.
    Int J Infect Dis. 2023 Jan 19:S1201-9712(23)00021.
    >> Share

  157. SONG J, Jing Q, Zhu E, Liu Q, et al
    Alterations in smell or taste in individuals infected with SARS-CoV-2 during periods of Omicron variant dominance.
    Int J Infect Dis. 2023 Jan 16:S1201-9712(23)00017.
    >> Share

  158. HIRAE K, Hoshina T, Koga H
    Impact of COVID-19 pandemic on the epidemiology of other communicable diseases in Japan.
    Int J Infect Dis. 2023 Jan 12:S1201-9712(23)00013.
    >> Share

  159. CHEN SH, Wu JL, Liu YC, Yen TY, et al
    Differential clinical characteristics and performance of home antigen tests between parents and children following household transmission of SARS-CoV-2 during the Omicron variant pandemic.
    Int J Infect Dis. 2023 Jan 12:S1201-9712(23)00014.
    >> Share

  160. SANTOS VS, Allgayer MF, Kontogianni K, Rocha JE, et al
    Pooling of sputum samples to increase tuberculosis diagnostic capacity in Brazil during the COVID-19 pandemic.
    Int J Infect Dis. 2023 Jan 12:S1201-9712(23)00011.
    >> Share

  161. LIN SM, Lee CS, Huang AC, Chiu TH, et al
    Effects of Dexamethasone Use on Viral Clearance Among Patients with COVID-19: A Multicenter Cohort Study.
    Int J Infect Dis. 2023 Jan 12:S1201-9712(23)00010.
    >> Share

  162. NUCHNOI P, Piromtong P, Siribal S, Anansilp K, et al
    Applicability of a Colorimetric RT-LAMP Assay for SARS-CoV-2 Detection in High Exposure Risk Setting.
    Int J Infect Dis. 2023 Jan 12:S1201-9712(23)00009.
    >> Share

  163. AHSBERG J, Bjerrum S, Ganu VJ, Kwashie A, et al
    The in-hospital tuberculosis diagnostic cascade and early clinical outcomes among people living with HIV before and during the COVID-19 pandemic - a prospective multisite cohort study from Ghana.
    Int J Infect Dis. 2023 Jan 9:S1201-9712(22)00683.
    >> Share

  164. JANG YR, Oh YJ, Kim JY
    Regdanvimab for patients with mild-to-moderate COVID-19: a retrospective cohort study and subgroup analysis of patients with the Delta variant.
    Int J Infect Dis. 2023 Jan 6:S1201-9712(22)00674.
    >> Share

  165. NGUIPDOP-DJOMO P, Oswald WE, Halliday KE, Cook S, et al
    Risk factors for SARS-CoV-2 infection in primary and secondary school students and staff in England in the 2020/2021 school year: a longitudinal study.
    Int J Infect Dis. 2023 Jan 5:S1201-9712(22)00673.
    >> Share

  166. IKEDA M, Okugawa S, Kashiwabara K, Moritoyo T, et al
    Multicenter, Single-Blind, Randomized Controlled Study of the Efficacy and Safety of Favipiravir and Nafamostat Mesilate in Patients with COVID-19 Pneumonia.
    Int J Infect Dis. 2023 Jan 3:S1201-9712(22)00684.
    >> Share

  167. BONACINA F, Boelle PY, Colizza V, Lopez O, et al
    Global patterns and drivers of influenza decline during the COVID-19 pandemic.
    Int J Infect Dis. 2023 Jan 3:S1201-9712(22)00682.
    >> Share

  168. WEE LE, Tan JY, Oon LLE, Pena AMT, et al
    Relapsing COVID-19 infection as a manifestation of Good's syndrome: a case report and literature review.
    Int J Infect Dis. 2023 Jan 3:S1201-9712(22)00681.
    >> Share

    December 2022
  169. JOO KIM W, Roberts CC, Young Song J, Yoon JG, et al
    Safety and immunogenicity of the bi-cistronic GLS-5310 COVID-19 DNA vaccine delivered with the GeneDerm suction device.
    Int J Infect Dis. 2022 Dec 30:S1201-9712(22)00678.
    >> Share

  170. JASSAT W, Mudara C, Vika C, Welch R, et al
    A cohort study of Post COVID-19 Condition across the Beta, Delta and Omicron waves in South Africa: 6-month follow up of hospitalised and non-hospitalised participants.
    Int J Infect Dis. 2022 Dec 29:S1201-9712(22)00676.
    >> Share

  171. KOHMER N, Stein S, Schenk B, Grikscheit K, et al
    Heterologous prime-boost immunisation with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study.
    Int J Infect Dis. 2022 Dec 29:S1201-9712(22)00672.
    >> Share

  172. MARKL B, Dintner S, Schaller T, Sipos E, et al
    Fatal cases after Omicron BA.1 and BA.2 infection: results of an autopsy study.
    Int J Infect Dis. 2022 Dec 27:S1201-9712(22)00669.
    >> Share

  173. YANG SL, Ripen AM, Ven Lee J, Koh K, et al
    Time from last immunity event against infection during Omicron dominant period in Malaysia.
    Int J Infect Dis. 2022 Dec 26:S1201-9712(22)00667.
    >> Share

  174. KAIZER AM, Shapiro NI, Wild J, Brown SM, et al
    Lopinavir/ritonavir for Treatment of Non-Hospitalized Patients with COVID-19: A Randomized Clinical Trial.
    Int J Infect Dis. 2022 Dec 26:S1201-9712(22)00665.
    >> Share

  175. HEIDARZADEH A, Moridani MA, Khoshmanesh S, Kazemi S, et al
    Effectiveness of COVID-19 vaccines on hospitalization and death in Guilan, Iran: a test negative case-control study.
    Int J Infect Dis. 2022 Dec 23:S1201-9712(22)00664.
    >> Share

  176. MOHAMMED NI, Mackenzie G, Ezeani E, Sidibeh M, et al
    Quantifying Excess Mortality during the Covid-19 pandemic in 2020 in The Gambia: A time-series analysis of three Health and Demographic Surveillance Systems.
    Int J Infect Dis. 2022 Dec 22:S1201-9712(22)00654.
    >> Share

  177. WESTERHOF I, de Hoog M, Ieven M, Lammens C, et al
    The impact of variant and vaccination on SARS-CoV-2 symptomatology; three prospective household cohorts.
    Int J Infect Dis. 2022 Dec 22:S1201-9712(22)00656.
    >> Share

  178. WATASE M, Masaki K, Chubachi S, Namkoong H, et al
    Impact of accumulative smoking exposure and chronic obstructive pulmonary disease on COVID-19 outcomes: Report based on findings from the Japan COVID-19 Task Force.
    Int J Infect Dis. 2022 Dec 20:S1201-9712(22)00655.
    >> Share

  179. FANO-SIZGORICH D, Vasquez-Velasquez C, Orellana LR, Ponce-Torres C, et al
    RISK OF DEATH, HOSPITALIZATION AND ICU ADMISSION BY SARS-CoV-2 VARIANTS IN PERU, A RETROSPECTIVE STUDY.
    Int J Infect Dis. 2022 Dec 20:S1201-9712(22)00657.
    >> Share

  180. PLASSE TF, Delgado B, Potts J, Abramson D, et al
    Randomized, placebo-controlled pilot study of upamostat, a host-directed serine protease inhibitor, for outpatient treatment of COVID-19.
    Int J Infect Dis. 2022 Dec 19:S1201-9712(22)00638.
    >> Share

  181. TENE L, Bergroth T, Eisenberg A, Ben David SS, et al
    Risk factors, health outcomes, healthcare services utilization, and direct medical costs of long COVID patient.
    Int J Infect Dis. 2022 Dec 15:S1201-9712(22)00640.
    >> Share

  182. PERETA I, Moracho A, Lopez N, Ibanez B, et al
    Hospital at Home treatment with Remdesivir for patients with COVID-19: Real life experience.
    Int J Infect Dis. 2022 Dec 12:S1201-9712(22)00648.
    >> Share

  183. NGALAMIKA O, Lidenge SJ, Mukasine MC, Kawimbe M, et al
    SARS-CoV-2 Specific T-cell and Humoral Immunity in HIV-infected and -uninfected Individuals in an African Population: A Prospective Cohort Study.
    Int J Infect Dis. 2022 Dec 11:S1201-9712(22)00646.
    >> Share

  184. TORRES C, Garcia J, Mesle F, Barbieri M, et al
    Identifying age- and sex-specific COVID-19 mortality trends over time in six countries.
    Int J Infect Dis. 2022 Dec 9:S1201-9712(22)00641.
    >> Share

  185. NGIAM JN, Chhabra S, Goh W, Sim MY, et al
    Continued demographic shifts in hospitalised COVID-19 patients from migrant workers to a vulnerable and more elderly local population at risk of severe disease.
    Int J Infect Dis. 2022 Dec 9:S1201-9712(22)00643.
    >> Share

  186. GUO Y, Wang H, Xiao M, Guan X, et al
    Long-term outcomes of COVID-19 convalescents: An 18.5-month longitudinal study in Wuhan.
    Int J Infect Dis. 2022 Dec 9:S1201-9712(22)00642.
    >> Share

  187. GARCIA HAV, Adu PA, Harrigan S, Wilton J, et al
    Risk factors for COVID-19 hospitalization following COVID-19 Vaccination: a population-based cohort study in Canada.
    Int J Infect Dis. 2022 Dec 8:S1201-9712(22)00639.
    >> Share

  188. LUO Y, Lv H, Zhao S, Sun Y, et al
    Age-related seroprevalence trajectories of seasonal coronaviruses in children including neonates in Guangzhou, China.
    Int J Infect Dis. 2022 Dec 5:S1201-9712(22)00636.
    >> Share

  189. NYAGWANGE J, Kutima B, Mwai K, Karanja HK, et al
    Serum IgG and mucosal IgA antibodies from pre-pandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro.
    Int J Infect Dis. 2022 Dec 4:S1201-9712(22)00633.
    >> Share

  190. VUORIO A, Raal F, Kovanen PT
    Drug-drug interaction with oral antivirals for early treatment of COVID-19.
    Int J Infect Dis. 2022 Dec 2:S1201-9712(22)00632.
    >> Share

  191. LARSEN CS
    Drug-drug interaction with oral antivirals for early treatment of COVID-19 - Authors' reply.
    Int J Infect Dis. 2022 Dec 2:S1201-9712(22)00631.
    >> Share

    November 2022
  192. FRIMPONG SO, Paintsil E
    Community engagement in Ebola outbreaks in sub-Saharan Africa and implications for COVID-19 control: A scoping review.
    Int J Infect Dis. 2022 Nov 30:S1201-9712(22)00625.
    >> Share

  193. FOWOKAN A, Samji H, Puyat J, Janjua N, et al
    Effectiveness of COVID-19 Vaccines in People Living with HIV in British Columbia and comparisons with a matched HIV-Negative Cohort: A Test Negative Design.
    Int J Infect Dis. 2022 Nov 30:S1201-9712(22)00624.
    >> Share

  194. WU S, Li Y, Mishra S, Bodner K, et al
    Effect of the incremental protection of previous infection against Omicron infection among individuals with a hybrid of infection- and vaccine-induced immunity: a population-based cohort study in Canada.
    Int J Infect Dis. 2022 Nov 28:S1201-9712(22)00620.
    >> Share

  195. CHUNG HY, Jian MJ, Chang CK, Chen CS, et al
    The application of a novel 5-in-1 multiplex RT-PCR assay for rapid detection of SARS-CoV-2 and differentiation between variants of concern.
    Int J Infect Dis. 2022 Nov 28:S1201-9712(22)00619.
    >> Share

  196. DAVIES MA, Morden E, Rosseau P, Arendse J, et al
    Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa.
    Int J Infect Dis. 2022 Nov 24:S1201-9712(22)00615.
    >> Share

  197. MIOCH D, Vanbrabant L, Reimerink J, Kuiper S, et al
    SARS-CoV-2 antibodies persist up to 12 months after natural infection in healthy employees working in non-medical contact-intensive professions.
    Int J Infect Dis. 2022 Nov 24:S1201-9712(22)00616.
    >> Share

  198. KANOKUDOM S, Chansaenroj J, Suntronwong N, Assawakosri S, et al
    Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (Covovax(TM)) after homologous and heterologous two-dose regimens.
    Int J Infect Dis. 2022 Nov 22:S1201-9712(22)00614.
    >> Share

  199. BYGDELL M, Leach S, Lundberg L, Gyll D, et al
    A comprehensive characterisation of patients diagnosed with post-COVID-19 condition in Sweden 16 months after the introduction of the ICD-10 diagnosis code (U09.9): a population-based cohort study.
    Int J Infect Dis. 2022 Nov 18:S1201-9712(22)00612.
    >> Share

  200. PUGA-GOMEZ R, Ricardo-Delgado Y, Rojas-Iriarte C, Cespedes-Henriquez L, et al
    Open-label phase I/II clinical trial of SARS-CoV-2 RBD-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with RBD-protein vaccine (FINLAY-FR-1A) in children.
    Int J Infect Dis. 2022 Nov 17:S1201-9712(22)00601.
    >> Share

  201. LANGER-GOULD A, Xu S, Myers LC, Chen A, et al
    Anakinra or high-dose corticosteroids in COVID-19 pneumonia patients who deteriorate on low-dose dexamethasone: An observational study of comparative effectiveness.
    Int J Infect Dis. 2022 Nov 17:S1201-9712(22)00603.
    >> Share

  202. JUTHI RT, Sazed SA, Sarmin M, Haque R, et al
    COVID-19 and Diarrhea: Putative Mechanisms and Management.
    Int J Infect Dis. 2022 Nov 17:S1201-9712(22)00602.
    >> Share

  203. BRUNVOLL SH, Nygaard AB, Fagerland MW, Holland P, et al
    Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection.
    Int J Infect Dis. 2022 Nov 11. pii: S1201-9712(22)00596.
    >> Share

  204. INTAWONG K, Chariyalertsak S, Chalom K, Wonghirundecha T, et al
    Heterologous third and fourth dose vaccines reduce severity and mortality in COVID-19 patients during the periods of delta and omicron predominance in Thailand.
    Int J Infect Dis. 2022 Nov 10. pii: S1201-9712(22)00593.
    >> Share

  205. LV Y, Yu G, Zhang X, Gu J, et al
    Comparative analysis of elderly hospitalized patients with coronavirus disease 2019 or influenza A H1N1 virus infections.
    Int J Infect Dis. 2022 Nov 9. pii: S1201-9712(22)00590.
    >> Share

  206. DECENTI EC, Salvatore MA, Mancon A, Portella G, et al
    A large series of molecular and serological specimens to evaluate mother-to-child SARS-CoV-2 transmission: a prospective study from the Italian Obstetric Surveillance System.
    Int J Infect Dis. 2022 Nov 8. pii: S1201-9712(22)00584.
    >> Share

  207. KITAGAWA H, Nomura T, Kaiki Y, Kakimoto M, et al
    Viable SARS-CoV-2 detected in the air of hospital rooms of COVID-19 patients with early infection.
    Int J Infect Dis. 2022 Nov 7. pii: S1201-9712(22)00589.
    >> Share

  208. SALDIVAR-ESPINOZA B, Macip G, Pujadas G, Garcia-Vallve S, et al
    Could nucleocapsid be a next-generation COVID-19 vaccine candidate?
    Int J Infect Dis. 2022 Nov 5. pii: S1201-9712(22)00586.
    >> Share

  209. S S, J LR, N W, P M, et al
    High prevalence of SARS-CoV-2 antibodies in pregnant women, after the second wave of infections in the inner city of Johannesburg, Gauteng Province, South Africa.
    Int J Infect Dis. 2022 Nov 5. pii: S1201-9712(22)00575.
    >> Share

  210. ORONS B, Larson C, Caroen S, Reid TR, et al
    Could nucleocapsid be a next-generation COVID-19 vaccine candidate - author's reply.
    Int J Infect Dis. 2022 Nov 5. pii: S1201-9712(22)00587.
    >> Share

  211. MUHAMMAD AZAMI NA, Perera D, Thayan R, Bakar SA, et al
    SARS-CoV-2 genomic surveillance in Malaysia: Displacement of B.1.617.2 with AY lineages as dominant Delta variants and the introduction of Omicron during the fourth epidemic wave.
    Int J Infect Dis. 2022 Nov 3. pii: S1201-9712(22)00582.
    >> Share

  212. ALVAREZ-DIAZ DA, Ruiz-Moreno HA, Zapata-Bedoya S, Franco-Munoz C, et al
    Clinical outcomes associated with Mu variant infection during the third epidemic peak of COVID-19 in Colombia.
    Int J Infect Dis. 2022 Nov 1. pii: S1201-9712(22)00566.
    >> Share

    October 2022
  213. LAKATOS B, Szabo BG, Bobek I, Kiss-Dala N, et al
    Baricitinib versus tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: A prospective, investigational, real-world study.
    Int J Infect Dis. 2022 Oct 31. pii: S1201-9712(22)00577.
    >> Share

  214. FARRONI C, Aiello A, Picchianti-Diamanti A, Lagana B, et al
    Booster dose of SARS-CoV-2 mRNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study.
    Int J Infect Dis. 2022 Oct 31. pii: S1201-9712(22)00576.
    >> Share

  215. MATONO T, Izumiya H, Koga H, Kaku M, et al
    Epidemiologic and genomic investigations of an unusual increase in Salmonella enterica serovar Paratyphi A infection among travelers returning from Myanmar in 2015.
    Int J Infect Dis. 2022;125:170-176.
    >> Share

  216. LANGER-GOULD A, Xu S, Myers LC, Chen A, et al
    High-dose corticosteroids in patients hospitalized for COVID-19 pneumonia: an observational study of comparative effectiveness.
    Int J Infect Dis. 2022;125:184-191.
    >> Share

  217. XIN H, Wang Z, Feng S, Sun Z, et al
    Transmission dynamics of SARS-CoV-2 Omicron variant infections in Hangzhou, Zhejiang, China, January-February 2022.
    Int J Infect Dis. 2022;126:132-135.
    >> Share

  218. VISSER MPJ, Walk J, Vermeer C, Bilkova S, et al
    Enhanced vitamin K expenditure as a major contributor to vitamin K deficiency in COVID-19.
    Int J Infect Dis. 2022;125:275-277.
    >> Share

  219. CHEN CS, Chang CN, Chen SJ, Hu CF, et al
    Workup of cerebral involvement in patients with COVID-19 - authors' reply.
    Int J Infect Dis. 2022 Oct 26. pii: S1201-9712(22)00563.
    >> Share

  220. SCORZA CA, Finsterer J, Scorza FA, Almeida AG, et al
    Workup of cerebral involvement in COVID-19 requires at least cerebral imaging, EEG, and cerebrospinal fluid studies.
    Int J Infect Dis. 2022 Oct 20. pii: S1201-9712(22)00564.
    >> Share

  221. WANG X, Wen D, He Q, Yang J, et al
    Effect of Corticosteroids in Patients with COVID-19: A Bayesian Network Meta-analysis: Corticosteroids in COVID-19.
    Int J Infect Dis. 2022 Oct 19. pii: S1201-9712(22)00557.
    >> Share

  222. SESSA R, Masciullo L, Filardo S, Pietro MD, et al
    SARS-CoV-2 vertical transmission in a twin-pregnant woman: a case report.
    Int J Infect Dis. 2022 Oct 19. pii: S1201-9712(22)00558.
    >> Share

  223. BLACKMORE C, Czachorowski M, Farrington E, O'Moore E, et al
    Testing for COVID-19 during an outbreak within a large UK prison: an evaluation of mass testing to inform outbreak control.
    Int J Infect Dis. 2022 Oct 17. pii: S1201-9712(22)00556.
    >> Share

  224. DAHL VN, Molhave M, Floe A, van Ingen PJ, et al
    Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review.
    Int J Infect Dis. 2022 Oct 13. pii: S1201-9712(22)00551.
    >> Share

  225. YIN J, Chen Y, Li Y, Wang C, et al
    Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis.
    Int J Infect Dis. 2022 Oct 11. pii: S1201-9712(22)00542.
    >> Share

  226. WANG X, Xu H, Chu P, Zeng Y, et al
    Effects of COVID-19-targeted NPIs on children's respiratory admissions in China: a national multicenter time series study.
    Int J Infect Dis. 2022 Oct 11. pii: S1201-9712(22)00546.
    >> Share

  227. AGGARWAL NR, Beaty LE, Bennett TD, Carlson NE, et al
    Change in Effectiveness of Sotrovimab for Preventing Hospitalization and Mortality for At-risk COVID-19 Outpatients During an Omicron BA.1 and BA.1.1-Predominant Phase.
    Int J Infect Dis. 2022 Oct 10. pii: S1201-9712(22)00540.
    >> Share

  228. MIMURA W, Ishiguro C, Maeda M, Murata F, et al
    Effectiveness of mRNA vaccines against SARS-CoV-2 infections during the periods of Delta and Omicron variant predominance in Japan: The VENUS Study.
    Int J Infect Dis. 2022 Oct 8. pii: S1201-9712(22)00539.
    >> Share

  229. DE FREITAS AVC, Magalhaes AM, Carricondo PC, Avakian Shinzato A, et al
    Face masks can reduce the frequency of face touching: an observational crossover study.
    Int J Infect Dis. 2022;123:54-57.
    >> Share

    September 2022
  230. DAITCH V, Yelin D, Awwad M, Guaraldi G, et al
    Characteristics of long COVID among older adults: a cross-sectional study.
    Int J Infect Dis. 2022 Sep 30. pii: S1201-9712(22)00535.
    >> Share

  231. MUADCHIMKAEW M, Siripongboonsitti T, Wongpatcharawarakul S, Boonsankaew C, et al
    Effect of Inactivated SARS-CoV-2 Vaccines and ChAdOx1 nCoV-19 Vaccination to Prevent COVID-19 in Thai Households (VacPrevent trial).
    Int J Infect Dis. 2022 Sep 27. pii: S1201-9712(22)00531.
    >> Share

  232. ALHINAI Z, Park S, Choe YJ, Michelow IC, et al
    A global epidemiological analysis of COVID-19 vaccine types and clinical outcomes.
    Int J Infect Dis. 2022 Sep 22. pii: S1201-9712(22)00514.
    >> Share

  233. CHOBER D, Czajkowski Z, Aksak-Was B, Dalewska-Kucharczyk K, et al
    Improved survival in ICU in severe COVID-19 associated with amantadine use - retrospective study.
    Int J Infect Dis. 2022 Sep 21. pii: S1201-9712(22)00525.
    >> Share

  234. ZAQOUT A, Almaslamani MA, Chemaitelly H, Hashim SA, et al
    Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild-to-moderate SARS-CoV-2 in Qatar.
    Int J Infect Dis. 2022;124:96-103.
    >> Share

  235. TAMURA D, Yamagishi H, Morisawa Y, Mato T, et al
    Diagnostic accuracy of a novel severe acute respiratory syndrome coronavirus 2 rapid antigen test and usefulness of specimens collected from the anterior nasal cavity.
    Int J Infect Dis. 2022 Sep 16. pii: S1201-9712(22)00517.
    >> Share

  236. FENIZIA C, Vanetti C, Rana F, Cappelletti G, et al
    SARS-CoV-2 vertical transmission during the first trimester of pregnancy in asymptomatic women.
    Int J Infect Dis. 2022 Sep 16. pii: S1201-9712(22)00520.
    >> Share

  237. KUBO M, Kubo K, Kobayashi KI, Komiya N, et al
    Non-severe COVID-19 complicated by cytotoxic lesions of the corpus callosum (mild encephalitis/encephalopathy with a reversible splenial lesion): a case report and literature review.
    Int J Infect Dis. 2022 Sep 16. pii: S1201-9712(22)00508.
    >> Share

  238. ANDO M, Satonaga Y, Takaki R, Yabe M, et al
    Acute asthma exacerbation due to SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine [Comirnaty(R)]).
    Int J Infect Dis. 2022 Sep 16. pii: S1201-9712(22)00518.
    >> Share

  239. VICENTINI C, Bordino V, Cornio AR, Meddis D, et al
    Seroprevalence of infection-induced SARS-CoV-2 antibodies among healthcare users of Northern Italy - results from two serosurveys (October-November 2019 - September-October 2021).
    Int J Infect Dis. 2022 Sep 15. pii: S1201-9712(22)00513.
    >> Share

  240. ROTUNDO S, Vecchio E, Abatino A, Giordano C, et al
    Spike-specific T-cell responses in COVID-19 patients successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2.
    Int J Infect Dis. 2022 Sep 15. pii: S1201-9712(22)00515.
    >> Share

  241. KIM AY, Woo W, Yon DK, Lee SW, et al
    Corrigendum to 'Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis' International Journal of Infectious Diseases, Volume 119, June 2022, Page 130-139.
    Int J Infect Dis. 2022;123:166.
    >> Share

  242. D'ABRAMO A, Vita S, Colavita F, Cimini E, et al
    The first case of meningitis associated to SARS-Coronavirus-2 BA.2 variant infection with persistent viremia.
    Int J Infect Dis. 2022 Sep 12. pii: S1201-9712(22)00510.
    >> Share

  243. ANTONAZZO IC, Fornari C, Rozza D, Conti S, et al
    Azithromycin use and outcomes in COVID-19 patients: an observational real-world study.
    Int J Infect Dis. 2022 Sep 8. pii: S1201-9712(22)00504.
    >> Share

  244. GIUSEPPE S, Guarini R, Vaia F, Maggi F, et al
    Monitoring of SARS-CoV-2 circulation using saliva testing in school children, Rome, Italy.
    Int J Infect Dis. 2022 Sep 8. pii: S1201-9712(22)00502.
    >> Share

  245. ZAYET S, Vuillemenot JB, Josset L, Gendrin V, et al
    Simultaneous co-infection with Omicron (B.1.1.529) and Delta (21A/478K.V1) SARS-CoV-2 variants confirmed by whole genome sequencing.
    Int J Infect Dis. 2022 Sep 7. pii: S1201-9712(22)00501.
    >> Share

  246. CHEN CS, Chang CN, Hu CF, Jian MJ, et al
    Critical pediatric neurological illness associated with COVID-19 (Omicron BA.2.3.7 variant) infection in Taiwan: Immunological assessment and viral genome analysis in tertiary medical center.
    Int J Infect Dis. 2022 Sep 7. pii: S1201-9712(22)00500.
    >> Share

  247. ABROI A, Talas UG, Pauskar M, Shablinskaja A, et al
    SARS-CoV-2 dual infection of Delta and Omicron variants in an immunocompetent host - a case report.
    Int J Infect Dis. 2022 Sep 5. pii: S1201-9712(22)00497.
    >> Share

  248. LI YE, Wang S, Reiter RJ, Ren J, et al
    Clinical Cardiovascular Emergencies and the Cellular Basis of COVID-19 Vaccination: from a Dream to Reality?
    Int J Infect Dis. 2022 Sep 5. pii: S1201-9712(22)00498.
    >> Share

  249. LEE SS, Viboud C, Petersen E
    Understanding the rebound of influenza in the post COVID-19 pandemic period holds important clues for epidemiology and control.
    Int J Infect Dis. 2022;122:1002-1004.
    >> Share

    August 2022
  250. WAITS A, Chen JY, Cheng WH, Yeh JI, et al
    Safety and Immunogenicity of MVC-COV1901 Vaccine in Older Adults: Phase 2 Randomized Dose-Comparison Trial.
    Int J Infect Dis. 2022 Aug 29. pii: S1201-9712(22)00491.
    >> Share

  251. BRUNNER WM, Freilich D, Victory J, Krupa N, et al
    Comparison of Antibody Response Durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 Vaccines in Healthcare Workers.
    Int J Infect Dis. 2022 Aug 28. pii: S1201-9712(22)00492.
    >> Share

  252. ASSERI AA, Assiri M, Alshehri MA, Asseri M, et al
    Acute Encephalopathy in a 6-Year-Old Child with Concurrent Coronavirus Disease-2019 Infection: A Case Report from Saudi Arabia.
    Int J Infect Dis. 2022 Aug 20. pii: S1201-9712(22)00483.
    >> Share

  253. SAINZ-GARCIA A, Toledano P, Muro-Fraguas I, Alvarez-Erviti L, et al
    Mask Disinfection using Atmospheric Pressure Cold Plasma.
    Int J Infect Dis. 2022 Aug 19. pii: S1201-9712(22)00482.
    >> Share

  254. OEHLER RL, Vega VR
    Global Vaccine Inequality Threatens to Unleash the Next COVID-19 Variant.
    Int J Infect Dis. 2022 Aug 18. pii: S1201-9712(22)00480.
    >> Share

  255. GHAFFARZADEGAN N
    Effect of mandating vaccination on COVID-19 cases in colleges and universities.
    Int J Infect Dis. 2022 Aug 17. pii: S1201-9712(22)00477.
    >> Share

  256. VIEL S, Markowicz S, Ait-Medjber L, Ouissa R, et al
    Dedicated team to ambulatory care for patients with COVID-19 requiring oxygen: low rate of hospital readmission.
    Int J Infect Dis. 2022 Aug 17. pii: S1201-9712(22)00452.
    >> Share

  257. YU T, Liu F, Yin H, Yi N, et al
    Comment to the article by Pedro Brotons: Validation and implementation of a direct RT-qPCR method for rapid screening of SARS-CoV-2 infection by using non-invasive saliva samples, IJID 110 (2021) 363-370.
    Int J Infect Dis. 2022 Aug 17. pii: S1201-9712(22)00478.
    >> Share

  258. SANCHEZ-CONDE M, Vizcarra P, Perez-Garcia JM, Gion M, et al
    Pembrolizumab in combination with tocilizumab in high-risk hospitalized COVID-19 patients (COPERNICO): A randomized proof-of-concept phase II study.
    Int J Infect Dis. 2022 Aug 17. pii: S1201-9712(22)00475.
    >> Share

  259. NAVARATNAM AMD, Shrotri M, Nguyen V, Braithwaite I, et al
    Nucleocapsid and spike antibody responses post virologically confirmed SARS-CoV-2 infection: An observational analysis in the Virus Watch community cohort.
    Int J Infect Dis. 2022 Aug 17. pii: S1201-9712(22)00449.
    >> Share

  260. RAYMENANTS J, Duthoo W, Stakenborg T, Verbruggen B, et al
    Exhaled breath SARS-CoV-2 shedding patterns across variants of concern.
    Int J Infect Dis. 2022 Aug 3. pii: S1201-9712(22)00466.
    >> Share

  261. LIANG Y, Mao X, Kuang M, Zhi J, et al
    IL-6 affects the severity of olfactory disorder: A cross-sectional survey of 148 patients who recovered from Omicron infection using the Sniffin' Sticks test in Tianjin, China.
    Int J Infect Dis. 2022 Aug 2. pii: S1201-9712(22)00468.
    >> Share

  262. ALMADHI M, Alsayyad AS, Conroy R, Atkin S, et al
    EPIDEMIOLOGICAL ASSESSMENT OF SARS-COV-2 REINFECTION.
    Int J Infect Dis. 2022 Aug 2. pii: S1201-9712(22)00470.
    >> Share

    July 2022
  263. DE OLIVEIRA JF, de Avila RE, de Oliveira NR, da Cunha Severino Sampaio N, et al
    Persistent symptoms, quality of life and risk factors in long COVID: a cross-sectional study of hospitalized patients in Brazil.
    Int J Infect Dis. 2022 Jul 28. pii: S1201-9712(22)00458.
    >> Share

  264. SRECKOVIC M, Marjanovic RR, Jovicic BP, Jankovic S, et al
    MULTISYSTEM INFLAMMATORY SYNDROME IN YOUNG ADULT SUCCESSFULLY TREATED WITH PLASMAPHERESIS, IMMUNOGLOBULINS AND CORTICOSTEROIDS: A CASE REPORT.
    Int J Infect Dis. 2022 Jul 28. pii: S1201-9712(22)00454.
    >> Share

  265. LI T, Song R, Wang J, Zhang J, et al
    Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer.
    Int J Infect Dis. 2022 Jul 26. pii: S1201-9712(22)00446.
    >> Share

  266. DAHAL S, Mamelund SE, Luo R, Sattenspiel L, et al
    Investigating COVID-19 transmission and mortality differences among Indigenous and non-Indigenous populations in Mexico.
    Int J Infect Dis. 2022 Jul 26. pii: S1201-9712(22)00447.
    >> Share

  267. AIELLO A, Coppola A, Vanini V, Petrone L, et al
    Accuracy of QuantiFERON SARS-CoV-2 RUO assay and characterization of the CD4(+) and CD8(+) T-cell-SARS-CoV-2 response: comparison with a homemade IFN-gamma release assay.
    Int J Infect Dis. 2022 Jul 22. pii: S1201-9712(22)00444.
    >> Share

  268. DORIA G, Clemente C, Coelho E, Colaco J, et al
    An isothermal lab-on-phone test for easy molecular diagnostic of SARS-CoV-2 near patient and in less than 1 hour.
    Int J Infect Dis. 2022 Jul 22. pii: S1201-9712(22)00436.
    >> Share

  269. VALLADARES-GARRIDO MJ, Failoc-Rojas VE, Soto-Becerra P, Zena-Nanez S, et al
    Clinical-epidemiological variation in patients treated in the first and second wave of COVID-19 in Lambayeque, Peru: A cluster analysis.
    Int J Infect Dis. 2022 Jul 21. pii: S1201-9712(22)00442.
    >> Share

  270. VILLAFUERTE DB, Lavrynenko O, Qazi R, Passeri MF, et al
    Chronic Active Epstein-Barr Exacerbated by COVID-19 Co-Infection.
    Int J Infect Dis. 2022 Jul 21. pii: S1201-9712(22)00439.
    >> Share

  271. AKHMETZHANOV AR, Ponce L, Thompson RN
    Emergence potential of Monkeypox in the Western Pacific Region, July 2022.
    Int J Infect Dis. 2022 Jul 21. pii: S1201-9712(22)00441.
    >> Share

  272. LU J, Zhu J, Zhu J, Duong TQ, et al
    LSTM machine learning of longitudinal clinical data accurately predicts acute kidney injury onset in COVID-19: a two-center study.
    Int J Infect Dis. 2022 Jul 21. pii: S1201-9712(22)00429.
    >> Share

  273. ASSAWAKOSRI S, Kanokudom S, Chansaenroj J, Suntronwong N, et al
    Persistence of immunity against Omicron BA.1 and BA.2 following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-doses AZD1222 vaccination.
    Int J Infect Dis. 2022 Jul 18. pii: S1201-9712(22)00433.
    >> Share

  274. BAIRD D, Muir A, Logan L, MacLennan M, et al
    Validation of the NeuMoDx SARS-CoV-2 Assay with COPAN eNAT(R) and E&O Viral PCR Sample Solution (VPSS) collection media types in comparison with other validated SARS-CoV-2 RNA assays.
    Int J Infect Dis. 2022 Jul 15. pii: S1201-9712(22)00418.
    >> Share

  275. BHATNAGAR T, Chaudhuri S, Ponnaiah M, Yadav PD, et al
    Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: A multi-centric hospital-based case-control study.
    Int J Infect Dis. 2022 Jul 14. pii: S1201-9712(22)00427.
    >> Share

  276. YIN Q, Li Y, Pan H, Hui T, et al
    Atypical pneumonia caused by Chlamydia Psittaci during the COVID-19 pandemic.
    Int J Infect Dis. 2022 Jul 13. pii: S1201-9712(22)00422.
    >> Share

  277. VOOR IN 'T HOLT AF, Haanappel CP, Rahamat-Langendoen J, Molenkamp R, et al
    Admissions to a large tertiary care hospital and Omicron BA.1 and BA.2 SARS-CoV-2 PCR positivity: primary, contributing, or incidental COVID-19.
    Int J Infect Dis. 2022 Jul 13. pii: S1201-9712(22)00424.
    >> Share

  278. MAAMARI KA, Busaidi IA, Kindi MA, Zadjali F, et al
    Short and long-term immune changes in different severity groups of COVID-19 disease.
    Int J Infect Dis. 2022 Jul 12. pii: S1201-9712(22)00421.
    >> Share

  279. ALOTAIBY M, Krissaane I, Seraihi AA, Alshenaifi J, et al
    SARS-CoV-2 Reinfection Rate and Outcomes in Saudi Arabia: A National Retrospective Study.
    Int J Infect Dis. 2022 Jul 12. pii: S1201-9712(22)00420.
    >> Share

  280. JUANOLA-FALGARONA M, Penarrubia L, Jimenez-Guzman S, Porco R, et al
    Ct values as a diagnostic tool for monitoring SARS-CoV-2 viral load using the QIAstat-Dx(R) Respiratory SARS-CoV-2 Panel.
    Int J Infect Dis. 2022 Jul 12. pii: S1201-9712(22)00419.
    >> Share

  281. TOCZYLOWSKI K, Lasecka-Zadrozna J, Palyga-Bysiecka I, Ludwikowska KM, et al
    Use of broad-spectrum antibiotics in children diagnosed with multisystem inflammatory syndrome temporarily associated with SARS-CoV-2 infection in Poland: the MOIS-CoR study.
    Int J Infect Dis. 2022 Jul 10. pii: S1201-9712(22)00416.
    >> Share

  282. DASTENAE ZH, Bahadori A, Dehghani M, Asadi-Samani M, et al
    Comparison of the effect of intravenous dexamethasone and methylprednisolone on the treatment of hospitalized patients with COVID-19: A randomized clinical trial.
    Int J Infect Dis. 2022 Jul 8. pii: S1201-9712(22)00413.
    >> Share

  283. PETERSEN MS, Kongsstovu SI, Eliasen EH, Larsen S, et al
    Clinical characteristics of the Omicron variant - results from a Nationwide Symptoms Survey in the Faroe Islands.
    Int J Infect Dis. 2022 Jul 7. pii: S1201-9712(22)00405.
    >> Share

  284. NATH H, Mallick A, Roy S, Kayal T, et al
    COVID-19 serum can be cross-reactive and neutralizing against Dengue virus (DV) as observed by DV neutralization test.
    Int J Infect Dis. 2022 Jul 7. pii: S1201-9712(22)00408.
    >> Share

  285. BIBER A, Harmelin G, Lev D, Ram L, et al
    The effect of ivermectin on the viral load and culture viability in early treatment of non-hospitalized patients with mild COVID-19 - A double-blind, randomized placebo-controlled trial.
    Int J Infect Dis. 2022 Jul 7. pii: S1201-9712(22)00399.
    >> Share

  286. FUKUSHIMA T, Chubachi S, Namkoong H, Otake S, et al
    U-shaped association between abnormal serum uric acid levels and COVID-19 severity: Reports from the Japan COVID-19 Task Force.
    Int J Infect Dis. 2022 Jul 7. pii: S1201-9712(22)00409.
    >> Share

  287. MURUGESAN M, Venkatesan P, Kumar S, Thangavelu P, et al
    Epidemiological investigation of the COVID-19 outbreak in Vellore district in South India using Geographic Information Surveillance (GIS).
    Int J Infect Dis. 2022 Jul 7. pii: S1201-9712(22)00402.
    >> Share

  288. RICCIARDI A, Zelini P, Cassaniti I, Avanzini MA, et al
    Serum and breastmilk SARS-CoV-2 specific antibodies following BNT162b2 vaccine: Prolonged protection from SARS-CoV-2 in newborns and older children.
    Int J Infect Dis. 2022 Jul 5. pii: S1201-9712(22)00392.
    >> Share

  289. TOBBACK E, Degroote S, Buysse S, Delesie L, et al
    Efficacy and safety of camostat mesylate in early Covid-19 disease in an ambulatory setting: A randomized placebo-controlled phase II trial.
    Int J Infect Dis. 2022 Jul 5. pii: S1201-9712(22)00388.
    >> Share

  290. MALINOWSKA J, Malecka-Gieldowska M, Bankowska D, Borecka K, et al
    Hypermagnesemia and hyperphosphatemia are highly prevalent in COVID-19 patients and increase the risk of death.
    Int J Infect Dis. 2022 Jul 5. pii: S1201-9712(22)00394.
    >> Share

  291. SALEH T, Kerin T, Fuller T, Paiola S, et al
    Clinical and epidemiological characteristics of SARS-CoV-2 Infection in Los Angeles County youth during the first year of the pandemic.
    Int J Infect Dis. 2022 Jul 5. pii: S1201-9712(22)00374.
    >> Share

  292. LARSEN CS
    Assessing the proportion of the Danish population at risk of clinically significant drug-drug interactions with new oral antivirals for early treatment of COVID-19.
    Int J Infect Dis. 2022 Jul 5. pii: S1201-9712(22)00391.
    >> Share

  293. DESWAL V, Phogat R, Sharma P, Kataria S, et al
    Is single dose of ChAdOx1 nCoV-19 vaccine (AZD1222) enough for persons with prior SARS-CoV-2 infection or baseline seropositive status?
    Int J Infect Dis. 2022 Jul 3. pii: S1201-9712(22)00384.
    >> Share

  294. DING L, Chen Y, Su N, Xu X, et al
    Comparison of acute respiratory distress syndrome in patients with COVID-19 and influenza A (H7N9) virus infection.
    Int J Infect Dis. 2022 Jul 3. pii: S1201-9712(22)00387.
    >> Share

  295. KOH K, Tang KC, Axhausen K, Loo BP, et al
    A metropolitan-scale, three-dimensional agent-based model to assess the effectiveness of the COVID-19 Omicron wave interventions in a hyperdense city: a case study of Hong Kong.
    Int J Infect Dis. 2022 Jul 3. pii: S1201-9712(22)00376.
    >> Share

  296. XIONG L, Li Q, Cao X, Xiong H, et al
    Recovery of functional fitness, lung function and immune function in health care workers with non-severe and severe COVID-19 at 13 months after discharge from the hospital: a prospective cohort study.
    Int J Infect Dis. 2022 Jul 3. pii: S1201-9712(22)00386.
    >> Share

  297. CHEN NY, Liu ZH, Kao SW, Lin HS, et al
    Changes in Interferon-Gamma Release Assay Readout after COVID-19 Vaccination: A Prospective Cohort Study.
    Int J Infect Dis. 2022 Jul 1. pii: S1201-9712(22)00382.
    >> Share

  298. ORONSKY B, Larson C, Caroen S, Hedjran F, et al
    Nucleocapsid as a Next Generation COVID-19 Vaccine Candidate.
    Int J Infect Dis. 2022 Jul 1. pii: S1201-9712(22)00379.
    >> Share

  299. ISA F, Forleo-Neto E, Meyer J, Zheng W, et al
    Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19.
    Int J Infect Dis. 2022 Jul 1. pii: S1201-9712(22)00380.
    >> Share

    June 2022
  300. FARIDL M, Mellyani K, Khoirunnisa K, Septiani P, et al
    RNA-seq analysis of nasopharyngeal swabs from asymptomatic and mildly symptomatic COVID-19 patients.
    Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00368.
    >> Share

  301. DOS SANTOS PG, Vieira HCVS, Wietholter V, Gallina JP, et al
    When to test for COVID-19 using RT-PCR: a systematic review.
    Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00370.
    >> Share

  302. SBERNA G, Fabeni L, Berno G, Carletti F, et al
    Rapid and qualitative identification of SARS-CoV-2 mutations associated with Variants Of Concern (VOC) using a multiplex RT-PCR assay coupled with melting analysis.
    Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00367.
    >> Share

  303. HIROTSU Y, Maejima M, Shibusawa M, Natori Y, et al
    Classification of Omicron BA.1, BA.1.1 and BA.2 sublineages by TaqMan assay consistent with whole genome analysis data.
    Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00373.
    >> Share

  304. FINSTERER J, Scorza FA
    Rule out appropriately all differentials before attributing severe rhabdomyolysis to SARS-CoV-2 vaccination: COVID-19 associated abdominal epilepsy.
    Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00372.
    >> Share

  305. KAMURA Y, Matsue K
    Severe rhabdomyolysis and SARS-CoV-2 vaccination: A reply to the letter by Dr Josef Finsterer.
    Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00366.
    >> Share

  306. PETERSEN MS, Kristiansen MF, Hanusson KD, Foldbo BM, et al
    Prevalence of long COVID in a national cohort: longitudinal measures from disease onset until 8 months follow up.
    Int J Infect Dis. 2022 Jun 23. pii: S1201-9712(22)00364.
    >> Share

  307. RUTER J, Pallerla SR, Meyer CG, Casadei N, et al
    Host genetic loci LZTFL1 and CCL2 associated with SARS-CoV-2 infection and severity of COVID-19.
    Int J Infect Dis. 2022 Jun 23. pii: S1201-9712(22)00365.
    >> Share

  308. KSHATRI JS, Giri S, Bhattacharya D, Palo SK, et al
    Analysis of the COVID-19 testing parameters and progression of the pandemic at the district level- findings from the ICMR- Hundred Million Test (HMT) database during the first wave in India.
    Int J Infect Dis. 2022 Jun 22. pii: S1201-9712(22)00361.
    >> Share

  309. ROVIDA F, Esposito GL, Rissone M, Novelli V, et al
    Characteristics and outcome of vaccinated and non-vaccinated patients hospitalized in a single Italian HUB for COVID-19 during the Delta and Omicron waves in Northern Italy.
    Int J Infect Dis. 2022 Jun 21. pii: S1201-9712(22)00362.
    >> Share

  310. RIZZO R, Bortolotti D, Morandi L, Rizzo S, et al
    Humoral and adaptive immune responses to SARS-CoV-2 vaccine.
    Int J Infect Dis. 2022 Jun 21. pii: S1201-9712(22)00355.
    >> Share

  311. QUARANTA EG, Fusaro A, Giussani E, D'Amico V, et al
    SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient.
    Int J Infect Dis. 2022 Jun 17. pii: S1201-9712(22)00359.
    >> Share

  312. STAMBOULI N, Driss A, Gargouri F, Bahrini K, et al
    COVID-19 prophylaxis with Doxycycline and Zinc in Health Care Workers: A prospective randomized double-blind clinical trial.
    Int J Infect Dis. 2022 Jun 17. pii: S1201-9712(22)00349.
    >> Share

  313. QIN J, Wang G, Han D
    Benefits of plasma exchange on mortality in patients with COVID-19: a systematic review and meta-analysis.
    Int J Infect Dis. 2022 Jun 13. pii: S1201-9712(22)00348.
    >> Share

  314. KOLLER JE, Villinger K, Lages NC, Absetz P, et al
    Individual and collective protective responses during the early phase of the COVID-19 pandemic in 10 different countries: Results from the EUCLID online-survey.
    Int J Infect Dis. 2022 Jun 13. pii: S1201-9712(22)00347.
    >> Share

  315. CLARO F, Silva D, Bogado JAP, Rangel HR, et al
    Lasting SARS-CoV-2 specific IgG Antibody response in health care workers from Venezuela, 6 months after vaccination with Sputnik V.
    Int J Infect Dis. 2022 Jun 8. pii: S1201-9712(22)00341.
    >> Share

  316. TARNAS MC, Desai AN, Parker DM, Almhawish N, et al
    Syndromic surveillance of respiratory infections during protracted conflict: experiences from northern Syria 2016-2021.
    Int J Infect Dis. 2022 Jun 7. pii: S1201-9712(22)00336.
    >> Share

  317. SASANAMI M, Kayano T, Nishiura H
    Monitoring the COVID-19 immune landscape in Japan.
    Int J Infect Dis. 2022 Jun 7. pii: S1201-9712(22)00338.
    >> Share

  318. MANNATHOKO N, Mospele M, Gross R, Smith RM, et al
    Colonization with Extended-Spectrum Cephalosporin-Resistant Enterobacterales (ESCrE) and Carbapenem-Resistant Enterobacterales (CRE) in Healthcare and Community Settings in Botswana: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
    Int J Infect Dis. 2022 Jun 7. pii: S1201-9712(22)00337.
    >> Share

  319. KHONGYOT T, Moriyasu T
    Invasive Pneumococcal Disease diminish during the coronavirus disease 2019 in Japan between 2019 and 2022.
    Int J Infect Dis. 2022 Jun 4. pii: S1201-9712(22)00333.
    >> Share

  320. HERNANDEZ PORTO M, Garcia S, Delgado T, Rodriguez Y, et al
    Humoral response to SARS-COV-2 after vaccination and C in dialyzed patients.
    Int J Infect Dis. 2022 Jun 4. pii: S1201-9712(22)00335.
    >> Share

  321. DIVINO F, Alaimo Di Loro P, Farcomeni A, Jona-Lasinio G, et al
    Decreased severity of the Omicron variant of concern: further evidence from Italy.
    Int J Infect Dis. 2022;119:21-23.
    >> Share

    May 2022
  322. LAI X, Deng S, Hu L, Chen R, et al
    J-shaped associations and joint effects of fasting glucose with inflammation and cytokines on COVID-19 mortality.
    Int J Infect Dis. 2022 May 31. pii: S1201-9712(22)00324.
    >> Share

  323. BORDI L, Sberna G, Piscioneri CN, Cocchiara RA, et al
    Longitudinal dynamics of SARS-CoV2 anti-Receptor Binding Domain IgG antibodies in a wide population of health care workers after BNT162b2 vaccination.
    Int J Infect Dis. 2022 May 31. pii: S1201-9712(22)00325.
    >> Share

  324. BACHELARD A, Sautereau A, Digumber M, Isernia V, et al
    Risk Factors Associated with Severe/Critical COVID-19 in People Living with HIV-1.
    Int J Infect Dis. 2022 May 29. pii: S1201-9712(22)00320.
    >> Share

  325. JIN T, Chen X, Nishio M, Zhuang L, et al
    Interventions to prevent surface transmission of an infectious virus based on real human touch behavior: A case study of the norovirus.
    Int J Infect Dis. 2022 May 29. pii: S1201-9712(22)00311.
    >> Share

  326. ALBERTO-ORLANDO S, Calderon JL, Leon-Sosa A, Patino L, et al
    SARS-CoV-2 transmission from infected owner to household dogs and cats is associated to food sharing.
    Int J Infect Dis. 2022 May 25. pii: S1201-9712(22)00313.
    >> Share

  327. TEGETHOFF SA, Danziger G, Kuhn D, Kimmer C, et al
    TRAIL, IP-10, and CRP in predicting the progression of SARS-CoV-2 infection: A prospective, cohort study.
    Int J Infect Dis. 2022 May 25. pii: S1201-9712(22)00315.
    >> Share

  328. ALI M, Bonna AS, Sarkar AS, Islam MA, et al
    SARS-CoV-2 infection is associated with low back pain: Findings from a community based case-control study.
    Int J Infect Dis. 2022 May 25. pii: S1201-9712(22)00312.
    >> Share

  329. WAWINA-BOKALANGA T, Logist AS, Sinnesael R, Van Holm B, et al
    Genomic evidence of co-identification with Omicron and Delta SARS-CoV-2 variants: A report of two cases.
    Int J Infect Dis. 2022 May 20. pii: S1201-9712(22)00304.
    >> Share

  330. KORAYEM GB, Aljuhani O, Altebainawi AF, Shaya AIA, et al
    The Safety and Efficacy of Tocilizumab in Older Adult Critically Ill Patients with Coronavirus Disease 2019 (COVID-19): A Multi-center, Cohort Study.
    Int J Infect Dis. 2022 May 20. pii: S1201-9712(22)00302.
    >> Share

  331. MATTIUZZI C, Lippi G
    Real-world effectiveness of COVID-19 vaccination among children in Italy.
    Int J Infect Dis. 2022 May 19. pii: S1201-9712(22)00309.
    >> Share

  332. NTAGEREKA PB, Oyola SO, Baenyi SP, Rono GK, et al
    Whole-Genome Sequencing of SARS-CoV-2 Reveals Diverse Mutations in Circulating Alpha and Delta Variants during the First, Second and Third Waves of Covid-19 in South Kivu, East of the Democratic Republic of Congo.
    Int J Infect Dis. 2022 May 19. pii: S1201-9712(22)00307.
    >> Share

  333. KUDHAIL K, Thompson J, Mathews V, Morrison B, et al
    Randomised controlled trials in COVID-19 patients: a systematic review and critical appraisal.
    Int J Infect Dis. 2022 May 18. pii: S1201-9712(22)00299.
    >> Share

  334. KIRSCH F, Lindemann AK, Geppert J, Borzekowski D, et al
    Personal Protective Measures During the Coronavirus Pandemic in Germany.
    Int J Infect Dis. 2022 May 18. pii: S1201-9712(22)00297.
    >> Share

  335. EYU P, Elyanu P, Ario AR, Ntono V, et al
    Investigation of Possible Preventable Causes of COVID-19 Deaths in the Kampala Metropolitan Area, Uganda, 2020-2021.
    Int J Infect Dis. 2022 May 17. pii: S1201-9712(22)00296.
    >> Share

  336. GUPTA S, Gupta T, Gupt N
    Global Respiratory Virus Surveillance: Strengths, Gaps and Way Forward.
    Int J Infect Dis. 2022 May 15. pii: S1201-9712(22)00294.
    >> Share

  337. XUE L, Jing S, Zhang K, Milne R, et al
    Infectivity versus fatality of SARS-CoV-2 mutations and influenza.
    Int J Infect Dis. 2022 May 15. pii: S1201-9712(22)00295.
    >> Share

  338. OKOTURO E, Amure M
    SARS-CoV-2 saliva testing using reverse transcriptase - polymerase chain reaction (RT-PCR): A Systematic Review.
    Int J Infect Dis. 2022 May 13. pii: S1201-9712(22)00272.
    >> Share

  339. NISHIURA H, Jung SM, Hayashi K
    High population burden of Omicron variant (B.1.1.529) is associated with the emergence of severe hepatitis of unknown etiology in children.
    Int J Infect Dis. 2022 May 13. pii: S1201-9712(22)00290.
    >> Share

  340. MARCO R, Angelo DV
    Commentary to the paper: Association of smoking and severity of covid-19 infection among 5889 patients in malaysia: a multi-centre observational study, by Ismail N, Hassan N, Hamid MHNA, Yusoff UN, Khamal NR, Omar MA, et al. published in Int J Infect
    Int J Infect Dis. 2022 May 12. pii: S1201-9712(22)00284.
    >> Share

  341. INGHELS M, Kane R, Lall P, Nelson D, et al
    Ethnicity and risk of SARS-CoV-2 infection among the healthcare workforce: Results of a retrospective cohort study in rural United Kingdom.
    Int J Infect Dis. 2022 May 12. pii: S1201-9712(22)00281.
    >> Share

  342. YILDIZ Y, Ozger HS, Senol E, Karakus R, et al
    Evaluation of long term antibody kinetics in healthcare workers (HCWs) vaccinated with inactivated COVID-19 vero cell vaccine (CoronaVac), a propensity score matched observational study: Antibody kinetics in HCWs after CoronaVac vaccination.
    Int J Infect Dis. 2022 May 11. pii: S1201-9712(22)00271.
    >> Share

  343. OLIVEIRA-SILVA J, Reis T, Lopes C, Batista-Silva R, et al
    Long term serological SARS-CoV-2 IgG kinetics following mRNA COVID-19 vaccine: real-world data from a large cohort of healthcare workers.
    Int J Infect Dis. 2022 May 11. pii: S1201-9712(22)00289.
    >> Share

  344. CHEN F, Tian Y, Zhang L, Shi Y, et al
    The Role of Children in Household Transmission of COVID-19: A Systematic Review and Meta-Analysis.
    Int J Infect Dis. 2022 May 10. pii: S1201-9712(22)00283.
    >> Share

  345. ICHIKAWA T, Torii S, Suzuki H, Takada A, et al
    Mutations in the non-structural proteins of SARS-CoV-2 may contribute to adverse clinical outcome in COVID-19 patients.
    Int J Infect Dis. 2022 May 10. pii: S1201-9712(22)00275.
    >> Share

  346. BALUSHI AA, Ajmi AA, Sinani QA, Menon V, et al
    COVID-19 Associated Mucormycosis: Opportunistic Fugal Infection. A case series and review.
    Int J Infect Dis. 2022 May 6. pii: S1201-9712(22)00267.
    >> Share

  347. COLANERI M, Amarasinghe N, Rezzonico L, Pieri TC, et al
    Early Remdesivir to prevent severe COVID-19 in solid organ transplant recipients: a real-life study from Northern Italy.
    Int J Infect Dis. 2022 May 6. pii: S1201-9712(22)00263.
    >> Share

    April 2022
  348. KAMEGAI K, Iwamoto N, Togano T, Maeda K, et al
    A Fatal Breakthrough Coronavirus Disease 2019 Case Following Bendamustine-Rituximab Therapy.
    Int J Infect Dis. 2022 Apr 29. pii: S1201-9712(22)00258.
    >> Share

  349. YOSHIMURA Y, Sasaki H, Miyata N, Miyazaki K, et al
    An autopsy case of COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination.
    Int J Infect Dis. 2022 Apr 29. pii: S1201-9712(22)00257.
    >> Share

  350. HUSIN M, Tok PSK, Suah JL, Thevananthan T, et al
    Real-world effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection among adolescents (12 to 17-year-olds) in Malaysia.
    Int J Infect Dis. 2022 Apr 29. pii: S1201-9712(22)00251.
    >> Share

  351. BHAKTA S, Sanghavi DK, Johnson PW, Kunze KL, et al
    Clinical and Laboratory Profiles of SARS-CoV-2 Delta Variant Compared to Pre-Delta Variants.
    Int J Infect Dis. 2022 Apr 26. pii: S1201-9712(22)00252.
    >> Share

  352. PAROLINA L, Pshenichnaya N, Vasilyeva I, Lizinfed I, et al
    Clinical characteristics of COVID-19 in TB patients and factors associated with the disease severity.
    Int J Infect Dis. 2022 Apr 25. pii: S1201-9712(22)00232.
    >> Share

  353. LI J, Liu B, Tang X, Wu Z, et al
    Development of a smartphone based quantum-dot lateral flow immunoassay strip for ultrasensitive detection of anti-SARS-CoV-2 IgG and neutralizing antibodies.
    Int J Infect Dis. 2022 Apr 25. pii: S1201-9712(22)00235.
    >> Share

  354. MURILLO-ZAMORA E, Trujillo X, Huerta M, Rios-Silva M, et al
    COVID-19 vaccines provide better protection against related pneumonia than previous symptomatic infection.
    Int J Infect Dis. 2022 Apr 24. pii: S1201-9712(22)00245.
    >> Share

  355. XIA Y, Ma H, Buckeridge DL, Brisson M, et al
    Mortality trends and lengths of stay among hospitalized COVID-19 patients in Ontario and Quebec (Canada): a population-based cohort study of the first three epidemic waves.
    Int J Infect Dis. 2022 Apr 24. pii: S1201-9712(22)00246.
    >> Share

  356. STEIN M, Cohen H, Nemet I, Atari N, et al
    Human Metapneumovirus prevalence during 2019-2021 in Israel is influence by the COVID-19 pandemic.
    Int J Infect Dis. 2022 Apr 23. pii: S1201-9712(22)00241.
    >> Share

  357. TORRES JP, Saure D, Basso LJ, Zuniga M, et al
    SARS-COV-2 IgG positivity in vaccinated and non-vaccinated Chilean children: a national cross-sectional study in Schools.
    Int J Infect Dis. 2022 Apr 23. pii: S1201-9712(22)00238.
    >> Share

  358. LAI MY, Bukhari FDM, Zulkefli NZ, Ismail I, et al
    Colorimetric detection of SARS-CoV-2 by uracil-DNA glycosylase (UDG) reverse transcription loop-mediated isothermal amplification (RT-LAMP).
    Int J Infect Dis. 2022 Apr 23. pii: S1201-9712(22)00239.
    >> Share

  359. MAMETJA S, Dessie ZG, Matoti L, Semenya M, et al
    Clinical Management of COVID-19 in Hospitals and the Community: A Snapshot from a Medical Insurance Database in South Africa.
    Int J Infect Dis. 2022 Apr 22. pii: S1201-9712(22)00231.
    >> Share

  360. HUNG DT, Ghula S, Aziz JMA, Makram AM, et al
    The efficacy and adverse effects of favipiravir on COVID-19 patients: a systematic review and meta-analysis of published clinical trials and observational studies.
    Int J Infect Dis. 2022 Apr 22. pii: S1201-9712(22)00237.
    >> Share

  361. PETRONE L, Picchianti-Diamanti A, Sebastiani GD, Aiello A, et al
    Humoral and cellular responses to spike of delta SARS-CoV-2 variant in vaccinated patients with Immune Mediated Inflammatory Diseases.
    Int J Infect Dis. 2022 Apr 21. pii: S1201-9712(22)00229.
    >> Share

  362. LIU Y, Yu Y, Zhao Y, He D, et al
    Reduction in the infection fatality rate of Omicron variant compared to previous variants in South Africa.
    Int J Infect Dis. 2022 Apr 21. pii: S1201-9712(22)00228.
    >> Share

  363. KOUTALOS AA, Stefanou N, Malizos KN
    Post-acute sequelae of SARS-CoV-2 infection. Osteonecrosis must not be overlooked.
    Int J Infect Dis. 2022 Apr 21. pii: S1201-9712(22)00226.
    >> Share

  364. JAHAN N, Brahma A, Kumar MS, Bagepally BS, et al
    Corrigendum to 'Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020-August 2021: a systematic review and meta-analysis' [International Journal of Infectious Diseases, Volume 116 (2022) P59-67].
    Int J Infect Dis. 2022;119:119.
    >> Share

  365. VOO TC, Ballantyne A, Jenn NC, Cowling BJ, et al
    Public acceptability of COVID-19 control measures in Singapore, Hong Kong, and Malaysia: A cross-sectional survey.
    Int J Infect Dis. 2022 Apr 14. pii: S1201-9712(22)00222.
    >> Share

  366. TEGELER CM, Bilich T, Maringer Y, Salih HR, et al
    Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort.
    Int J Infect Dis. 2022 Apr 14. pii: S1201-9712(22)00219.
    >> Share

  367. RAMIREZ C, Duron RM
    The Russia-Ukraine war could bring catastrophic public-health challenges beyond COVID-19.
    Int J Infect Dis. 2022 Apr 12. pii: S1201-9712(22)00215.
    >> Share

  368. TEMBO J, Egbe NF, Maluzi K, Mulonga K, et al
    Evaluation of SARS-CoV-2 diagnostics and risk factors associated with SARS-CoV-2 infection in Zambia.
    Int J Infect Dis. 2022 Apr 12. pii: S1201-9712(22)00216.
    >> Share

  369. LIU K, Wang X, Song G
    Association of epicardial adipose tissue with the severity and adverse clinical outcomes of COVID-19: A meta-analysis.
    Int J Infect Dis. 2022 Apr 11. pii: S1201-9712(22)00212.
    >> Share

  370. JABAL KA, Edelstein M
    Using SARS-CoV-2 anti-S IgG levels as a marker of previous infection: Example from an Israeli Healthcare worker cohort.
    Int J Infect Dis. 2022 Apr 9. pii: S1201-9712(22)00209.
    >> Share

  371. WOLDAY D, de Wit TFR
    Response to Abdelrahman M et al commentary on "Parasites Protect from Severe COVID-19. Myth or Reality?"
    Int J Infect Dis. 2022 Apr 9. pii: S1201-9712(22)00211.
    >> Share

  372. SOMAN R, Chakraborty S, Joe G
    Posaconazole or Isavuconazole as sole or predominant anti-fungal therapy for COVID-19 associated Mucormycosis. A retrospective observational case series.
    Int J Infect Dis. 2022 Apr 8. pii: S1201-9712(22)00208.
    >> Share

  373. HAMBRIDGE HL, Kahn R, Onnela JP
    Effect of a Two-Dose vs Three-Dose Vaccine Strategy in Residential Colleges Using an Empirical Proximity Network.
    Int J Infect Dis. 2022 Apr 8. pii: S1201-9712(22)00206.
    >> Share

  374. DI LEGO V, Sanchez-Romero M, Prskawetz A
    The impact of COVID-19 vaccines on the Case Fatality Rate: The importance of monitoring breakthrough infections.
    Int J Infect Dis. 2022 Apr 6. pii: S1201-9712(22)00197.
    >> Share

  375. HO LL, Gurung S, Mirza I, Nicolas HD, et al
    Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns.
    Int J Infect Dis. 2022 Apr 6. pii: S1201-9712(22)00204.
    >> Share

  376. WANG X, Wei J, Zhu R, Chen L, et al
    Contribution of CD4+ T cell mediated inflammation to diarrhoea in patients with COVID-19.
    Int J Infect Dis. 2022 Apr 6. pii: S1201-9712(22)00201.
    >> Share

  377. MEDHAT R, El Lababidi R, Abdelsalam M, Nusair A, et al
    Varicella Zoster Virus (VZV) Meningitis in an Immunocompetent Adult following BNT162b2 mRNA COVID-19 Vaccination: A Case Report.
    Int J Infect Dis. 2022 Apr 6. pii: S1201-9712(22)00200.
    >> Share

    March 2022
  378. BURANASAKDA M, Kotruchin P, Phanthachai K, Mootsikapun P, et al
    Varicella zoster meningitis following COVID-19 vaccination: a report of two cases.
    Int J Infect Dis. 2022 Mar 30. pii: S1201-9712(22)00192.
    >> Share

  379. KLOPFENSTEIN T, Tipirdamaz C, Gendrin V, Osman M, et al
    Third of patients have gustatory dysfunction 9 months after SARS-CoV-2 infection: the ANOSVID study.
    Int J Infect Dis. 2022 Mar 29. pii: S1201-9712(22)00193.
    >> Share

  380. JEGERLEHNER S, Suter-Riniker F, Jent P, Bittel P, et al
    Diagnostic accuracy of SARS-CoV-2 saliva antigen testing in a real-life clinical setting.
    Int J Infect Dis. 2022 Mar 29. pii: S1201-9712(22)00176.
    >> Share

  381. GHOSH A, Walia S, Rattan R, Kanampalliwar A, et al
    Genomic profiles of vaccine breakthrough SARS-CoV-2 strains from Odisha, India.
    Int J Infect Dis. 2022 Mar 28. pii: S1201-9712(22)00181.
    >> Share

  382. ARKELL P, Gusmao C, Sheridan SL, Tanesi MY, et al
    Serological surveillance of healthcare workers to evaluate natural infection- and vaccine-derived immunity to SARS-CoV-2 during an outbreak in Dili, Timor-Leste.
    Int J Infect Dis. 2022 Mar 28. pii: S1201-9712(22)00183.
    >> Share

  383. JACKSON I, Jaradeh H, Aurit S, Aldamen A, et al
    Role of procalcitonin as a predictor of clinical outcomes in hospitalized patients with COVID-19.
    Int J Infect Dis. 2022 Mar 28. pii: S1201-9712(22)00179.
    >> Share

  384. ABU-ODAH H, Su JJ, Musa SS
    Unwillingness or reluctance of Palestinians to get COVID-19 vaccine: the reasons behind it and how to persuade them.
    Int J Infect Dis. 2022 Mar 25. pii: S1201-9712(22)00178.
    >> Share

  385. CHANDA-KAPATA P, Ntoumi F, Kapata N, Lungu P, et al
    Tuberculosis, HIV/AIDS and Malaria Health Services in sub-Saharan Africa - A Situation Analysis of the Disruptions and Impact of the COVID-19 Pandemic.
    Int J Infect Dis. 2022 Mar 24. pii: S1201-9712(22)00173.
    >> Share

  386. KIM AY, Woo W, Yon DK, Lee SW, et al
    Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis.
    Int J Infect Dis. 2022 Mar 23. pii: S1201-9712(22)00171.
    >> Share

  387. LI R, Liu H, Fairley CK, Zou Z, et al
    Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States.
    Int J Infect Dis. 2022 Mar 22. pii: S1201-9712(22)00168.
    >> Share

  388. SUAH JL, Husin M, Keng PS, Hwa B, et al
    Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study.
    Int J Infect Dis. 2022 Mar 21. pii: S1201-9712(22)00167.
    >> Share

  389. GUO Q, Wang J, Estill J, Lan H, et al
    Risk of COVID-19 Transmission Aboard Aircraft: An Epidemiological Analysis Based on the National Health Information Platform.
    Int J Infect Dis. 2022 Mar 21. pii: S1201-9712(22)00163.
    >> Share

  390. MAKRAM AM, Alied M, Khan ZA, Huy NT, et al
    Parasites Protect from Severe COVID-19. Myth or Reality?
    Int J Infect Dis. 2022 Mar 21. pii: S1201-9712(22)00164.
    >> Share

  391. JEREMIAH C, Petersen E, Nantanda R, Mungai BN, et al
    The WHO Global Tuberculosis 2021 Report - not so good news and turning the tide back to End TB.
    Int J Infect Dis. 2022 Mar 20. pii: S1201-9712(22)00149.
    >> Share

  392. SHANAUBE K, Schaap A, Klinkenberg E, Floyd S, et al
    SARS-CoV-2 seroprevalence and associated risk factors in peri-urban Zambia: a population-based study.
    Int J Infect Dis. 2022 Mar 16. pii: S1201-9712(22)00158.
    >> Share

  393. INADA M, Ishikane M, Terada M, Matsunaga A, et al
    Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection.
    Int J Infect Dis. 2022 Mar 16. pii: S1201-9712(22)00155.
    >> Share

  394. ONO A, Koizumi R, Tsuzuki S, Asai Y, et al
    Antimicrobial Use Fell Substantially in Japan in 2020-The COVID-19 Pandemic May Have Played a Role.
    Int J Infect Dis. 2022 Mar 16. pii: S1201-9712(22)00157.
    >> Share

  395. ELEC F, Magnusson J, Elec A, Muntean A, et al
    COVID-19 AND KIDNEY TRANSPLANTATION: THE IMPACT OF REMDESIVIR ON RENAL FUNCTION AND OUTCOME- A RETROSPECTIVE COHORT STUDY.
    Int J Infect Dis. 2022 Mar 14. pii: S1201-9712(22)00151.
    >> Share

  396. NTOUMI F, Petersen E, Mwaba P, Aklillu E, et al
    Blue Skies research is essential for ending the Tuberculosis pandemic and advancing a personalized medicine approach for holistic management of Respiratory Tract infections.: Invited viewpoint: IJID World TB Day series 2022.
    Int J Infect Dis. 2022 Mar 14. pii: S1201-9712(22)00150.
    >> Share

  397. O'KELLY B, Vidal L, Avramovic G, Broughan J, et al
    Assessing the impact of COVID-19 at 1 year using the SF-12 questionnaire: Data from the Anticipate longitudinal cohort study.
    Int J Infect Dis. 2022 Mar 14. pii: S1201-9712(22)00152.
    >> Share

  398. MATTIUZZI C, Henry BM, Lippi G
    COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a light at the end of the tunnel?
    Int J Infect Dis. 2022 Mar 9. pii: S1201-9712(22)00146.
    >> Share

  399. LEE DS, Kim JW, Lee KL, Jung YJ, et al
    Adverse events following coronavirus disease 2019 vaccination in South Korea between February 28 and August 21, 2021: A nationwide observational study.
    Int J Infect Dis. 2022 Mar 8. pii: S1201-9712(22)00145.
    >> Share

  400. GLINERT I, Ben-Shmuel A, Szwartcwort-Cohen M, Beth-Din A, et al
    Revisiting SARS-CoV-2 environmental contamination by COVID-19 patients: The Omicron variant does not differ from previous strains.
    Int J Infect Dis. 2022 Mar 4. pii: S1201-9712(22)00139.
    >> Share

  401. LIU ZG, Li XY
    Interpretation of Discrepancies between Cities in the Transmission of COVID-19: Evidence from China in the First Weeks of the Pandemic: Interpreting the Discrepancies of COVID-19 Transmission.
    Int J Infect Dis. 2022 Mar 4. pii: S1201-9712(22)00142.
    >> Share

  402. MORENO-GARCIA E, Puerta-Alcalde P, Letona L, Meira F, et al
    Bacterial co-infection at hospital admission in patients with COVID-19.
    Int J Infect Dis. 2022 Mar 4. pii: S1201-9712(22)00143.
    >> Share

  403. ADRIEN CSK, Alexandre C, Marie M, Cedric J, et al
    Number of initial symptoms is more related to long COVID-19 than acute severity of infection: a prospective cohort of hospitalized patients.
    Int J Infect Dis. 2022 Mar 4. pii: S1201-9712(22)00141.
    >> Share

  404. RODRIGUEZ GD, Wu Y, Karnik K, Ruddy S, et al
    Implementation of a Collaborated Antimicrobial Stewardship Program and Outpatient Parenteral Antimicrobial Therapy (OPAT) Unit-driven Monoclonal Antibody Therapy Program for COVID-19 at a NYC Hospital.
    Int J Infect Dis. 2022 Mar 3. pii: S1201-9712(22)00137.
    >> Share

  405. ASSAL HH, Abdelrahman S, Abdelbasset MA, Abdelaziz M, et al
    Presepsin as a Novel Biomarker in predicting Inhospital Mortality in COVID-19 Pneumonia Patients.
    Int J Infect Dis. 2022 Mar 3. pii: S1201-9712(22)00136.
    >> Share

  406. PETERSEN E, Al-Abri S, Chakaya J, Goletti D, et al
    World TB Day 2022: Revamping and Reshaping Global TB Control Programs by Advancing Lessons learnt from the COVID-19 pandemic.
    Int J Infect Dis. 2022 Mar 3. pii: S1201-9712(22)00138.
    >> Share

  407. MUSSO N, Maugeri JG, Bongiorno D, Stracquadanio S, et al
    SARS-CoV-2's high rate of genetic mutation under immune selective pressure: from oropharyngeal B.1.1.7 to intrapulmonary B.1.533 in a post-vaccine patient.
    Int J Infect Dis. 2022 Mar 2. pii: S1201-9712(22)00123.
    >> Share

  408. LAYER E, Hoehl S, Ciesek S, Widera M, et al
    SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach.
    Int J Infect Dis. 2022 Mar 2. pii: S1201-9712(22)00121.
    >> Share

  409. EFIMENKO I, Nackeeran S, Jabori S, Zamora JAG, et al
    REMOVED: Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients: Analysis of a National Federated Database.
    Int J Infect Dis. 2022;116S:S40.
    >> Share

    February 2022
  410. HUSSEY H, Davies MA, Heekes A, Williamson C, et al
    Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections - a survival analysis.
    Int J Infect Dis. 2022 Feb 27. pii: S1201-9712(22)00129.
    >> Share

  411. SHURRAB FM, Younes N, Al-Sadeq DW, Liu N, et al
    Performance evaluation of novel fluorescent-based lateral immune flow assay (LIFA) for rapid detection and quantification of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals.
    Int J Infect Dis. 2022 Feb 26. pii: S1201-9712(22)00130.
    >> Share

  412. ROUAMBA T, Ouedraogo E, Barry H, Yameogo NV, et al
    Assessment of Recovery Time, Worsening and Death, among COVID-19 inpatients and outpatients, under treatment with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso.
    Int J Infect Dis. 2022 Feb 25. pii: S1201-9712(22)00111.
    >> Share

  413. ALBAHRANI S, Ahmadi NA, Hamdan S, Elsheikh N, et al
    Clinical Presentation and Outcome of hospitalized patients with COVID-19 in the first and second wave in Saudi Arabia.
    Int J Infect Dis. 2022 Feb 25. pii: S1201-9712(22)00127.
    >> Share

  414. THEOHARIDES TC, Guerra L, Patel K
    Successful Treatment of a Severe COVID-19 Patient Using an Integrated Approach Addressing Mast Cells and Their Mediators.
    Int J Infect Dis. 2022 Feb 25. pii: S1201-9712(22)00128.
    >> Share

  415. HIRATA M, Fukuchi T, Sugawara H
    Trajectory of SARS-CoV-2 anti-S IgG levels following transfusion and a third dose of BNT162b2 vaccine in a patient with massive postoperative bleeding: A case report.
    Int J Infect Dis. 2022 Feb 24. pii: S1201-9712(22)00122.
    >> Share

  416. XIE M, Dong N, Zhang X, He D, et al
    Exported Cases were Infected on the Way: A Conjecture Derived from Analysis on Hong Kong Monthly Exported Covid-19 Cases.
    Int J Infect Dis. 2022 Feb 23. pii: S1201-9712(22)00102.
    >> Share

  417. ROSENTHAL VD, Myatra SN, Divatia JV, Biswas S, et al
    The impact of COVID-19 on healthcare-associated infections in intensive care units in low and middle income countries: International Nosocomial Infection Control Consortium (INICC) findings.
    Int J Infect Dis. 2022 Feb 23. pii: S1201-9712(22)00120.
    >> Share

  418. LITCHFIELD M, Brookes P, Ojrzynska A, Kavi J, et al
    Comparison of the clinical sensitivity and specificity of two commercial RNA SARS-CoV-2 assays.
    Int J Infect Dis. 2022 Feb 22. pii: S1201-9712(22)00109.
    >> Share

  419. VICKERS DM, Baral S, Mishra S, Kwong JC, et al
    Stringency of Containment and Closures on the Growth of SARS-CoV-2 in Canada prior to Accelerated Vaccine Roll-Out.
    Int J Infect Dis. 2022 Feb 21. pii: S1201-9712(22)00108.
    >> Share

  420. CUCUNAWANGSIH C, Wijaya RS, Lugito NPH, Suriapranata I, et al
    Antibody response after a third dose mRNA-1273 vaccine among vaccinated healthcare workers with two doses of inactivated SARS-CoV-2 vaccine.
    Int J Infect Dis. 2022 Feb 19. pii: S1201-9712(22)00114.
    >> Share

  421. TSUZUKI S, Hayakawa K, Uemura Y, Shinozaki T, et al
    Efficacy of remdesivir in hospitalized nonsevere COVID-19 patients in Japan: A large observational study using the COVID-19 Registry Japan.
    Int J Infect Dis. 2022 Feb 19. pii: S1201-9712(22)00118.
    >> Share

  422. DIAS R, Caldas JP, Silva-Pinto A, Costa A, et al
    Delirium severity in critical COVID-19 patients from an Infectious Disease Intensive Care Unit.
    Int J Infect Dis. 2022 Feb 19. pii: S1201-9712(22)00112.
    >> Share

  423. DHUMAL S, Patil A, More A, Kamtalwar S, et al
    SARS-COV-2 reinfection after previous infection and vaccine breakthrough infection through the second wave of pandemic in India: An observational study.
    Int J Infect Dis. 2022 Feb 19. pii: S1201-9712(22)00115.
    >> Share

  424. GRAVNINGEN K, Henriksen S, Hungnes O, Svendsen K, et al
    Risk factors, immune response and whole-genome sequencing of SARS-CoV-2 in a cruise ship outbreak in Norway.
    Int J Infect Dis. 2022 Feb 18. pii: S1201-9712(22)00104.
    >> Share

  425. KAMURA Y, Terao T, Akao S, Kono Y, et al
    Fatal thrombotic microangiopathy with rhabdomyolysis as an initial symptom after the first dose of mRNA-1273 vaccine: A case report.
    Int J Infect Dis. 2022 Feb 18. pii: S1201-9712(22)00107.
    >> Share

  426. MORITA Y, Kurano M, Jubishi D, Ikeda M, et al
    Urine sediment findings were milder in patients with COVID-19-associated renal injuries than in those with non-COVID-19-associated renal injuries.
    Int J Infect Dis. 2022 Feb 16. pii: S1201-9712(22)00101.
    >> Share

  427. KAKINOKI Y, Yamada K, Tanino Y, Suzuki K, et al
    Impact of Antibody Cocktail Therapy Combined with Casirivimab and Imdevimab on Clinical Outcome for Covid-19 patients in A Real-Life Setting: A Single Institute Analysis.
    Int J Infect Dis. 2022 Feb 14. pii: S1201-9712(22)00076.
    >> Share

  428. FALTIN K, Lewandowska Z, Malecki P, Czyz K, et al
    SARS-CoV-2 attacks the weakest point - COVID-19 course in a pediatric patient with Friedreich's ataxia.
    Int J Infect Dis. 2022 Feb 13. pii: S1201-9712(22)00098.
    >> Share

  429. MORENO-PEREZ O, Ribes I, Boix V, Martinez-Garcia MA, et al
    Hospitalized patients with breakthrough COVID-19: Clinical features and poor outcome predictors.
    Int J Infect Dis. 2022 Feb 13. pii: S1201-9712(22)00084.
    >> Share

  430. HAFEZ W, Ziade MA, Arya A, Saleh H, et al
    Reduced ADAMTS13 Activity in Correlation with Pathophysiology, Severity, and Outcome of COVID-19; A Retrospective Observational Study.
    Int J Infect Dis. 2022 Feb 12. pii: S1201-9712(22)00097.
    >> Share

  431. MURILLO-ZAMORA E, Sanchez-Pina RA, Trujillo X, Huerta M, et al
    Independent risk factors of COVID-19 pneumonia in vaccinated Mexican adults.
    Int J Infect Dis. 2022 Feb 12. pii: S1201-9712(22)00078.
    >> Share

  432. FINSTERER J, Matovu D
    Exclude differentials before diagnosing SARS-CoV-2 assocaited acute, hemorrhaghic, necrotising encephalitis.
    Int J Infect Dis. 2022 Feb 10. pii: S1201-9712(22)00094.
    >> Share

  433. MIERZEWSKA-SCHMIDT M, Baranowski A, Szymanska K, Ciaston M, et al
    Authors' response to Dr Finsterer's comment "Exclude differentials before diagnosing SARS-CoV-2 associated acute, hemorrhaghic, necrotising encephalitis".
    Int J Infect Dis. 2022 Feb 10. pii: S1201-9712(22)00092.
    >> Share

  434. KOJIMA N, Roshani A, Brobeck M, Baca A, et al
    Incidence of Severe Acute Respiratory Syndrome Coronavirus-2 infection among previously infected or vaccinated employees.
    Int J Infect Dis. 2022 Feb 10. pii: S1201-9712(22)00091.
    >> Share

  435. BIRGAND G, Charani E, Ahmad R, Bonaconsa C, et al
    Interventional research to tackle antimicrobial resistance in Low Middle Income Countries in the era of the COVID-19 pandemic: lessons in resilience from an international consortium.
    Int J Infect Dis. 2022 Feb 9. pii: S1201-9712(22)00090.
    >> Share

  436. FERNANDEZ-DE-LAS-PENAS C, Martin-Guerrero JD, Cancela-Cilleruelo I, Moro-Lopez-Menchero P, et al
    Exploring the Trajectory Recovery Curve of the number of Post-COVID Symptoms: The LONG-COVID-EXP-CM Multicenter Study.
    Int J Infect Dis. 2022 Feb 9. pii: S1201-9712(22)00083.
    >> Share

  437. VICIANI E, Gaibani P, Castagnetti A, Liberatore A, et al
    Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in Candida spp colonized patients.
    Int J Infect Dis. 2022 Feb 9. pii: S1201-9712(22)00088.
    >> Share

  438. MONTANO MA, Bemer MJ, Heller KB, Meisner A, et al
    Performance of anterior nares and tongue swabs for nucleic acid, Nucleocapsid and Spike antigen testing for detecting SARS-CoV-2 against nasopharyngeal PCR and viral culture.
    Int J Infect Dis. 2022 Feb 8. pii: S1201-9712(22)00086.
    >> Share

  439. GARGOURI S, Abid N, Karray-Hakim H, Rebai A, et al
    Reply to letter to the editor by Lippi and Plebani: << The presence of anti-SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization >> (THEIJID-D-22-00085).
    Int J Infect Dis. 2022 Feb 6. pii: S1201-9712(22)00067.
    >> Share

  440. LIU N, Yang D, Zhang T, Sun J, et al
    Systematic review and meta-analysis of olfactory and gustatory dysfunction in coronavirus disease 2019.
    Int J Infect Dis. 2022 Feb 5. pii: S1201-9712(22)00079.
    >> Share

  441. AVERHOFF F, Berg M, Rodgers M, Osmanov S, et al
    The Abbott Pandemic Defense Coalition: a unique multi-sector approach adds to global pandemic preparedness efforts.
    Int J Infect Dis. 2022 Feb 5. pii: S1201-9712(22)00080.
    >> Share

  442. LIM RHF, Htun HL, Li AL, Guo H, et al
    Fending off Delta - Hospital measures to reduce nosocomial transmission of COVID-19.
    Int J Infect Dis. 2022 Feb 3. pii: S1201-9712(22)00077.
    >> Share

  443. XIE H, Wen X, Li J, Chen W, et al
    Evaluation of Immunogenicity by Pseudovirus Neutralization Assays for Coronavirus Disease 2019 (COVID-19) Variants after Primary and Booster Immunization.
    Int J Infect Dis. 2022 Feb 2. pii: S1201-9712(22)00075.
    >> Share

  444. MARZOUK M, Alhiraki OA, Aguas R, Gao B, et al
    SARS-CoV-2 transmission in opposition-controlled Northwest Syria: modelling pandemic responses during political conflict.
    Int J Infect Dis. 2022 Feb 2. pii: S1201-9712(22)00071.
    >> Share

  445. ZHANG H, Liu X, Liu Q, Mei H, et al
    Serological reactivity of inactivated SARS-CoV-2 vaccine based on an S-RBD neutralizing antibody assay.
    Int J Infect Dis. 2022 Feb 1. pii: S1201-9712(22)00069.
    >> Share

  446. JONES T, Marimuthu K, Bearman G
    Virtual Infection Prevention and Control in Low- and Middle-Income Countries.
    Int J Infect Dis. 2022 Feb 1. pii: S1201-9712(22)00074.
    >> Share

    January 2022
  447. LIU B, Su X, Yu G, Yang S, et al
    Corrigendum to 'An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 neutralizing antibody levels in COVID-19 patients and vaccines ' [International Journal of Infectious Diseases, Volume 115, 2022, Pages 116-125, ISSN 1201-9712].
    Int J Infect Dis. 2022 Jan 31. pii: S1201-9712(22)00045.
    >> Share

  448. LIPPI G, Plebani M
    The presence of anti-SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization.
    Int J Infect Dis. 2022 Jan 31. pii: S1201-9712(22)00066.
    >> Share

  449. MUSA SS, Zhao S, Abdullahi ZU, Habib AG, et al
    COVID-19 and Lassa fever in Nigeria: A deadly alliance?
    Int J Infect Dis. 2022 Jan 30. pii: S1201-9712(22)00065.
    >> Share

  450. ZHA L, Sobue T, Hirayama A, Takeuchi T, et al
    Characteristics and Outcomes of COVID-19 in Reproductive-Aged Pregnant and Non-Pregnant Women in Osaka, Japan.
    Int J Infect Dis. 2022 Jan 29. pii: S1201-9712(22)00063.
    >> Share

  451. MA X, Wu K, Li Y, Li S, et al
    Contact tracing period and epidemiological characteristics of an outbreak by SARS-CoV-2 Delta variant in Guangzhou.
    Int J Infect Dis. 2022 Jan 28. pii: S1201-9712(22)00036.
    >> Share

  452. WEE LE, Conceicao EP, Sim JX, Venkatachalam I, et al
    Correspondence on "The Low Yield of SARS-CoV-2 Rapid Antigen Testing in Screening Asymptomatic Hospital Visitors in Low-incidence Settings".
    Int J Infect Dis. 2022 Jan 27. pii: S1201-9712(22)00057.
    >> Share

  453. RADULESCU A, Istrate A, Muntean M
    Treatment with Tocilizumab in Adult Patients with Moderate to Critical COVID-19 Pneumonia: A Single-Center Retrospective Study.
    Int J Infect Dis. 2022 Jan 27. pii: S1201-9712(22)00056.
    >> Share

  454. BODDETI NL, Berezowski I, Taylor D, Prajapati D, et al
    The Low Yield of SARS-CoV-2 Rapid Antigen Testing in Screening Asymptomatic Hospital Visitors in Low-incidence Settings.
    Int J Infect Dis. 2022 Jan 27. pii: S1201-9712(22)00054.
    >> Share

  455. SAN-JUAN R, Fernandez-Ruiz M, Lopez-Medrano F, Carretero O, et al
    Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19.
    Int J Infect Dis. 2022 Jan 23. pii: S1201-9712(22)00050.
    >> Share

  456. HONGE BL, Hindhede L, Kaspersen KA, Harritshoj LH, et al
    Long-term detection of SARS-CoV-2 antibodies after infection and risk of re-infection.
    Int J Infect Dis. 2022 Jan 22. pii: S1201-9712(22)00046.
    >> Share

  457. JURAJ S, Martin K, Kristina B, Samuel N, et al
    COVID-19 pneumonia patients with 25(OH)D levels lower than 12 ng/ml are at increased risk of death.
    Int J Infect Dis. 2022 Jan 22. pii: S1201-9712(22)00052.
    >> Share

  458. KOYAMA AK, Koumans EH, Sircar K, Lavery A, et al
    Severe Outcomes, Readmission, and Length of Stay Among COVID-19 Patients with Intellectual and Developmental Disabilities.
    Int J Infect Dis. 2022 Jan 22. pii: S1201-9712(22)00048.
    >> Share

  459. LUO T, Wang J, Wang Q, Wang X, et al
    Reconstruction of the Transmission Chain of COVID-19 Outbreak in Beijing's Xinfadi Market, China.
    Int J Infect Dis. 2022 Jan 21. pii: S1201-9712(22)00037.
    >> Share

  460. MORENO-TORRES V, Munoz A, Calderon-Parra J, Mills-Sanchez P, et al
    Mortality by Covid-19 Prior to Vaccination - One Year Experience of Hospitalized Patients in Madrid.
    Int J Infect Dis. 2022 Jan 21. pii: S1201-9712(22)00049.
    >> Share

  461. KO YK, Furuse Y, Ninomiya K, Otani K, et al
    Secondary transmission of SARS-CoV-2 during the first two waves in Japan: Demographic characteristics and overdispersion.
    Int J Infect Dis. 2022 Jan 20. pii: S1201-9712(22)00034.
    >> Share

  462. PEREIRA DN, Silveira LFG, Guimaraes MMM, Polanczyk CA, et al
    Hypothyroidism does not lead to worse prognosis in COVID-19: findings from the Brazilian COVID-19 registry.
    Int J Infect Dis. 2022 Jan 19. pii: S1201-9712(22)00016.
    >> Share

  463. AMIYA S, Fujimoto J, Matsumoto K, Yamamoto M, et al
    Case report: Acute exacerbation of interstitial pneumonia related to mRNA COVID-19 vaccination.
    Int J Infect Dis. 2022 Jan 19. pii: S1201-9712(22)00032.
    >> Share

  464. HU Z, Tao B, Li Z, Song Y, et al
    Effectiveness of inactivated COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant-infected patients in Jiangsu, China.
    Int J Infect Dis. 2022 Jan 19. pii: S1201-9712(22)00033.
    >> Share

  465. NAKANISHI Y, Honda S, Yamano M, Kawasaki T, et al
    Constrictive pericarditis after SARS-CoV-2 vaccination: A case report.
    Int J Infect Dis. 2022 Jan 18. pii: S1201-9712(22)00027.
    >> Share

  466. LUCIENA CMO, Lenzoni F, Suarez MV, Duarte AA, et al
    Hypersensitivity reaction to hyaluronic acid dermal filler after vaccination against COVID-19: A series of cases in Sao Paulo, Brazil.
    Int J Infect Dis. 2022 Jan 18. pii: S1201-9712(22)00029.
    >> Share

  467. TARDIF JC, Cossette M, Guertin MC, Bouabdallaoui N, et al
    Predictive risk factors for hospitalization and response to colchicine in patients with COVID-19.
    Int J Infect Dis. 2022 Jan 14. pii: S1201-9712(22)00021.
    >> Share

  468. MOLLER IJB, Utke AR, Rysgaard UK, Ostergaard LJ, et al
    Diagnostic performance, user acceptability, and safety of unsupervised SARS-CoV-2 rapid antigen detecting tests performed at home.
    Int J Infect Dis. 2022 Jan 14. pii: S1201-9712(22)00020.
    >> Share

  469. KRIGER O, Gefen-Halevi S, Leshem E, Smollan G, et al
    Viral co-pathogens in COVID-19 acute respiratory syndrome - what did we learn from the first year of pandemic?
    Int J Infect Dis. 2022 Jan 13. pii: S1201-9712(22)00018.
    >> Share

  470. ISMAIL N, Hassan N, Hamid MHNA, Yusoff UN, et al
    ASSOCIATION OF SMOKING AND SEVERITY OF COVID-19 INFECTION AMONG 5889 PATIENTS IN MALAYSIA: A MULTI-CENTRE OBSERVATIONAL STUDY.
    Int J Infect Dis. 2022 Jan 9. pii: S1201-9712(22)00012.
    >> Share

  471. ZHANG Z, Lin F, Liu F, Li Q, et al
    Proteomic profiling reveals a distinctive molecular signature for critically ill COVID-19 patients compared with asthma and COPD: A distinctive molecular signature for critically ill COVID-19 patients.
    Int J Infect Dis. 2022 Jan 8. pii: S1201-9712(22)00001.
    >> Share

  472. GARGOURI S, Souissi A, Abid N, Chtourou A, et al
    Evidence of SARS-CoV-2 Symptomatic Reinfection in Four Health Care Professionals from the Same Hospital Despite the Presence of Antibodies.
    Int J Infect Dis. 2022 Jan 8. pii: S1201-9712(22)00005.
    >> Share

  473. WU H, Dai R, He P, Liang J, et al
    Characteristics analysis for clinical study design relating to COVID-19 based on the database of ClinicalTrials.gov.
    Int J Infect Dis. 2022 Jan 8. pii: S1201-9712(22)00015.
    >> Share

  474. FERNANDEZ-DE-LAS-PENAS C, Pellicer-Valero OJ, Navarro-Pardo E, Palacios-Cena D, et al
    Symptoms Experienced at the Acute Phase of SARS-CoV-2 Infection as Risk Factor of Long-term Post-COVID Symptoms: The LONG-COVID-EXP-CM Multicenter Study.
    Int J Infect Dis. 2022 Jan 8. pii: S1201-9712(22)00007.
    >> Share

  475. YIN Y, Gao J, Zhang Y, Zhang X, et al
    Evaluation of reporting quality of abstracts of randomized controlled trials regarding patients with COVID-19 using the CONSORT statement for abstracts.
    Int J Infect Dis. 2022 Jan 6. pii: S1201-9712(22)00003.
    >> Share

  476. NOVAZZI F, Baj A, Pasciuta R, Genoni A, et al
    A CLUSTER OF SARS-COV-2 DELTA VARIANT OF CONCERN ADDITIONALLY HARBORING F490S, NORTHERN LOMBARDY, ITALY.
    Int J Infect Dis. 2022 Jan 4. pii: S1201-9712(21)01258.
    >> Share

  477. DRAGO F, Broccolo F, Ciccarese G
    Comment on a case of pityriasis rosea shortly after Moderna COVID-19 vaccination.
    Int J Infect Dis. 2022 Jan 3. pii: S1201-9712(21)01260.
    >> Share

  478. YAKOVLEV AS, Belyaletdinova IK, Mazankova LN, Samitova ER, et al
    SARS-CoV-2 infection in children in Moscow in 2020: clinical features and impact on circulation of other respiratory viruses.
    Int J Infect Dis. 2022 Jan 2. pii: S1201-9712(21)01216.
    >> Share

  479. KOHANOVSKI I, Obolski U, Ram Y
    Inferring the effective start dates of non-pharmaceutical interventions during COVID-19 outbreaks.
    Int J Infect Dis. 2022 Jan 2. pii: S1201-9712(21)01262.
    >> Share

  480. MARTINOT M
    Should remdesivir be recommended in France in the early stage of COVID-19.
    Int J Infect Dis. 2022 Jan 2. pii: S1201-9712(21)01259.
    >> Share

  481. CURCIO R, Gandolfo V, Alcidi R, Giacomino L, et al
    VACCINE-INDUCED MASSIVE PULMONARY EMBOLISM AND THROMBOCYTOPENIA FOLLOWING A SINGLE DOSE OF JANSSEN AD26.COV2.S VACCINATION.
    Int J Infect Dis. 2022 Jan 2. pii: S1201-9712(21)01244.
    >> Share

  482. BAOS E, Delgado-Iribarren A, O Connor S, Bardon I, et al
    Negative effect of the second dose of the BNT162b2 vaccine in a significant percentage of individuals with previous COVID infection.
    Int J Infect Dis. 2022;114:85-87.
    >> Share

    December 2021
  483. GROBUSCH LC, Grobusch MP
    A hot topic at the environment-health nexus: Investigating the impact of climate change on infectious diseases.
    Int J Infect Dis. 2021 Dec 29. pii: S1201-9712(21)01250.
    >> Share

  484. CALDERON-PARRA J, Cuervas-Mons V, Moreno-Torres V, Rubio-Rivas M, et al
    Influence of chronic corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: Analysis of a nationwide registry.
    Int J Infect Dis. 2021 Dec 28. pii: S1201-9712(21)01222.
    >> Share

  485. ABDULLAH F, Myers J, Basu D, Tintinger G, et al
    Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa.
    Int J Infect Dis. 2021 Dec 28. pii: S1201-9712(21)01256.
    >> Share

  486. DAYANAND D, Irudhayanathan I, Kundu D, Manesh A, et al
    Community seroprevalence and risk factors for SARS CoV-2 infection in different subpopulations in Vellore, India and its implications for future prevention.
    Int J Infect Dis. 2021 Dec 28. pii: S1201-9712(21)01255.
    >> Share

  487. JAHAN N, Brahma A, Kumar MS, Bagepally BS, et al
    Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020-August 2021: a systematic review and meta-analysis.
    Int J Infect Dis. 2021 Dec 27. pii: S1201-9712(21)01251.
    >> Share

  488. CHAN EWW, Leung MTY, Lau LKW, Leung J, et al
    Comparing self-reported reactogenicity between adolescents and adults following the use of BNT162b2 (Pfizer-BioNTech) messenger RNA Covid-19 vaccine: a prospective cohort study.
    Int J Infect Dis. 2021 Dec 26. pii: S1201-9712(21)01253.
    >> Share

  489. HWANG J, Han YJ, Yon DK, Lee SW, et al
    Clinical significance of hepatosplenic thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination.
    Int J Infect Dis. 2021 Dec 24. pii: S1201-9712(21)01248.
    >> Share

  490. AFZAL A, Gutierrez VP, Gomez E, Mon AM, et al
    Bloodstream infections in hospitalized patients before and during the COVID-19 surge in a community hospital in the South Bronx.
    Int J Infect Dis. 2021 Dec 24. pii: S1201-9712(21)01249.
    >> Share

  491. PROMLEK T, Thanunchai M, Phumisantiphong U, Hansirisathit T, et al
    Performance of colorimetric RT-LAMP as a diagnostic tool for SARS-CoV-2 infection during the fourth wave of COVID-19 in Thailand.
    Int J Infect Dis. 2021 Dec 24. pii: S1201-9712(21)01252.
    >> Share

  492. CAKMAKLI C, Demiralp S, Ergonul O, Yesiltas S, et al
    The Role of Institutional, Cultural, and Economic Factors on the Effectiveness of the Lockdown Measures.
    Int J Infect Dis. 2021 Dec 23. pii: S1201-9712(21)01233.
    >> Share

  493. LIEU A, Mah J, Church D
    A Case of Multisystem Inflammatory Syndrome in Adults Following Natural Infection and Subsequent Immunization.
    Int J Infect Dis. 2021 Dec 23. pii: S1201-9712(21)01239.
    >> Share

  494. O'FEE JR, Li J, Chang JR
    Bell's Phenomenon is a normal finding, distinct from Bell's Palsy; Response to "Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database" by Sato et al.
    Int J Infect Dis. 2021 Dec 23. pii: S1201-9712(21)01246.
    >> Share

  495. MCKINNON JE, Wang DD, Zervos M, Saval M, et al
    Safety and Tolerability of Hydroxychloroquine in healthcare workers and first responders for the prevention of COVID-19: WHIP COVID-19 Study.
    Int J Infect Dis. 2021 Dec 22. pii: S1201-9712(21)01243.
    >> Share

  496. HOEFER A, Pampaka D, Castrillejo D, Luenga-Cabrera J, et al
    Considerations for COVID-19 management in reception centers for refugees, asylum seekers and migrants, Spain 2020.
    Int J Infect Dis. 2021 Dec 21. pii: S1201-9712(21)01240.
    >> Share

  497. CLAISE C, Saleh J, Rezek M, Vaulont S, et al
    Low Transferrin Levels Predict Heightened Inflammation in COVID-19 Patients: New Insights.
    Int J Infect Dis. 2021 Dec 21. pii: S1201-9712(21)01237.
    >> Share

  498. DIEZ JM, Romero C, Gajardo R
    Effective presence of antibodies against common human coronavirus in IgG immunoglobulin medicinal products.: Antibodies to common coronaviruses in IgG medicinal products.
    Int J Infect Dis. 2021 Dec 17. pii: S1201-9712(21)01228.
    >> Share

  499. MIERZEWSKA-SCHMIDT M, Baranowski A, Szymanska K, Ciaston M, et al
    The case of fatal acute hemorrhagic necrotizing encephalitis in a two-month-old boy with Covid-19.
    Int J Infect Dis. 2021 Dec 17. pii: S1201-9712(21)01232.
    >> Share

  500. BIN-GOUTH AS, Al-Shoteri S, Mahmoud N, Musani A, et al
    SARS-CoV-2 Seroprevalence in Aden, Yemen: A population-based study.
    Int J Infect Dis. 2021 Dec 17. pii: S1201-9712(21)01229.
    >> Share

  501. MEINUS C, Singer R, Nandi B, Jagot O, et al
    SARS-CoV-2 prevalence and immunity: a hospital-based study from Malawi.
    Int J Infect Dis. 2021 Dec 17. pii: S1201-9712(21)01234.
    >> Share

  502. AYAZ A, Demir AGO, Ozturk G, Kocak M, et al
    A Pooled RT-PCR Testing Strategy for More Efficient Covid-19 Pandemic Management.
    Int J Infect Dis. 2021 Dec 15. pii: S1201-9712(21)01225.
    >> Share

  503. RUIZ-STERNBERG AM, Chaparro-Solano HM, Albornoz LLA, Pinzon-Rondon AM, et al
    GENOMIC CHARACTERIZATION OF SARS-CoV-2 AND ITS ASSOCIATION WITH CLINICAL OUTCOMES: A ONE-YEAR LONGITUDINAL STUDY OF THE PANDEMIC IN COLOMBIA.
    Int J Infect Dis. 2021 Dec 14. pii: S1201-9712(21)01220.
    >> Share

  504. KOSEKI T, Nakajima K, Iwasaki H, Yamada S, et al
    Baseline uric acid levels and steady-state favipiravir concentrations are associated with occurrence of hyperuricemia among COVID-19 patients.
    Int J Infect Dis. 2021 Dec 12. pii: S1201-9712(21)01219.
    >> Share

  505. KOBAYASHI T, Yoshii K, Linton NM, Suzuki M, et al
    Age dependence of the natural history of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): An analysis of Diamond Princess data.
    Int J Infect Dis. 2021 Dec 10. pii: S1201-9712(21)01213.
    >> Share

  506. VENETI L, Salamanca BV, Seppala E, Starrfelt J, et al
    No difference in risk of hospitalisation between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway.
    Int J Infect Dis. 2021 Dec 10. pii: S1201-9712(21)01218.
    >> Share

  507. TRAN LK, Huang DW, Li NK, Li LM, et al
    The impact of the COVID-19 preventive measures on influenza transmission: molecular and epidemiological evidence.
    Int J Infect Dis. 2021 Dec 10. pii: S1201-9712(21)01215.
    >> Share

  508. FINSTERER J, Scorza FA, Fiorini AC
    Impaired hearing following SARS-CoV-2 vaccinations.
    Int J Infect Dis. 2021 Dec 9. pii: S1201-9712(21)01209.
    >> Share

  509. LIU B, Su X, Yu G, Yang S, et al
    An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 Neutralizing antibody levels in COVID-19 patients and vaccinees.
    Int J Infect Dis. 2021 Dec 9. pii: S1201-9712(21)01207.
    >> Share

  510. GUREVICH M, Zilkha-Falb R, Sonis P, Magalashvili D, et al
    SARS-COV-2 Memory B and T Cells Profile in Mild COVID-19 Convalescents subjects.
    Int J Infect Dis. 2021 Dec 8. pii: S1201-9712(21)01203.
    >> Share

  511. DAVIES M, Bramwell LR, Jeffery N, Bunce B, et al
    Persistence of clinically-relevant levels of SARS-CoV2 envelope gene subgenomic RNAs in non-immunocompromised individuals.
    Int J Infect Dis. 2021 Dec 7. pii: S1201-9712(21)01206.
    >> Share

  512. YADAV SK, Zhao S, Akhter Y
    Response to Comments on "Preliminary estimation of the basic reproduction number of novel Coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven Analysis in the early phase of the outbreak".
    Int J Infect Dis. 2021 Dec 5. pii: S1201-9712(21)01204.
    >> Share

  513. CLAPHAM HE, Chia WN, Tan LWL, Kumar V, et al
    Contrasting SARS-CoV-2 epidemics in Singapore: Cohort studies in migrant workers and the general population.
    Int J Infect Dis. 2021 Dec 2. pii: S1201-9712(21)00891.
    >> Share

  514. PETERSEN E, Ntoumi F, Hui DS, Abubakar A, et al
    Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts.
    Int J Infect Dis. 2021 Dec 1. pii: S1201-9712(21)00888.
    >> Share

    November 2021
  515. RINDI LV, Moghazi SA, Donno DR, Cataldo MA, et al
    Predictive scores for the diagnosis of Pulmonary Embolism in COVID-19: A systematic review.
    Int J Infect Dis. 2021 Nov 27. pii: S1201-9712(21)00885.
    >> Share

  516. NGUYEN NN, Hoang VT, Dao TL, Meddeb L, et al
    Long-term persistence of symptoms of dyspnoea in COVID-19 patients.
    Int J Infect Dis. 2021 Nov 27. pii: S1201-9712(21)00882.
    >> Share

  517. JIAN MJ, Perng CL, Chung HY, Chang CK, et al
    Clinical assessment of SARS-CoV-2 antigen rapid detection compared with RT-PCR assay for emerging variants at a high-throughput community testing site in Taiwan.
    Int J Infect Dis. 2021 Nov 26. pii: S1201-9712(21)00883.
    >> Share

  518. LI H, Wu Q, Qin Z, Hou X, et al
    Serum levels of laminin and von Willebrand factor in COVID-19 survivors 6 months after discharge.
    Int J Infect Dis. 2021 Nov 26. pii: S1201-9712(21)00879.
    >> Share

  519. FAGYAS M, Fejes Z, Suto R, Nagy Z, et al
    Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients.
    Int J Infect Dis. 2021 Nov 25. pii: S1201-9712(21)00876.
    >> Share

  520. RAMACHANDRAN R, Bhosale V, Reddy H, Atam V, et al
    Phase III, Randomized, Double-blind, Placebo controlled trial of Efficacy, Safety and Tolerability of Antiviral drug Umifenovir vs Standard care of therapy in non-severe COVID-19 patients.
    Int J Infect Dis. 2021 Nov 18. pii: S1201-9712(21)00872.
    >> Share

  521. ASAI S, Seki A, Akai Y, Tazawa H, et al
    Nationwide external quality assessment of SARS-CoV-2 nucleic acid amplification tests in Japan.
    Int J Infect Dis. 2021 Nov 17. pii: S1201-9712(21)00869.
    >> Share

  522. FERNANDEZ LS, Iturriaga LAR, Yandiola PPE, Ocana RM, et al
    BACTERAEMIC PNEUMOCOCCAL PNEUMONIA AND SARS-CoV-2 PNEUMONIA: DIFFERENCES AND SIMILARITIES.
    Int J Infect Dis. 2021 Nov 17. pii: S1201-9712(21)00871.
    >> Share

  523. ZOU Z, Fairley CK, Shen M, Scott N, et al
    Critical timing and extent of public health interventions to control outbreaks dominated by SARS-CoV-2 variants in Australia: a mathematical modelling study.
    Int J Infect Dis. 2021 Nov 17. pii: S1201-9712(21)00870.
    >> Share

  524. ZHENG C, Shao W, Chen X, Zhang B, et al
    Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis.
    Int J Infect Dis. 2021 Nov 17. pii: S1201-9712(21)00857.
    >> Share

  525. DOTAN A, Shoenfeld Y
    Post-COVID syndrome: the aftershock of SARS-CoV-2.
    Int J Infect Dis. 2021 Nov 13. pii: S1201-9712(21)00867.
    >> Share

  526. ALI MM, Malik SMMR, Ahmed AY, Bashir AM, et al
    Survival analysis of all critically ill patients with COVID-19 admitted to the main hospital in Mogadishu, Somalia, 30 March-12 June 2020: what interventions are proving effective in fragile states?
    Int J Infect Dis. 2021 Nov 12. pii: S1201-9712(21)00865.
    >> Share

  527. WEE LE, Conceicao EP, Sim JX, Venkatachalam I, et al
    Utilisation of SARS-CoV-2 rapid antigen assays in screening asymptomatic hospital visitors: mitigating the risk in low-incidence settings.
    Int J Infect Dis. 2021 Nov 9. pii: S1201-9712(21)00859.
    >> Share

  528. GHOSH P, Chowdhury R, Hossain ME, Hossain F, et al
    Evaluation of recombinase-based isothermal amplification assays for point-of-need detection of SARS-CoV-2 in resource-limited settings.
    Int J Infect Dis. 2021 Nov 7. pii: S1201-9712(21)00854.
    >> Share

  529. JIAN MJ, Chung HY, Chang CK, Lin JC, et al
    SARS-CoV-2 Variants with T135I Nucleocapsid Mutations may Affect Antigen Test Performance.
    Int J Infect Dis. 2021 Nov 7. pii: S1201-9712(21)00853.
    >> Share

  530. FAVAS C, Jarrett P, Ratnayake R, Watson OJ, et al
    Country differences in transmissibility, age distribution and case-fatality of SARS-CoV-2: a global ecological analysis.
    Int J Infect Dis. 2021 Nov 5. pii: S1201-9712(21)00850.
    >> Share

  531. ABOBAKER A, Idris MA, Ogunjimi O
    A localised vasculitic-like skin rash following the second dose of COVID-19 vaccine.
    Int J Infect Dis. 2021 Nov 3. pii: S1201-9712(21)00848.
    >> Share

  532. MANOUANA GP, Maloum MN, Bikangui R, Oye Bingono SO, et al
    Emergence of B.1.1.318 SARS-CoV-2 viral lineage and high incidence of alpha B.1.1.7 variant of concern in Republic of Gabon.
    Int J Infect Dis. 2021 Nov 3. pii: S1201-9712(21)00846.
    >> Share

  533. SHIN SH, Hong JK, Hong SA, Li K, et al
    Pityriasis rosea shortly after mRNA-1273 COVID-19 vaccination.
    Int J Infect Dis. 2021 Nov 2. pii: S1201-9712(21)00844.
    >> Share

  534. VAN GORDON MM
    Regional differences in NPI efficacy and recommendations for Africa.
    Int J Infect Dis. 2021;112:235-236.
    >> Share

    October 2021
  535. HOEBEL J, Michalski N, Diercke M, Hamouda O, et al
    Emerging socioeconomic disparities in COVID-19-related deaths during the second pandemic wave in Germany.
    Int J Infect Dis. 2021 Oct 29. pii: S1201-9712(21)00832.
    >> Share

  536. KUCHINSKI KS, Nguyen J, Lee TD, Hickman R, et al
    Mutations in emerging variant of concern lineages disrupt genomic sequencing of SARS-CoV-2 clinical specimens.
    Int J Infect Dis. 2021 Oct 29. pii: S1201-9712(21)00838.
    >> Share

  537. LANDSBERG HE, Turcinovic J, Sullivan M, Connor JH, et al
    Efficacy of Pfizer-BioNTech in SARS-CoV-2 Delta cluster.
    Int J Infect Dis. 2021 Oct 29. pii: S1201-9712(21)00840.
    >> Share

  538. LEUNG WF, Chorlton S, Tyson J, Al-Rawahi GN, et al
    COVID-19 in an Immunocompromised Host: Persistent Shedding of Viable SARS-CoV-2 and Emergence of Multiple Mutations, a Case Report.
    Int J Infect Dis. 2021 Oct 28. pii: S1201-9712(21)00829.
    >> Share

  539. BOGERE N, Bongomin F, Katende A, Ssebambulidde K, et al
    Performance and Cost-Effectiveness of a Pooled-Testing Strategy for SARS-CoV-2 Using Real-Time Polymerase Chain Reaction in Uganda.
    Int J Infect Dis. 2021 Oct 28. pii: S1201-9712(21)00834.
    >> Share

  540. PENETRA SLS, da Silva MFB, Resende P, Pina-Costa A, et al
    Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil.
    Int J Infect Dis. 2021 Oct 28. pii: S1201-9712(21)00836.
    >> Share

  541. DESAI A, Desai P, Mehta J, Sachora W, et al
    "Measuring the Impact of single dose of ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant) on hospital stay, ICU requirement, and mortality outcome in a tertiary care centre".
    Int J Infect Dis. 2021 Oct 21. pii: S1201-9712(21)00819.
    >> Share

  542. HOU X, Fan W, Wang G, Chen X, et al
    T cell receptor repertoires as potential diagnostic markers for patients with COVID-19.
    Int J Infect Dis. 2021 Oct 21. pii: S1201-9712(21)00820.
    >> Share

  543. RIEDEL PG, Sakai VF, Castro Cardoso Toniasso S, Brum MCB, et al
    Heart failure secondary to myocarditis after SARS-CoV-2 reinfection: a case report.
    Int J Infect Dis. 2021 Oct 21. pii: S1201-9712(21)00822.
    >> Share

  544. FEKADU G, Jiang X, Yao J, You JHS, et al
    Cost-effectiveness of video-observed therapy for ambulatory management of active tuberculosis during COVID-19 pandemic in a high-income country.
    Int J Infect Dis. 2021 Oct 21. pii: S1201-9712(21)00817.
    >> Share

  545. AMARSY R, Trystram D, Cambau E, Monteil C, et al
    Surging bloodstream infections and antimicrobial resistance during the first wave of COVID-19: a study in a large multihospital institution in the Paris region.
    Int J Infect Dis. 2021 Oct 21. pii: S1201-9712(21)00821.
    >> Share

  546. ASANO M, Okada H, Itoh Y, Hirata H, et al
    Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: A double-blind, randomized controlled phase 1/2 trial.
    Int J Infect Dis. 2021 Oct 21. pii: S1201-9712(21)00818.
    >> Share

  547. DAHAL S, Luo R, Swahn MH, Chowell G, et al
    Geospatial Variability in Excess Death Rates during the COVID-19 Pandemic in Mexico: Examining Socio Demographic, Climate and Population Health Characteristics.
    Int J Infect Dis. 2021 Oct 19. pii: S1201-9712(21)00814.
    >> Share

  548. THIRION-ROMERO DI, Guerrero-Zuniga DS, Arias-Mendoza DA, Cornejo-Juarez DDP, et al
    EVALUATION OF PANBIO RAPID ANTIGEN TEST FOR SARS-CoV-2 IN SYMPTOMATIC PATIENTS AND THEIR CONTACTS: A MULTICENTER STUDY.
    Int J Infect Dis. 2021 Oct 19. pii: S1201-9712(21)00811.
    >> Share

  549. JEONG J, Choi HS
    Sudden sensorineural hearing loss after COVID-19 vaccination.
    Int J Infect Dis. 2021 Oct 17. pii: S1201-9712(21)00815.
    >> Share

  550. BRANDAO AAGS, de Oliveira CZ, Rojas SO, Ordinola AAM, et al
    Thromboembolic and bleeding events in ICU patients with COVID-19: results from a Brazilian tertiary hospital.
    Int J Infect Dis. 2021 Oct 17. pii: S1201-9712(21)00812.
    >> Share

  551. BOZZI G, Lombardi A, Ludovisi S, Muscatello A, et al
    TRANSIENT INCREASE OF PLASMA HIV RNA AFTER COVID-19 VACCINATION WITH mRNA-1272.
    Int J Infect Dis. 2021 Oct 16. pii: S1201-9712(21)00806.
    >> Share

  552. HASAN ZT, Atrakji DMQYMAA, Mehuaiden DAK
    The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients.
    Int J Infect Dis. 2021 Oct 12. pii: S1201-9712(21)00798.
    >> Share

  553. HERIYANTO RS, Kurniawan A, Wijovi F, Halim DA, et al
    The role of COVID-19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after sinovac vaccine administration on clinical year medical student in Indonesia.
    Int J Infect Dis. 2021 Oct 12. pii: S1201-9712(21)00797.
    >> Share

  554. MASAI AN, Akin PL
    Practice of COVID-19 preventive measures and risk of acute respiratory infections: a longitudinal study in students from 95 countries.
    Int J Infect Dis. 2021 Oct 12. pii: S1201-9712(21)00803.
    >> Share

  555. SPICER KB, Glick C, Cavanaugh AM, Thoroughman D, et al
    Protective Immunity after Natural Infection with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) - Kentucky, USA, 2020.
    Int J Infect Dis. 2021 Oct 11. pii: S1201-9712(21)00800.
    >> Share

  556. LUO G, Zhang X, Zheng H, He D, et al
    Infection fatality ratio and case fatality ratio of COVID-19.
    Int J Infect Dis. 2021 Oct 7. pii: S1201-9712(21)00793.
    >> Share

  557. GIOVACCHINI N, Coppi M, Aiezza N, Baccani I, et al
    Rapid screening for SARS-CoV-2 VOC Alpha (202012/01, B.1.1.7) using the Allplex SARS-CoV-2 / FluA / FluB / RSV Assay.
    Int J Infect Dis. 2021 Oct 7. pii: S1201-9712(21)00792.
    >> Share

  558. ANDRADE MC, Bonan PRF, Hilan E, Marques NP, et al
    COVID-19 Pandemic Causes Increased Clinic Visits with Diagnosis of Tegumentary Leishmaniasis in Brazil in 2020.
    Int J Infect Dis. 2021 Oct 7. pii: S1201-9712(21)00795.
    >> Share

  559. RAMIREZ-ROSAS A, Benitez-Guerrero T, Corona-Cervantes K, Velez-Ixta JM, et al
    Study of perinatal transmission of SARS-CoV-2 in a Mexican public hospital.
    Int J Infect Dis. 2021 Oct 7. pii: S1201-9712(21)00790.
    >> Share

  560. JUNG SM, Endo A, Akhmetzhanov AR, Nishiura H, et al
    Predicting the effective reproduction number of COVID-19: Inference using human mobility, temperature, and risk awareness.
    Int J Infect Dis. 2021 Oct 7. pii: S1201-9712(21)00794.
    >> Share

  561. PIERCE J, Stevens MP
    COVID-19 and Antimicrobial Stewardship: Lessons Learned, Best Practices and Future Implications.
    Int J Infect Dis. 2021 Oct 5. pii: S1201-9712(21)00789.
    >> Share

  562. HAMBRIDGE HL, Kahn R, Onnela JP
    Examining SARS-CoV-2 Interventions in Residential Colleges Using an Empirical Network.
    Int J Infect Dis. 2021 Oct 5. pii: S1201-9712(21)00796.
    >> Share

  563. CUCUNAWANGSIH C, Wijaya RS, Lugito NPH, Suriapranata I, et al
    Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia.
    Int J Infect Dis. 2021 Oct 3. pii: S1201-9712(21)00787.
    >> Share

  564. BERTIN D, Kaphan E, Weber S, Babacci B, et al
    Persistent IgG anti-cardiolipin autoantibodies are associated with post-covid syndrome.
    Int J Infect Dis. 2021 Oct 3. pii: S1201-9712(21)00788.
    >> Share

  565. ZIMMERMANN IR, Sanchez MN, Alves LC, Frio GS, et al
    COVID-19 as a leading cause of hospitalizations with death in the Brazilian Public Health System in 2020.
    Int J Infect Dis. 2021 Oct 1. pii: S1201-9712(21)00785.
    >> Share

    September 2021
  566. PAN L, Zhang Y, Cui Y, Wu X, et al
    Bilateral uveitis after inoculation with COVID-19 vaccine: A case report.
    Int J Infect Dis. 2021 Sep 30. pii: S1201-9712(21)00779.
    >> Share

  567. AL-ABRI SS, Al-Wahaibi A, Al-Kindi H, Kurup PJ, et al
    SARS-COV-2 antibody seroprevalence in the general population of Oman: results from four successive nationwide seroepidemiological surveys.
    Int J Infect Dis. 2021 Sep 30. pii: S1201-9712(21)00770.
    >> Share

  568. ROQUEBERT B, Haim-Boukobza S, Trombert-Paolantoni S, Lecorche E, et al
    SARS-CoV-2 variants of concern are associated with lower RT-PCR amplification cycles between January and March 2021 in France.
    Int J Infect Dis. 2021 Sep 30. pii: S1201-9712(21)00784.
    >> Share

  569. KRUSE M, Dark C, Aspden M, Cochrane D, et al
    Performance of the T-SPOT(R).COVID test for detecting SARS-CoV-2-responsive T cells.
    Int J Infect Dis. 2021 Sep 30. pii: S1201-9712(21)00778.
    >> Share

  570. HEYMING TW, Nugent D, Tongol A, Knudsen-Robbins C, et al
    Rapid antibody testing for SARS-CoV-2 vaccine response in pediatric healthcare workers.
    Int J Infect Dis. 2021 Sep 30. pii: S1201-9712(21)00772.
    >> Share

  571. TANAKA H, Lee H, Morita A, Namkoong H, et al
    Clinical Characteristics of Patients with Coronavirus Disease (COVID-19): Preliminary Baseline Report of Japan COVID-19 Task Force, a Nation-wide Consortium to Investigate Host Genetics of COVID-19.
    Int J Infect Dis. 2021 Sep 30. pii: S1201-9712(21)00775.
    >> Share

  572. MUSA S, Kissling E, Valenciano M, Dizdar F, et al
    Household transmission of SARS-CoV-2: a prospective observational study in Bosnia and Herzegovina, August - December 2020.
    Int J Infect Dis. 2021 Sep 29. pii: S1201-9712(21)00771.
    >> Share

  573. SHINOZUKA J, Hata M, Eguchi H, Mori M, et al
    COVID-19 vaccination: effective utilization of low dead space (LDS) syringes.
    Int J Infect Dis. 2021 Sep 29. pii: S1201-9712(21)00776.
    >> Share

  574. SBERNA G, Basile F, Guarino ML, Capobianchi MR, et al
    Comparison of Allplex SARS-CoV-2 Assay, Easy SARS-CoV-2 WE and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19.
    Int J Infect Dis. 2021 Sep 28. pii: S1201-9712(21)00781.
    >> Share

  575. NIGO M, Rasmy L, May SB, Rao A, et al
    Real World Long-term Assessment of The Efficacy of Tocilizumab in Patients with COVID19: Results From A Large De-identified Multicenter Electronic Health Record Dataset in the United States.
    Int J Infect Dis. 2021 Sep 28. pii: S1201-9712(21)00774.
    >> Share

  576. HAWLADER MDH, Rahman ML, Nazir A, Ara T, et al
    Belief, Attitude, and Intention to take COVID-19 Vaccine among South Asian Population: A Multi-country Study.
    Int J Infect Dis. 2021 Sep 28. pii: S1201-9712(21)00759.
    >> Share

  577. KARALI EA, Karadenizli A, Uzuner H, Karakaya N, et al
    Comparison of an inactivated Covid19 vaccine-induced antibody response with concurrent natural Covid19 infection.
    Int J Infect Dis. 2021 Sep 28. pii: S1201-9712(21)00768.
    >> Share

  578. SAIA RS, Giusti H, Silva FL, Pedroso KJB, et al
    Clinical investigation of intestinal fatty acid-binding protein (I-FABP) as a biomarker of SARS-CoV-2 infection.
    Int J Infect Dis. 2021 Sep 28. pii: S1201-9712(21)00761.
    >> Share

  579. SAVVA D, Battineni G, Amenta F, Nittari G, et al
    Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2 virus.
    Int J Infect Dis. 2021 Sep 28. pii: S1201-9712(21)00773.
    >> Share

  580. FREMONT-SMITH M, Gherlone N, Smith N, Tisdall P, et al
    Models for COVID-19 Early Cardiac Pathology Following SARS-CoV-2 Infection.
    Int J Infect Dis. 2021 Sep 27. pii: S1201-9712(21)00763.
    >> Share

  581. OYGAR PD, Buyukcam A, Bal ZS, Dalgic N, et al
    SARS-CoV-2 seropositivity among pediatric health care personnel just after the first peak of pandemic: A nationwide surveillance.
    Int J Infect Dis. 2021 Sep 27. pii: S1201-9712(21)00762.
    >> Share

  582. RAVINDRA K, Ahlawat A
    Five probable factors responsible for COVID-associated mucormycosis outbreak in India.
    Int J Infect Dis. 2021 Sep 27. pii: S1201-9712(21)00765.
    >> Share

  583. MARUKI T, Ishikane M, Suzuki T, Ujiie M, et al
    A case of varicella zoster virus meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient.
    Int J Infect Dis. 2021 Sep 26. pii: S1201-9712(21)00767.
    >> Share

  584. BAMOROVAT M, Sharifi I, Aflatoonian MR, Karamoozian A, et al
    Prophylactic effect of cutaneous leishmaniasis against COVID-19: A case-control field assessment.
    Int J Infect Dis. 2021 Sep 24. pii: S1201-9712(21)00757.
    >> Share

  585. WARSAME A, Bashiir F, Freemantle T, Williams C, et al
    Excess mortality during the COVID-19 pandemic: a geospatial and statistical analysis in Mogadishu, Somalia.
    Int J Infect Dis. 2021 Sep 24. pii: S1201-9712(21)00758.
    >> Share

  586. MORECCHIATO F, Coppi M, Baccani I, Maggini N, et al
    Evaluation of extraction-free RT-PCR methods for faster and cheaper detection of SARS-CoV-2 using two commercial systems.
    Int J Infect Dis. 2021 Sep 23. pii: S1201-9712(21)00754.
    >> Share

  587. BUCHY P, Buisson Y, Cintra O, Dwyer DE, et al
    COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control.
    Int J Infect Dis. 2021 Sep 23. pii: S1201-9712(21)00752.
    >> Share

  588. WEINSTOCK LB, Brook JB, Walters AS, Goris A, et al
    Mast cell activation symptoms are prevalent in Long-COVID.
    Int J Infect Dis. 2021 Sep 23. pii: S1201-9712(21)00751.
    >> Share

  589. BRUNETTI ND, Poliseno M, Bottalico IF, Centola A, et al
    Safety and heart rate changes in Covid-19 patients treated with Remdesivir.
    Int J Infect Dis. 2021 Sep 19. pii: S1201-9712(21)00741.
    >> Share

  590. FINSTERER J
    SARS-CoV-2 in cardiomyocytes.
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00737.
    >> Share

  591. EGWANG TG, Owalla TJ, Okurut E, Apungia G, et al
    Differential pre-pandemic breast milk IgA reactivity against SARS-CoV-2 and circulating human coronaviruses in Ugandan and American mothers.
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00747.
    >> Share

  592. KHALIFA BA, Abbey EJ, Ayeh SK, Yusuf HE, et al
    The Global Health Security Index is not predictive of vaccine rollout responses among OECD countries.
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00744.
    >> Share

  593. BONACCORSI G, Paoli S, Biamonte MA, Moscadelli A, et al
    COVID-19 and schools: what is the risk of contagion? The results of an antigen rapid test-based screening campaign in Florence (Italy).
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00734.
    >> Share

  594. CORREIA AM, Borges V, Isidro J, Lima AR, et al
    Potential recurrence of COVID-19 in a healthcare professional: SARS-CoV-2 genome sequencing confirms contagiousness after re-positivity.
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00739.
    >> Share

  595. MORENO A, Vargas C, Azocar F, Villarroel F, et al
    STEROIDS AND MORTALITY IN NON-CRITICALLY ILL COVID-19 PATIENTS: A PROPENSITY SCORE WEIGHTED STUDY IN A CHILEAN COHORT.
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00745.
    >> Share

  596. COLANERI M, De Filippo M, Licari A, Marseglia A, et al
    COVID vaccination and asthma exacerbation: might there be a link?
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00733.
    >> Share

  597. DESPHANDE GR, Kaduskar O, Deshpande K, Bhatt V, et al
    Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2.
    Int J Infect Dis. 2021 Sep 17. pii: S1201-9712(21)00732.
    >> Share

  598. LUTALO T, Nalumansi A, Olara D, Kayiwa J, et al
    Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute.
    Int J Infect Dis. 2021 Sep 15. pii: S1201-9712(21)00728.
    >> Share

  599. VACHARATHIT V, Srichatrapimuk S, Manopwisedjaroen S, Kirdlarp S, et al
    SARS-CoV-2 neutralizing antibodies decline after one year and patients with severe COVID-19 pneumonia display a unique cytokine profile.
    Int J Infect Dis. 2021 Sep 15. pii: S1201-9712(21)00729.
    >> Share

  600. BARANDALLA I, Alvarez C, Barreiro P, de Mendoza C, et al
    Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in Spain.
    Int J Infect Dis. 2021 Sep 15. pii: S1201-9712(21)00730.
    >> Share

  601. VON HUTH S, Lillevang ST, Roge BT, Madsen JS, et al
    SARS-CoV-2 seroprevalence among 7,950 health-care workers in the Region of Southern Denmark. (THEIJID-D-21-01420R1).
    Int J Infect Dis. 2021 Sep 14. pii: S1201-9712(21)00731.
    >> Share

  602. HASAN MR, Kalikiri MKR, Mirza F, Sundararaju S, et al
    Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar.
    Int J Infect Dis. 2021 Sep 12. pii: S1201-9712(21)00709.
    >> Share

  603. ZHAO Y, Yang C, An X, Xiong Y, et al
    Follow-up study on the COVID-19 survivors after one year discharged from hospital.
    Int J Infect Dis. 2021 Sep 11. pii: S1201-9712(21)00726.
    >> Share

  604. ELOY P, Tardivon C, Martin-Blondel G, Isnard M, et al
    Severity of self-reported symptoms and psychological burden 6-months after hospital admission for COVID-19: a prospective cohort study.
    Int J Infect Dis. 2021 Sep 10. pii: S1201-9712(21)00724.
    >> Share

  605. ZHOU D, Wang Q, Liu H
    Coronavirus disease-19 and the gut-lung axis.
    Int J Infect Dis. 2021 Sep 10. pii: S1201-9712(21)00722.
    >> Share

  606. LEINER J, Pellissier V, Nitsche A, Konig S, et al
    SARS-CoV-2 rapid antigen testing in the healthcare sector: A clinical prediction model for identifying false negative results.
    Int J Infect Dis. 2021 Sep 10. pii: S1201-9712(21)00717.
    >> Share

  607. HARA H, Uemura Y, Hayakawa K, Togano T, et al
    Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan.
    Int J Infect Dis. 2021 Sep 10. pii: S1201-9712(21)00725.
    >> Share

  608. LOBIE TA, Roba AA, Booth JA, Kristiansen KI, et al
    Antimicrobial resistance: A challenge awaiting the post COVID-19 era.
    Int J Infect Dis. 2021 Sep 8. pii: S1201-9712(21)00708.
    >> Share

  609. GOLDIN L, Elders T, Werhane L, Korwek K, et al
    Reactions and COVID-19 disease progression following SARS-CoV-2 monoclonal antibody infusion.
    Int J Infect Dis. 2021 Sep 8. pii: S1201-9712(21)00713.
    >> Share

  610. BYLICKI O, Delarbre D, Mayet A, Ferrier A, et al
    Neutralizing antibodies response to SARS-CoV-2 are persistent 9 months post symptom onset in mild or asymptomatic patients.
    Int J Infect Dis. 2021 Sep 8. pii: S1201-9712(21)00707.
    >> Share

  611. SATO K, Mano T, Niimi Y, Toda T, et al
    Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of self-reporting database.
    Int J Infect Dis. 2021 Sep 4. pii: S1201-9712(21)00704.
    >> Share

  612. LOUCA S
    SARS-CoV-2 infections in 165 countries over time.
    Int J Infect Dis. 2021 Sep 3. pii: S1201-9712(21)00701.
    >> Share

  613. VICENTI I, Basso M, Gatti F, Scaggiante R, et al
    Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose.
    Int J Infect Dis. 2021 Sep 2. pii: S1201-9712(21)00683.
    >> Share

  614. NGERE I, Dawa J, Hunsperger E, Otieno N, et al
    sssHigh seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya.
    Int J Infect Dis. 2021 Sep 2. pii: S1201-9712(21)00696.
    >> Share

    August 2021
  615. DE GUADIANA-ROMUALDO LG, Martinez MM, Mulero MDR, Torrella PE, et al
    Circulating MR-proADM levels, as indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients.
    Int J Infect Dis. 2021 Aug 27. pii: S1201-9712(21)00692.
    >> Share

  616. SALVAGNO GL, Henry BM, Lippi G
    The strength of association between pre- and post-booster BNT162b2 anti-SARS-CoV-2 antibodies levels depends on the immunoassay.
    Int J Infect Dis. 2021 Aug 26. pii: S1201-9712(21)00693.
    >> Share

  617. DIRKX KKT, Mulder B, Post AS, Rutten MH, et al
    The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained.
    Int J Infect Dis. 2021 Aug 26. pii: S1201-9712(21)00691.
    >> Share

  618. CHEN Y, Yao H, Fu J, Shu Q, et al
    The low contagiousness and new A958D mutation of SARS-CoV-2 in children: An observational cohort study.
    Int J Infect Dis. 2021 Aug 25. pii: S1201-9712(21)00672.
    >> Share

  619. POUR OB, Yahyavi Y, Karimi A, Khamaneh AM, et al
    Serum trace elements levels and clinical outcomes among Iranian COVID-19 patients.
    Int J Infect Dis. 2021 Aug 25. pii: S1201-9712(21)00686.
    >> Share

  620. BHANUPRASAD K, Manesh A, Devasagayam E, Varghese L, et al
    Risk Factors Associated with the Mucormycosis Epidemic During the COVID-19 Pandemic.
    Int J Infect Dis. 2021 Aug 24. pii: S1201-9712(21)00670.
    >> Share

  621. VAN DAM CS, Lede I, Schaar J, Al-Dulaimy M, et al
    Herpes Zoster after COVID-vaccination.
    Int J Infect Dis. 2021 Aug 21. pii: S1201-9712(21)00681.
    >> Share

  622. VAN HEERDEN J, Nel J, Moodley P, Govender P, et al
    Multisystem Inflammatory Syndrome (MIS): a multicentre retrospective review of adults and adolescents in South Africa.
    Int J Infect Dis. 2021 Aug 21. pii: S1201-9712(21)00673.
    >> Share

  623. YANG J, Han Y, Zhang R, Zhang R, et al
    Comparison of analytical sensitivity of SARS-CoV-2 molecular detection kits.
    Int J Infect Dis. 2021 Aug 21. pii: S1201-9712(21)00676.
    >> Share

  624. L SBB, Wanve S, Koradia P, Bhomia V, et al
    Efficacy and Safety of Pegylated Interferon-alpha2b in Moderate COVID-19: A phase 3, randomized, comparator-controlled, open-label study.
    Int J Infect Dis. 2021 Aug 21. pii: S1201-9712(21)00677.
    >> Share

  625. MOUALLEM RE, Moussally K, Williams A, Repetto E, et al
    How COVID-19 highlighted the need for infection prevention and control measures to become central to the global conversation: experience from the conflict settings of the Middle-East.
    Int J Infect Dis. 2021 Aug 19. pii: S1201-9712(21)00668.
    >> Share

  626. TIMELLI L, Liuzzi G, Cannavacciuolo A, Petrosillo N, et al
    Association of COVID-19 case-fatality rate with disease burden: an ecological analysis in Italy during the first wave.
    Int J Infect Dis. 2021 Aug 19. pii: S1201-9712(21)00665.
    >> Share

  627. GONG C, Song X, Li X, Lu L, et al
    Immunological Changes after COVID-19 Vaccination in an HIV-Positive Patient.
    Int J Infect Dis. 2021 Aug 19. pii: S1201-9712(21)00667.
    >> Share

  628. VELAVAN T, Pallerla S, Kremsner P
    How to ab(use) a COVID-19 antigen rapid test with soft drinks?
    Int J Infect Dis. 2021 Aug 18. pii: S1201-9712(21)00654.
    >> Share

  629. CUI LY, Cheng WW, Mou ZW, Xiao D, et al
    Risk factors for pulmonary embolism in patients with COVID-19: a systemic review and meta-analysis.
    Int J Infect Dis. 2021 Aug 18. pii: S1201-9712(21)00649.
    >> Share

  630. ELMOHEEN A, Abdelhafez I, Awad W, Bahgat M, et al
    External Validation and Recalibration of the CURB-65 and PSI for Predicting 30-Day Mortality and Critical Care Intervention in Multiethnic Patients with COVID-19.
    Int J Infect Dis. 2021 Aug 17. pii: S1201-9712(21)00660.
    >> Share

  631. PASQUINI Z, Barocci I, Brescini L, Candelaresi B, et al
    Bloodstream infections in the COVID-19 era: results from an Italian multicenter study.
    Int J Infect Dis. 2021 Aug 17. pii: S1201-9712(21)00623.
    >> Share

  632. DARBANDI A, Asadi A, Ghanavati R, Afifirad R, et al
    Corrigendum to 'The effect of probiotics on respiratory tract infection with special emphasis on COVID-19: Systemic review 2010-20' [International Journal of Infectious Diseases 105 (April 2021) 91-104].
    Int J Infect Dis. 2021;110:337.
    >> Share

  633. TADESSE EB, Endris AA, Solomon H, Alayu M, et al
    Seroprevalence and risk factors for SARS-CoV-2 Infection in selected urban areas in Ethiopia: a cross-sectional evaluation during July 2020.
    Int J Infect Dis. 2021 Aug 16. pii: S1201-9712(21)00661.
    >> Share

  634. IMAI K, Matsuoka M, Tabata S, Kitagawa Y, et al
    Cross-reactive humoral immune responses against seasonal human coronaviruses in COVID-19 patients with different disease severity.
    Int J Infect Dis. 2021 Aug 15. pii: S1201-9712(21)00659.
    >> Share

  635. WRIGHT J, Achana F, Diwakar L, Semple MG, et al
    Cycle threshold values are inversely associated with poorer outcomes in hospitalised patients with Covid-19: a prospective, observational cohort study conducted at a UK tertiary hospital.
    Int J Infect Dis. 2021 Aug 14. pii: S1201-9712(21)00657.
    >> Share

  636. SELINGER C, Choisy M, Alizon S
    Predicting COVID-19 incidence in French hospitals using human contact network analytics.
    Int J Infect Dis. 2021 Aug 14. pii: S1201-9712(21)00662.
    >> Share

  637. BIRKHEAD M, Glass AJ, Allan-Gould H, Goossens C, et al
    Ultrastructural evidence for vertical transmission of SARS-CoV2.
    Int J Infect Dis. 2021 Aug 14. pii: S1201-9712(21)00653.
    >> Share

  638. LIANG L, Guo Q, Zhang H, Lin S, et al
    Low infectious risk of re-positive COVID-19 patients: a single-center study.
    Int J Infect Dis. 2021 Aug 12. pii: S1201-9712(21)00652.
    >> Share

  639. KEITOKU K, Nishimura Y, Hagiya H, Koyama T, et al
    Impact of the World Antimicrobial Awareness Week on public interest between 2015 and 2020: A Google Trends analysis.
    Int J Infect Dis. 2021 Aug 12. pii: S1201-9712(21)00651.
    >> Share

  640. MARRA V, Quartin M
    A Bayesian estimate of the early COVID-19 infection fatality ratio in Brazil based on a random seroprevalence survey.
    Int J Infect Dis. 2021 Aug 11. pii: S1201-9712(21)00648.
    >> Share

  641. NONAKA CKV, Graf T, Barcia CAL, Costa VF, et al
    SARS-CoV-2 variant of concern P.1 (Gamma) infection in young and middle-aged patients admitted to the intensive care units of a single hospital in Salvador, northeast Brazil, February 2021.
    Int J Infect Dis. 2021 Aug 11. pii: S1201-9712(21)00635.
    >> Share

  642. SAEED BQ, Al-Shahrabi R, Alhaj SS, Alkokhardi ZM, et al
    Side Effects and Perceptions Following Sinopharm COVID-19 Vaccination.
    Int J Infect Dis. 2021 Aug 9. pii: S1201-9712(21)00646.
    >> Share

  643. NAKAMURA Y, Katano H, Nakajima N, Sato Y, et al
    SARS-CoV-2 is localized in cardiomyocytes: a post-mortem biopsy case.
    Int J Infect Dis. 2021 Aug 9. pii: S1201-9712(21)00647.
    >> Share

  644. JACOB L, Koyanagi A, Smith L, Haro JM, et al
    Prevalence of and factors associated with COVID-19 diagnosis in symptomatic patients followed in general practices in Germany between March 2020 and March 2021.
    Int J Infect Dis. 2021 Aug 8. pii: S1201-9712(21)00642.
    >> Share

  645. BUTT AA, Nafady-Hego H, Chemaitelly H, Abou-Samra AB, et al
    Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination: Breakthrough SARS-CoV-2 infection.
    Int J Infect Dis. 2021 Aug 7. pii: S1201-9712(21)00639.
    >> Share

  646. PIMENOFF VN, Bjornstedt M, Dillner J
    Severe features during outbreak but low mortality observed immediately before and after a March-May Covid-19 outbreak in Stockholm, Sweden.: Mortality before, during and after a COVID-19 outbreak.
    Int J Infect Dis. 2021 Aug 7. pii: S1201-9712(21)00637.
    >> Share

  647. DIAZ-AROCUTIPA C, Melgar-Talavera B, Alvarado-Yarasca A, Saravia-Bartra MM, et al
    Statins reduce mortality in patients with COVID-19: an updated meta-analysis of 147,824 patients.
    Int J Infect Dis. 2021 Aug 7. pii: S1201-9712(21)00636.
    >> Share

  648. THANGARAJU P, B AK, Venkatesan S
    Vigilance in selection of low-dose versus high-dose steroids in COVID-19.
    Int J Infect Dis. 2021;109:54-55.
    >> Share

    July 2021
  649. CLARO F, Silva D, Rodriguez M, Rangel R, et al
    IgG Antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals might need just one vaccine dose.
    Int J Infect Dis. 2021 Jul 31. pii: S1201-9712(21)00626.
    >> Share

  650. CHAU NVV, Nhan LNT, Nguyet LA, Tu NTK, et al
    Absence of SARS-CoV-2 antibodies in pre-pandemic plasma from children and adults in Vietnam.
    Int J Infect Dis. 2021 Jul 30. pii: S1201-9712(21)00629.
    >> Share

  651. PATINO LH, Ballesteros N, Munoz M, Castaneda S, et al
    SARS-CoV-2 in transit: characterization of SARS-CoV-2 genomes from Venezuelan migrants in Colombia.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00624.
    >> Share

  652. YARANAGULA SD, Koduri VKC
    DimachkieSpectrum of Acute Neuropathy Associated with Covid-19: Clinical and electrophysiological study of 13 patients from a single center.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00621.
    >> Share

  653. AMIR M, Yoseph H, Farisi ATA, Phie JKP, et al
    Symptomatic Bradycardia in Covid-19 Hospitalized Patients: a Case Series.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00625.
    >> Share

  654. CHEN YH, Fang CT, Huang YL
    Effect of Non-lockdown Social Distancing and Testing-Contact Tracing During a COVID-19 Outbreak in Daegu, South Korea, February to April 2020: A Modeling Study.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00614.
    >> Share

  655. VELASQUEZ SR, Jacques L, Dalal J, Sestito P, et al
    The toll of COVID-19 on African children: A descriptive analysis on the COVID-19-related morbidity and mortality among the pediatric population in Sub-Saharan Africa.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00616.
    >> Share

  656. PALOMBA E, Carrabba M, Zuglian G, Alagna L, et al
    Treatment of SARS-CoV-2 Relapse with Remdesivir and Neutralizing Antibodies Cocktail in a Patient with X-Linked Agammaglobulinemia.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00619.
    >> Share

  657. PERKMANN T, Perkmann-Nagele N, Mucher P, Radakovics A, et al
    Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00620.
    >> Share

  658. QUACH HL, Nguyen KC, Hoang NA, Pham TQ, et al
    Association of public health interventions and COVID-19 incidence in Vietnam, January to December 2020.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00600.
    >> Share

  659. ZANDI M, Behboudi E, Soltani S
    Can seasonal influenza vaccine for 2019/2020 has cross reactivity with some of SARS-CoV-2 proteins?
    Int J Infect Dis. 2021 Jul 26. pii: S1201-9712(21)00611.
    >> Share

  660. PAUL E, Brown GW, Dechamps M, Kalk A, et al
    Covid-19: An extra-terrestrial disease?
    Int J Infect Dis. 2021 Jul 26. pii: S1201-9712(21)00609.
    >> Share

  661. ILIC I, Stojanovic DU, Loncar G
    Influenza immunization and COVID-19 - can viral structure be responsible for the effect?
    Int J Infect Dis. 2021 Jul 26. pii: S1201-9712(21)00610.
    >> Share

  662. AHMED S, Khan WA
    A Five-day Course of Ivermectin may Reduce the Duration of COVID-19 Illness.
    Int J Infect Dis. 2021 Jul 26. pii: S1201-9712(21)00606.
    >> Share

  663. ALBAHRANI S, AlBarraK A, Alghamdi OA, Abdullah Alghamdi M, et al
    Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 vaccine in Vaccinee in Saudi Arabia.
    Int J Infect Dis. 2021 Jul 25. pii: S1201-9712(21)00608.
    >> Share

  664. BROTONS P, Perez-Arguello A, Launes C, Torrents F, et al
    Validation and implementation of a direct RT-qPCR method for rapid screening of SARS-CoV-2 infection by using non-invasive saliva samples.
    Int J Infect Dis. 2021 Jul 25. pii: S1201-9712(21)00607.
    >> Share

  665. MARCOLINO MS, Pires MC, Ramos LEF, Silva RT, et al
    ABC2-SPH risk score for in-hospital mortality in COVID-19 patients: development, external validation and comparison with other available scores.
    Int J Infect Dis. 2021 Jul 23. pii: S1201-9712(21)00605.
    >> Share

  666. GORDON PDMMV, McCarthy PDKA, Proctor PDJL, Hagedorn MBL, et al
    Evaluating COVID-19 reporting data in the context of testing strategies across 31 LMICs.
    Int J Infect Dis. 2021 Jul 22. pii: S1201-9712(21)00599.
    >> Share

  667. KUMAR NP, Padmapriyadarsini C, Rajamanickam A, Bhavani PK, et al
    BCG vaccination induces enhanced frequencies of dendritic cells and altered plasma levels of type I and type III interferons in elderly individuals.
    Int J Infect Dis. 2021 Jul 21. pii: S1201-9712(21)00598.
    >> Share

  668. SIRIPURAPU G, Samad SA, Fatima S, Wig N, et al
    SUCCESSFUL MANAGEMENT OF POST-COVID-19 ACANTHAMOEBIC ENCEPHALITIS.
    Int J Infect Dis. 2021 Jul 21. pii: S1201-9712(21)00602.
    >> Share

  669. GERTLER M, Krause E, van Loon W, Krug N, et al
    Self-collected oral, nasal and saliva samples yield sensitivity comparable to professional-collected oro-nasopharyngeal swabs in SARS-CoV-2 diagnosis among symptomatic outpatients.
    Int J Infect Dis. 2021 Jul 21. pii: S1201-9712(21)00601.
    >> Share

  670. LELI C, Matteo LD, Gotta F, Cornaglia E, et al
    Performance of a SARS CoV-2 antigen rapid immunoassay in patients admitted to the Emergency Department.
    Int J Infect Dis. 2021 Jul 21. pii: S1201-9712(21)00597.
    >> Share

  671. OKPALA OV, Dim CC, Ugwu CI, Onyemaechi S, et al
    Population seroprevalence of SARS-CoV-2 antibodies in Anambra state, South-East, Nigeria.
    Int J Infect Dis. 2021 Jul 19. pii: S1201-9712(21)00596.
    >> Share

  672. ALSHUKAIRI AN, El-Kafrawy SA, Dada A, Yasir M, et al
    Re-infection with different SARS-CoV-2 clade and prolonged viral shedding in a patient with hematopoietic stem cell transplantation: SARS-CoV-2 Re-infection with different clade.
    Int J Infect Dis. 2021 Jul 18. pii: S1201-9712(21)00592.
    >> Share

  673. RENISI G, Lombardi A, Massimo S, Alessandro I, et al
    ANTERIOR UVEITIS ONSET AFTER BNT162b2 VACCINATION: IS THIS JUST A COINCIDENCE?
    Int J Infect Dis. 2021 Jul 18. pii: S1201-9712(21)00591.
    >> Share

  674. LALWANI P, Salgado BB, Filho IVP, da Silva DSS, et al
    SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00576.
    >> Share

  675. ALKOFIDE H, Almohaizeie A, Almuhaini S, Alotaibi B, et al
    Tocilizumab and Systemic Corticosteroids in the Management of COVID-19 Patients:A Systematic Review and Meta-Analysis.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00578.
    >> Share

  676. HUSNAYAIN A, Chuang TW, Fuad A, Su EC, et al
    High variability in model performance of Google relative search volume in spatially clustered COVID-19 areas of the United States.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00587.
    >> Share

  677. YAMAGUCHI T, Shinagawa T, Kobata H, Nakagawa H, et al
    Immunity against seasonal human coronavirus OC43 mitigates fatal deterioration of COVID-19.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00571.
    >> Share

  678. MARKEWITZ R, Torge A, Wandinger KP, Pauli D, et al
    Analysis of SARS-CoV-2 RT-qPCR Ct values vis-a-vis anti-SARS-CoV-2 antibodies from a high incidence region.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00570.
    >> Share

  679. DARCIS G, Bouquegneau A, Maes N, Thys M, et al
    Long-term clinical follow up of patients suffering from moderate to severe COVID-19 infection: A monocentric prospective observational cohort study.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00572.
    >> Share

  680. TONIASSOA SCC, Fernandesa FS, Jovelevithsb D, Filhoc FFD, et al
    Reduction in COVID-19 prevalence in health care workers in a university hospital in southern Brazil after the start of vaccination.
    Int J Infect Dis. 2021 Jul 13. pii: S1201-9712(21)00582.
    >> Share

  681. CONNOR BA, Couto-Rodriguez M, Barrows JE, Gardner M, et al
    Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case.
    Int J Infect Dis. 2021 Jul 13. pii: S1201-9712(21)00586.
    >> Share

  682. IRWIN N, Murray L, Ozynski B, Richards GA, et al
    nnAge significantly influences the sensitivity of SARS-CoV-2 rapid antibody assays.
    Int J Infect Dis. 2021 Jul 13. pii: S1201-9712(21)00585.
    >> Share

  683. NUNEZ-ZAPATA SF, Benites-Peralta B, Mayta-Tristan P, Rodriguez-Morales AJ, et al
    High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for heard immunity!
    Int J Infect Dis. 2021 Jul 11. pii: S1201-9712(21)00579.
    >> Share

  684. KIM JH, Roh YH, Ahn JG, Kim MY, et al
    Respiratory syncytial virus and influenza epidemics disappearance in Korea during the 2020-2021 season of COVID-19.
    Int J Infect Dis. 2021 Jul 7. pii: S1201-9712(21)00560.
    >> Share

  685. MALIK M, Kunze AC, Bahmer T, Herget-Rosenthal S, et al
    SARS-CoV-2: Viral Loads of Exhaled Breath and Oronasopharyngeal Specimens in Hospitalized Patients with COVID-19.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00567.
    >> Share

  686. SOLDEVILA L, Valerio-Sallent L, Roure S, Perez-Quilez O, et al
    Drug exposure may have a substantial influence on COVID-19 prognosis among residents of long-term care facilities: an exploratory analysis.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00562.
    >> Share

  687. ALSHAMRANI MM, El-Saed A, Zunitan MA, Almulhem R, et al
    Risk of COVID-19 morbidity and mortality among healthcare workers working in a Large Tertiary Care Hospital.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00564.
    >> Share

  688. ELHARAKE JA, Galal B, Alqahtani SA, Kattan RF, et al
    COVID-19 Vaccine Acceptance among Health Care Workers in the Kingdom of Saudi Arabia.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00559.
    >> Share

  689. JEGERLEHNER S, Suter-Riniker F, Jent P, Bittel P, et al
    Diagnostic accuracy of a SARS-CoV-2 rapid antigen test in real-life clinical settings.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00565.
    >> Share

  690. ROVIDA F, Cassaniti I, Percivalle E, Sarasini A, et al
    Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-control study.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00558.
    >> Share

  691. MUCHELENG'ANGA LA, Telendiy V, Hamukale A, Shibemba AL, et al
    COVID-19 and Sudden Unexpected Community Deaths in Lusaka, Zambia, Africa - A Medico-Legal Whole-Body Autopsy Case Series.
    Int J Infect Dis. 2021;109:160-167.
    >> Share

  692. JACOB L, Koyanagi A, Smith L, Tanislav C, et al
    Prevalence of and factors associated with long-term COVID-19 sick leave in working-age patients followed in general practices in Germany.
    Int J Infect Dis. 2021 Jul 2. pii: S1201-9712(21)00552.
    >> Share

    June 2021
  693. FERGUSON J, Murugesan K, Banaei N, Liu A, et al
    Interferon-gamma release assay testing to assess COVID-19 vaccination response in a SARS-CoV-2 seronegative patient on rituximab: a case report.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00542.
    >> Share

  694. W T, A A, A T, V V, et al
    Evaluation of potassium peroxymonosulfate (MPS) efficacy against SARS-CoV-2 virus using RT-qPCR-based method.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00545.
    >> Share

  695. BALUSHI AA, AlShekaili J, Kindi MA, Ansari Z, et al
    Immunological predictors of disease severity in patients with COVID-19.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00546.
    >> Share

  696. HSU SH, Chang SH, Gross C, Wang SY, et al
    Relative risks of Covid-19 fatality between the first and second waves of the pandemic in Ontario, Canada.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00548.
    >> Share

  697. BUNDGAARD JS, Raaschou-Pedersen DT, Todsen T, Ringgaard A, et al
    Danish Citizen s Preferences for at-home Oropharyngeal/nasal SARS-CoV-2 Specimen Collection.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00550.
    >> Share

  698. LASTRUCCI V, Bonaccorsi G, Forni S, D'Arienzo S, et al
    The indirect impact of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia in the elderly: a region-wide population-based study in Tuscany, Italy.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00547.
    >> Share

  699. PANDIT A, Bhalani N, Bhushan BLS, Koradia P, et al
    Corrigendum to "Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study" [International Journal of Infectious Diseases, Volume 105, April 2021, Pages 516-521].
    Int J Infect Dis. 2021 Jun 27. pii: S1201-9712(21)00519.
    >> Share

  700. WIBOWO A, Pranata R, Lim MA, Akbar MR, et al
    Endotheliopathy Marked by High von Willebrand Factor (vWF) Antigen in COVID-19 is Associated with Poor Outcome: A Systematic Review and Meta-analysis.
    Int J Infect Dis. 2021 Jun 27. pii: S1201-9712(21)00540.
    >> Share

  701. KUMAR SHUKLA DA, Misra DS
    Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible.
    Int J Infect Dis. 2021 Jun 24. pii: S1201-9712(21)00535.
    >> Share

  702. SPEECKAERT MM, Delanghe JR
    The potential significance of vitamin D binding protein polymorphism in COVID-19.
    Int J Infect Dis. 2021 Jun 23. pii: S1201-9712(21)00532.
    >> Share

  703. YAMAMOTO K, Suzuki M, Yamada G, Sudo T, et al
    Corrigendum to "Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission" [Int J Infect Dis 104 (2021) 65-72].
    Int J Infect Dis. 2021 Jun 22. pii: S1201-9712(21)00498.
    >> Share

  704. BRUNO A, de Mora D, Freire-Paspuel B, Rodriguez AS, et al
    Analytical and clinical evaluation of a heat shock SARS-CoV-2 diagnosis method without RNA extraction for N and E genes RT-qPCR.
    Int J Infect Dis. 2021 Jun 21. pii: S1201-9712(21)00526.
    >> Share

  705. KAMALADASA A, Gunasekara B, Jeewandara C, Jayathilaka D, et al
    Comparison of two assays to detect IgG antibodies to the receptor binding domain of the SARSCoV2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients.
    Int J Infect Dis. 2021 Jun 20. pii: S1201-9712(21)00520.
    >> Share

  706. ALHINAI ZA, Elsidig N
    Countries with similar Covid-19 vaccination rates yet divergent outcomes: are all vaccines created equal?
    Int J Infect Dis. 2021 Jun 19. pii: S1201-9712(21)00527.
    >> Share

  707. FW H, Tc L, Dt A, R L, et al
    Is convalescent plasma futile in COVID-19? A Bayesian re-analysis of the RECOVERY randomised controlled trial.
    Int J Infect Dis. 2021 Jun 19. pii: S1201-9712(21)00523.
    >> Share

  708. TANISALI G, Sozak A, Bulut AS, Sander TZ, et al
    Effectiveness of different types of Masks in Aerosol Dispersion in SARS-CoV-2 Infection.
    Int J Infect Dis. 2021 Jun 17. pii: S1201-9712(21)00518.
    >> Share

  709. DUARTE CM, Jamil T, Gojobori T, Alam I, et al
    Detection of SARS-CoV-2 variants requires urgent global coordination.
    Int J Infect Dis. 2021 Jun 17. pii: S1201-9712(21)00516.
    >> Share

  710. HIMWAZE CM, Telendiy V, Maate F, Mupeta S, et al
    Post-mortem examination of Hospital Inpatient COVID-19 Deaths in Lusaka, Zambia - A Descriptive Whole-body Autopsy Series.
    Int J Infect Dis. 2021;108:363-369.
    >> Share

  711. SONG G, Qiao W, Wang X, Yu X, et al
    Association of lung ultrasound score with mortality and severity of COVID-19: A Meta-analysis and Trial Sequential Analysis.
    Int J Infect Dis. 2021 Jun 16. pii: S1201-9712(21)00513.
    >> Share

  712. AKHMETZHANOV AR, Jung SM, Cheng HY, Thompson RN, et al
    A hospital-related outbreak of SARS-CoV-2 associated with a novel variant Cal.20C (B.1.429) in Taiwan: transmission potential and outbreak containment under intensified contact tracing, January-February 2021.
    Int J Infect Dis. 2021 Jun 16. pii: S1201-9712(21)00517.
    >> Share

  713. HANS L, Steegen K, Ketseoglou I, Mahlumba Z, et al
    Preparing for the next pandemic: Lessons from rapid scale-up of SARS-CoV-2 testing in a South African high-throughput automated HIV molecular laboratory.
    Int J Infect Dis. 2021 Jun 14. pii: S1201-9712(21)00508.
    >> Share

  714. MONEDERO-RECUERO I, Gegia M, Wares DF, S Chadha S, et al
    Situational analysis of the 10 high drug resistant tuberculosis burden countries two years post-UNHLM declaration: progress and setbacks in a changing landscape.
    Int J Infect Dis. 2021 Jun 14. pii: S1201-9712(21)00511.
    >> Share

  715. BOOGAARD LH, Sikkema RS, van Beek J, Brockhoff HJ, et al
    A mixed methods approach to elucidate SARS-CoV-2 transmission routes and clustering in outbreaks in native workers and labour migrants in the fruit and vegetable packaging industry in South Holland, the Netherlands, May to July 2020.
    Int J Infect Dis. 2021 Jun 14. pii: S1201-9712(21)00510.
    >> Share

  716. KASPERSEN KA, Greve T, Nielsen KJ, Jespersen S, et al
    Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020.
    Int J Infect Dis. 2021 Jun 11. pii: S1201-9712(21)00506.
    >> Share

  717. GUZMAN NA, De la Hoz Restrepo F, Serrano-Coll H, Gastelbondo B, et al
    Using serological studies to assess COVID-19 infection fatality rate in developing countries. A case study from one Colombian department.
    Int J Infect Dis. 2021 Jun 11. pii: S1201-9712(21)00507.
    >> Share

  718. VALLEJO-JANETA AP, Morales-Jadan D, Freire-Paspuel B, Lozada T, et al
    COVID-19 outbreaks at shelters for women victims of gender-based violence from Ecuador.
    Int J Infect Dis. 2021 Jun 10. pii: S1201-9712(21)00501.
    >> Share

  719. MEDINA N, Alastruey-Izquierdo A, Bonilla O, Ortiz B, et al
    Impact of the COVID-19 pandemic on HIV care in Guatemala.
    Int J Infect Dis. 2021 Jun 10. pii: S1201-9712(21)00500.
    >> Share

  720. PORTO MH, Castro B, Diaz Z, Pedroso Y, et al
    SARS-CoV-2 infection in properly vaccinated healthcare workers.
    Int J Infect Dis. 2021 Jun 9. pii: S1201-9712(21)00499.
    >> Share

  721. DIAZ Y, Ortiz A, Weeden A, Castillo D, et al
    SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama.
    Int J Infect Dis. 2021 Jun 6. pii: S1201-9712(21)00493.
    >> Share

  722. CHEN S, Zheng T, Wang S, Yu Y, et al
    Association between risk of VTE and mortality in patients with COVID-19.
    Int J Infect Dis. 2021 Jun 6. pii: S1201-9712(21)00494.
    >> Share

  723. YEN MY, Yen YF, Chen SY, Lee TI, et al
    Learning from the past: Taiwan's responses to COVID-19 versus SARS.
    Int J Infect Dis. 2021 Jun 4. pii: S1201-9712(21)00490.
    >> Share

  724. LI X, Yin Y, Pang L, Xu S, et al
    Colloidal gold immunochromatographic assay (GICA) is an effective screening method for identifying detectable anti-SARS-CoV-2 neutralizing antibodies.
    Int J Infect Dis. 2021 Jun 3. pii: S1201-9712(21)00484.
    >> Share

  725. MAYANSKIY N, Brzhozovskaya E, Fedorova N, Lebedin Y, et al
    Parallel detection of SARS-CoV-2 RNA and nucleocapsid antigen in nasopharyngeal specimens from a COVID-19 patient screening cohort.
    Int J Infect Dis. 2021 Jun 3. pii: S1201-9712(21)00486.
    >> Share

  726. KINOSHITA M, Sato K, Vellingiri B, Green SJ, et al
    Inverse association between hypertension treatment and COVID-19 prevalence in Japan.
    Int J Infect Dis. 2021 Jun 2. pii: S1201-9712(21)00474.
    >> Share

  727. TOCZYLOWSKI K, Jackowska K, Lewandowski D, Kurylonek S, et al
    Rotavirus gastroenteritis in children hospitalized in northeastern Poland in 2006-2020: severity, seasonal trends, and impact of immunization.
    Int J Infect Dis. 2021 Jun 2. pii: S1201-9712(21)00473.
    >> Share

  728. MOLINA GA, Ayala AV, Endara SA, Aguayo WG, et al
    Ecuador and Covid-19, A Pandemic we won't be able to run away from.
    Int J Infect Dis. 2021 Jun 2. pii: S1201-9712(21)00480.
    >> Share

  729. GREUEL S, Ihlow J, Dragomir MP, Streit S, et al
    COVID-19: Autopsy findings in six patients between 26 and 46 years of age.
    Int J Infect Dis. 2021 Jun 2. pii: S1201-9712(21)00472.
    >> Share

  730. PETERSEN E, Schlagenhauf P, Lee SS, Blumberg L, et al
    Mandatory immunization against SARS-CoV-2 of athletes, companions and supporters for the Tokyo Olympics.
    Int J Infect Dis. 2021;108:156-158.
    >> Share

  731. RAGHAV K, Anand S, Gothwal A, Singh P, et al
    Underreporting of race/ethnicity in COVID-19 research.
    Int J Infect Dis. 2021 Jun 1. pii: S1201-9712(21)00479.
    >> Share

  732. CAMELENA F, Poncin T, Dudoignon E, Salmona M, et al
    rcent agreement; NPA: negative percent agreeRapid identification of bacteria from respiratory samples of patients hospitalized in intensive care units, with FilmArray Pneumonia Panel Plus.
    Int J Infect Dis. 2021 Jun 1. pii: S1201-9712(21)00477.
    >> Share

  733. LEIXNER G, Voill-Glaninger A, Bonner E, Kreil A, et al
    Evaluation of the AMP SARS-CoV-2 Rapid Antigen Test in a Hospital Setting.
    Int J Infect Dis. 2021 Jun 1. pii: S1201-9712(21)00466.
    >> Share

  734. NG DC, Tan KK, Ling C, Ali MM, et al
    Clinical and epidemiological characteristics of children with COVID-19 in Negeri Sembilan, Malaysia.
    Int J Infect Dis. 2021 Jun 1. pii: S1201-9712(21)00476.
    >> Share

  735. KAMSTRUP P, Sivapalan P, Eklof J, Hoyer N, et al
    Hydroxychloroquine as a primary prophylactic agent against sars-cov-2 infection: a cohort study.
    Int J Infect Dis. 2021 Jun 1. pii: S1201-9712(21)00478.
    >> Share

    May 2021
  736. HIROTSU Y, Sugiura H, Maejima M, Hayakawa M, et al
    Comparison of Roche and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19.
    Int J Infect Dis. 2021 May 31. pii: S1201-9712(21)00470.
    >> Share

  737. LIM AY, Cheong HK, Oh YJ, Lee JK, et al
    Modeling the early temporal dynamics of viral load in respiratory tract specimens of COVID-19 patients in Incheon, the Republic of Korea.
    Int J Infect Dis. 2021 May 28. pii: S1201-9712(21)00465.
    >> Share

  738. YOUSEFINAGHANI S, Dara R, Mubareka S, Papadopoulos A, et al
    An Analysis of COVID-19 Vaccine Sentiments and Opinions on Twitter.
    Int J Infect Dis. 2021 May 27. pii: S1201-9712(21)00462.
    >> Share

  739. PAGNESI M, Inciardi RM, Lombardi CM, Agostoni P, et al
    Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study.
    Int J Infect Dis. 2021 May 27. pii: S1201-9712(21)00458.
    >> Share

  740. UMEMURA Y, Mitsuyama Y, Minami K, Nishida T, et al
    Efficacy and safety of nintedanib for pulmonary fibrosis in severe pneumonia induced by Coronavirus disease 2019: An interventional study.
    Int J Infect Dis. 2021 May 25. pii: S1201-9712(21)00456.
    >> Share

  741. ARMINANZAS C, Arnaiz de Las Revillas F, Gutierrez Cuadra M, Arnaiz A, et al
    USEFULNESS OF THE COVID-GRAM AND CURB-65 SCORES FOR PREDICTING SEVERITY IN PATIENTS WITH COVID-19.
    Int J Infect Dis. 2021 May 24. pii: S1201-9712(21)00450.
    >> Share

  742. RUBIO CP, Franco-Martinez L, Resalt CS, Torres-Cantero A, et al
    Evaluation of different sample treatments options in a simple and safe procedure for the detection of SARS-COV-2 in saliva.
    Int J Infect Dis. 2021 May 24. pii: S1201-9712(21)00455.
    >> Share

  743. LEE H, Noh E, Jeon H, Nam EW, et al
    Association between the traffic level from other areas and the COVID-19 prevalence at the provincial levels in South Korea.
    Int J Infect Dis. 2021 May 24. pii: S1201-9712(21)00457.
    >> Share

  744. AHMAD F, Ahmed A, Rajendraprasad SS, Loranger A, et al
    Multisystem Inflammatory Syndrome in Adults: A Rare Sequela of SARS-CoV-2 Infection.
    Int J Infect Dis. 2021 May 24. pii: S1201-9712(21)00452.
    >> Share

  745. LUKITO AA, Widysanto A, Lemuel TAY, Prasetya IB, et al
    Candesartan as a tentative treatment for COVID-19: a prospective non-randomized open-label study.
    Int J Infect Dis. 2021 May 23. pii: S1201-9712(21)00420.
    >> Share

  746. NAGANO H, Takada D, Shin JH, Morishita T, et al
    Corrigendum to 'Hospitalization of mild cases of community-acquired pneumonia decreased more than severe cases during the COVID-19 pandemic.' [Int J Infect Dise. Vol 106 (2021) P323-328].
    Int J Infect Dis. 2021;107:254.
    >> Share

  747. BABU GR, Sundaresan R, Athreya S, Akhtar J, et al
    The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide sentinel-based population survey in Karnataka, India.
    Int J Infect Dis. 2021 May 21. pii: S1201-9712(21)00445.
    >> Share

  748. CAMICI M, Zuppi P, Lorenzini P, Scarnecchia L, et al
    The role of testosterone in SARS-CoV-2 infection: a key pathogenic factor and a biomarker for severe pneumonia.
    Int J Infect Dis. 2021 May 20. pii: S1201-9712(21)00444.
    >> Share

  749. MURHEKAR MV, Bhatnagar T, Thangaraj JWV, Saravanakumar V, et al
    SARS-CoV-2 sero-prevalence among general population and healthcare workers in India, December 2020 - January 2021.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00442.
    >> Share

  750. NIELSEN KJ, Vestergaard JM, Schlunssen V, Bonde JP, et al
    Day by day symptoms following positive and negative PCR tests for SARS-CoV-2 in non-hospitalised health-care workers: a 90-day follow-up study.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00434.
    >> Share

  751. KIM J, Gomez REG, Hong K, Yum S, et al
    The changing influenza activity in the Southern hemisphere countries during the COVID-19 pandemic.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00441.
    >> Share

  752. RAY JG, Colacci M, Schull MJ, Vermeulen MJ, et al
    Non-ABO red cell antibodies and risk of COVID-19.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00440.
    >> Share

  753. FAY FF, Alvarez-Moreno CA, Bonvehi PE, Espinoza CC, et al
    A simplified alternative diagnostic algorithm for SARS-CoV-2 suspected symptomatic patients and confirmed close contacts (asymptomatic): A consensus of Latin American experts.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00412.
    >> Share

  754. HAMMER CC, Boender TS, Thomas DR
    Social media for field epidemiologists (#SoMe4epis): How to use Twitter during the #COVID19 pandemic.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00437.
    >> Share

  755. SASIKALA M, Shashidhar J, Deepika G, Ravikanth V, et al
    Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00436.
    >> Share

  756. VICENTI I, Gatti F, Scaggiante R, Boccuto A, et al
    Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00435.
    >> Share

  757. HAYER J, Kasapic D, Zemmrich C
    Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: A systematic meta-analysis of available data as per November 20, 2020.
    Int J Infect Dis. 2021 May 17. pii: S1201-9712(21)00431.
    >> Share

  758. ALSHUKAIRI AN, Tolah AM, Dada A, Al-Tawfiq JA, et al
    Test-based De-isolation in COVID-19 Immunocompromised patients: Ct value versus SARS-CoV-2 viral cultures.
    Int J Infect Dis. 2021 May 15. pii: S1201-9712(21)00429.
    >> Share

  759. FATTEH N, Sutherland GE, Santos RG, Zeidan R, et al
    Association of Hypothermia with Increased Mortality Rate in SARS-CoV-2 Infection.
    Int J Infect Dis. 2021 May 15. pii: S1201-9712(21)00433.
    >> Share

  760. MUMOLI N, Evangelista I, Colombo A, Conte G, et al
    Transient perivascular inflammation of the carotid artery (TIPIC) syndrome in a patient with COVID-19.
    Int J Infect Dis. 2021 May 14. pii: S1201-9712(21)00418.
    >> Share

  761. JASPARD M, Sow MS, Juchet S, Diendere E, et al
    Clinical presentation, outcomes and factors associated with mortality: a prospective study from three COVID-19 referral care centers in West Africa.
    Int J Infect Dis. 2021 May 14. pii: S1201-9712(21)00425.
    >> Share

  762. MARTHA JW, Pranata R, Lim MA, Wibowo A, et al
    Active Prescription of Low-dose Aspirin During or Prior to Hospitalization and Mortality in COVID-19 - A Systematic Review and Meta-analysis of Adjusted Effect Estimates.
    Int J Infect Dis. 2021 May 14. pii: S1201-9712(21)00417.
    >> Share

  763. ZAQOUT A, Daghfal J, Alaqad I, Hussein SAN, et al
    The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout.
    Int J Infect Dis. 2021 May 13. pii: S1201-9712(21)00422.
    >> Share

  764. CUCUNAWANGSIH C, Wijaya RS, Lugito NPH, Suriapranata I, et al
    Post-vaccination COVID-19 cases among healthcare workers at Siloam Teaching Hospital, Indonesia.
    Int J Infect Dis. 2021 May 13. pii: S1201-9712(21)00421.
    >> Share

  765. SMAGHI BS, Collins J, Dagina R, Hiawalyer G, et al
    Barriers and enablers experienced by health care workers in swabbing for COVID-19 in Papua New Guinea: a multi-methods cross-sectional study, November - December 2020.
    Int J Infect Dis. 2021 May 12. pii: S1201-9712(21)00390.
    >> Share

  766. DE SIQUEIRA IC, Camelier AA, Maciel EAP, Nonaka CKV, et al
    Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil.
    Int J Infect Dis. 2021 May 11. pii: S1201-9712(21)00411.
    >> Share

  767. WANNIGAMA DL, Amarasiri M, Hurst C, Phattharapornjaroen P, et al
    Tracking COVID-19 with wastewater to understand asymptomatic transmission.
    Int J Infect Dis. 2021 May 11. pii: S1201-9712(21)00406.
    >> Share

  768. WU J, Chen X, Gong L, Huo S, et al
    Epidemiological and clinical features of SARS-CoV-2 cluster infection in Anhui Province, Eastern China.
    Int J Infect Dis. 2021 May 10. pii: S1201-9712(21)00376.
    >> Share

  769. ZHANG X, Jiang M, Yang J
    Potential value of circulating endothelial cells for the diagnosis and treatment of COVID-19.
    Int J Infect Dis. 2021 May 6. pii: S1201-9712(21)00402.
    >> Share

  770. SUZUKI T, Kutsuna S, Saito S, Kawashima A, et al
    Clinical course of alopecia after severe acute respiratory syndrome coronavirus 2 infection.
    Int J Infect Dis. 2021 May 4. pii: S1201-9712(21)00400.
    >> Share

  771. BEZERRA ALVES JG, Natal Figueiroa J, Urquia ML
    Impact of COVID-19 on immunization of Brazilian infants.
    Int J Infect Dis. 2021 May 4. pii: S1201-9712(21)00401.
    >> Share

  772. PENA M, Ampuero M, Garces C, Gaggero A, et al
    Performance of SARS-CoV-2 rapid antigen test compared with real-time RT-PCR in asymptomatic individuals.
    Int J Infect Dis. 2021 May 1. pii: S1201-9712(21)00399.
    >> Share

  773. CAVALCANTE PINTO V JUNIOR, Moura LFWG, Cavalcante RC, Rubens Costa Lima J, et al
    Prevalence of COVID-19 in children, adolescents, and adults in remote education situation in the city of Fortaleza - Brazil.
    Int J Infect Dis. 2021 May 1. pii: S1201-9712(21)00398.
    >> Share

  774. HAUSDORFF WP, Flores J
    Hausdorff and Flores Author Reply to Letter to the Editor by Prof G. Bauer (THEIJID-D-21-00652).
    Int J Infect Dis. 2021;106:78.
    >> Share

  775. BONILLA-ALDANA DK, Jimenez-Diaz SD, Arango-Duque JS, Aguirre-Florez M, et al
    Reply to "Misconceptions and misinformation about bats and viruses".
    Int J Infect Dis. 2021;106:197-198.
    >> Share

    April 2021
  776. NASIRI M, Khodadadi J, Molaei S
    Does vitamin D serum level affect prognosis of COVID-19 patients?
    Int J Infect Dis. 2021 Apr 30. pii: S1201-9712(21)00395.
    >> Share

  777. PETERSEN E, Buchy P
    Vaccination against SARS-CoV-2 should be included in childhood vaccination programs.
    Int J Infect Dis. 2021 Apr 29. pii: S1201-9712(21)00394.
    >> Share

  778. CASTRO ABREU PINTO T, Silva Costa N, Andrade Oliveira LM
    The World Meningitis Day and the WHO roadmap to defeat bacterial meningitis in the COVID-19 pandemic era.
    Int J Infect Dis. 2021 Apr 28. pii: S1201-9712(21)00382.
    >> Share

  779. GERHARDS C, Thiaucourt M, Kittel M, Becker C, et al
    Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescent from COVID-19 infection.
    Int J Infect Dis. 2021 Apr 28. pii: S1201-9712(21)00392.
    >> Share

  780. LUO C, Liu M, Li Q, Zheng X, et al
    Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: multiple factors-based analysis.
    Int J Infect Dis. 2021 Apr 28. pii: S1201-9712(21)00389.
    >> Share

  781. SONG Y, Chen C, Wang Y, Zhang J, et al
    Early and consecutive RT-PCR tests with both oropharyngeal swabs and sputum could improve testing yield for patients with COVID-19: An Observation Cohort Study in China.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00388.
    >> Share

  782. SORIANO V, de Mendoza C, Gomez-Gallego F, Corral O, et al
    Third wave of COVID-19 in Madrid, Spain.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00386.
    >> Share

  783. AZNAR ML, Espinosa-Pereiro J, Saborit N, Jove N, et al
    Impact of the COVID-19 pandemic on tuberculosis management in Spain.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00387.
    >> Share

  784. SEVILLANO G, Ortega-Paredes D, Loaiza K, Zurita-Salinas C, et al
    Evidence of SARS-CoV-2 reinfection within the same clade in Ecuador: A case study.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00385.
    >> Share

  785. AL-MAANI A, Al Wahaibi A, Al-Sooti J, Al Abri B, et al
    The role of supporting services in driving SARS-CoV-2 transmission within healthcare settings: a multicenter seroprevalence study.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00383.
    >> Share

  786. BRUZZONE B, De Pace V, Caligiuri P, Ricucci V, et al
    Comparative diagnostic performance of different rapid antigen detection tests for COVID-19 in the real-world hospital setting.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00384.
    >> Share

  787. LAGI F, Trevisan S, Piccica M, Graziani L, et al
    Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00377.
    >> Share

  788. LACAP EM JR, Varghese A, Khamis F, Bahrani MA, et al
    Development and Validation of CoV19-OM Intensive Care Unit Score: An Early ICU Identification for Laboratory-Confirmed SARS-CoV-2 Patients from a Retrospective Cohort Study in Oman.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00381.
    >> Share

  789. D'ABRAMO A, Vita S, Maffongelli G, Mariano A, et al
    Prolonged and severe SARS-CoV-2 infection in patients under B-cell-depleting drug successfully treated: a tailored approach.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00380.
    >> Share

  790. RADULESCU A, Istrate A, Flonta M, Lupse M, et al
    Antibody and viral RNA kinetics in SARS-CoV2 infected patients admitted in a Romanian University Hospital of Infectious Diseases.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00379.
    >> Share

  791. CRUZ C, White NJ
    COVID-19 chemoprevention.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00356.
    >> Share

  792. LEBOURGEOIS S, Storto A, Gout B, Le Hingrat Q, et al
    Performance Evaluation of the QIAstat-Dx(R) Respiratory SARS-CoV-2 Panel.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00378.
    >> Share

  793. LEDNICKY JA, Lauzardo M, Alam MM, Elbadry MA, et al
    Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00375.
    >> Share

  794. NEKLUDOVA GV, Avdeev SN, Tsareva NA, Trushenko NV, et al
    Using TAPSE as a predictor of poor prognosis of COVID-19: is it enough?
    Int J Infect Dis. 2021 Apr 22. pii: S1201-9712(21)00368.
    >> Share

  795. AL-SAKKAF E, Ghaleb Y, Al-Dabis E, Qairan M, et al
    First COVID-19 Cases with High Secondary Infection among Health Workers, Sana'a Capital, April 2020: Lessons Learned and Future Opportunities.
    Int J Infect Dis. 2021 Apr 22. pii: S1201-9712(21)00333.
    >> Share

  796. ARNAUD DE, Apoline SK, Risgou OA, Lucien DD, et al
    Predictors of severe hypoxemia among COVID-19 patients in Burkina Faso (West Africa): findings from hospital based cross-sectional study.
    Int J Infect Dis. 2021 Apr 21. pii: S1201-9712(21)00318.
    >> Share

  797. OSMAN W, Al Fahdi F, Khamis F, Salmi IA, et al
    Serum Calcium and Vitamin D levels correlation with severity of COVID-19 in hospitalized patients in Royal Hospital, Oman.
    Int J Infect Dis. 2021 Apr 20. pii: S1201-9712(21)00361.
    >> Share

  798. SUGHAYER MA, Mansour A, Al Nuirat A, Souan L, et al
    Dramatic Rise of Seroprevalence Rates of SARS-CoV-2 Antibodies among Healthy Blood Donors: The evolution of a Pandemic.
    Int J Infect Dis. 2021 Apr 20. pii: S1201-9712(21)00371.
    >> Share

  799. BIRLUTIU V, Feiereisz AI, Oprinca G, Dobritoiu S, et al
    Cutaneous manifestations associated with anosmia, ageusia and enteritis in SARS-CoV-2 infection - a possible pattern? Observational study and review of the literature.
    Int J Infect Dis. 2021 Apr 19. pii: S1201-9712(21)00370.
    >> Share

  800. SIAMI Z, Aghajanian S, Mansouri S, Mokhames Z, et al
    Effect of Ammonium Chloride in addition to standard of care in outpatients and hospitalized COVID-19 patients: a randomized clinical trial.
    Int J Infect Dis. 2021 Apr 17. pii: S1201-9712(21)00354.
    >> Share

  801. CAPUTO V, Bax C, Colantoni L, Peconi C, et al
    Comparative analysis of antigen and molecular tests for the detection of Sars-CoV-2 and related variants: a study on 4266 samples.
    Int J Infect Dis. 2021 Apr 17. pii: S1201-9712(21)00359.
    >> Share

  802. HANSEN T, Titze U, Kulamadayil-Heidenreich NSA, Glombitza S, et al
    First case of postmortem study in a patient vaccinated against SARS CoV2.
    Int J Infect Dis. 2021 Apr 16. pii: S1201-9712(21)00364.
    >> Share

  803. KADALI RAK, Janagama R, Peruru S, Malayala SV, et al
    Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers.
    Int J Infect Dis. 2021 Apr 15. pii: S1201-9712(21)00358.
    >> Share

  804. AIELLO A, Fard SN, Petruccioli E, Petrone L, et al
    Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients.
    Int J Infect Dis. 2021 Apr 14. pii: S1201-9712(21)00344.
    >> Share

  805. SEET RCS, Quek AML, Ooi DSQ, Sengupta S, et al
    Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: an open-label randomized trial.
    Int J Infect Dis. 2021 Apr 14. pii: S1201-9712(21)00345.
    >> Share